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Summary 
In the developing world, there is a lack of convenient and accurate tools to diagnose pathogens. As a 
consequence, numerous diseases remain untreated or receive inappropriate treatment. The World Health 
Organization recommends that an ideal point-of-care assay has to be ASSURED: it must be affordable, 
sensitive, specific, user-friendly, rapid and robust, equipment-free, and delivered to those who need it. In line 
with the strategy of simplicity, lateral flow immunoassays (LFIAs) based on nanoparticle (NP) labels are very 
promising nanodiagnostic tools, fulfilling most of the specified requirements. LFIAs have already been 
successfully applied to the detection of various acute and chronic diseases. However, they show limitations in 
terms of sensitivity, a shortcoming that can prevent early stage disease detection. Dengue fever (DF) is a 
tropical viral mosquito-transmitted disease that affects 50-100 million people every year. About 400 000 
people develop hemorrhagic fever and 5% of them die annually. In this case, the death rate may be reduced 
from 5 to less than 1% when early detection is provided. Commercially available LFIAs for DF based on non-
structural protein 1 (NS1) detection show low sensitivity for the first days of the infection. This low sensitivity 
is due to the inefficiency of the detection label consisted of gold nanoparticles.  
This thesis aims to enhance the performance of paper based immunoassays by selecting and comparing the 
performance of already used labels for LFIA and developing nanostructures to replace the conventional gold 
nanoparticles. A screening of possible labels using the biotin-streptavidin system was performed among the 
four most used detection labels: gold and silver coated gold NPs, polystyrene beads and carbon black. The 
results from an immunospot assay showed that carbon black provides the lowest detection limit (DL) of all 
labels. Therefore, it was used as detection system for DF in LFIA, achieving a DL 50 times lower (10ng/L) 
than the commercially used standard gold NPs (500 ng/L). Due to the high sensitivity of tools based on 
fluorescence, fluorescent NPs were used to produce immunospot assays (ISA) combining the principles of 
LFIA, fluorophore linked immunosorbent assay and enzyme linked immunospotting. This assay is an 
alternative for the time-consuming enzyme linked immunosorbent assay (ELISA). The procedure needs 10 
times less serum sample (4 µL) and requires 2-4h less than ELISA (45-60 min). The DL for NS1 protein, 5.2 
ng/mL, is comparable to ELISA. The evaluation of 83 serum samples compared to a commercial ELISA 
showed sensitivity of 81% and specificity of 88%. The method allowed faster, cheaper and convinient 
detection using common laboratory equipment. Another problem affecting the paper based assay performance 
is the particle agglomeration. To overcome this problem, poly[styrene-co-(2-hydroxyethyl methacrylate)] 
core-shell particles containing [Ru(4,4’-dicarboxilate-2,2’-bpy)3] luminescent complexes were synthesized 
and used as alternative labels for ISA. These particles showed promising uses in diagnostics, besides cell 
tracking and imaging, due to their low aggregation, monodispersity, biocompatibility and easy 
functionalization. The best performance for LFIA and ISA was obtained by combining colorimetry and 
fluorescence detection using clusters of gold and fluorescent NPs. The cluster concentrates gold NPs reducing 
the NS1 DL (10 ng/mL) by 50 times in comparison to gold labels. The use of fluorescent portable lamps 
additionally decreases the NS1 DL (2.5 ng/mL), resulting in a 200 times overall DL reduction. The sensitivity 
improvements observed by using carbon black and NP cluster anticipate the Dengue fever diagnosis to the 
first day of the infection in comparison to the third day detected by commercial kits. Faster, cheaper and 
reliable methods were also possible by using fluorescence detection. The scientific progress described in this 
work is an important step forward towards to produce more reliable and sensitive diagnostic tools for 
developing countries, maintaining the necessary assay simplicity. The improvements are not only relevant for 
DF detection, but apply to every analytes that make use of LFIA to provide point-of-care assistance. 
  
Zusammenfassung 
Abseits der großen Industriestaaten existiert auch heute ein Mangel an einfachen und genauen Verfahren zur 
Diagnose von Pathogenen. Aus diesem Grund wird eine Vielzahl verschiedener Erkrankungen nicht oder nur 
unzureichend behandelt. Ideale “Point-Of-Care Assays” (POC) entsprechen laut Empfehlung der 
Weltgesundheitsorganisation  dem Merkwort ASSURED: “affordable, sensitive, specific, user-friendly, rapid 
and robust, equipment-free, and delivered to those who need it”. Um diese Analysetools einfach zu halten, 
sind “Lateral Flow Immunoassays (LFIAs)“, welche auf Nanopartikeln (NP) basieren, sehr vielversprechend, 
da sie die meisten der genannten Anforderungen erfüllen.  LFIAs wurden bereits erfolgreich zur Detektion 
verschiedener akuter und chronischer Krankheiten eingesetzt. Trotzdem weisen sie durch ihre eingeschränkte 
Empfindlichkeit einen Nachteil auf, der sich im Besonderen auf die Erkennung von Erkrankungen im 
Frühstadium auswirkt. Denguefieber (DF) ist eine von Moskitos übertragene Viruserkrankung, welche 
jährlich 50-100 Millionen Menschen befällt. Etwa 400.000 von ihnen entwickeln hämorrhagisches Fieber, die 
Letalitätsrate beträgt 5%. Die Letalitätsrate könnte jedoch auf weniger als 1% gesenkt werden, wenn eine 
Diagnose im Frühstadium der Erkrankung möglich wäre. Kommerziell verfügbare LFIAs, welche auf der 
Detektion des “Non-Structural Protein 1“ (NS1) basieren, sind jedoch nicht empfindlich genug um eine 
Diagnose an den ersten Tagen der Erkrankung zu ermöglichen, weil das Detektionssystem, welches auf 
antikörperbeschichtete Goldnanopartikel aufbaut, nicht ausreichend effizient ist. 
Diese Arbeit beschreibt, wie sich die Leistungsfähigkeit von papierbasierten Immunoassays durch die Wahl 
und den Vergleich bereits vorhandener LFIA Labels sowie der Entwicklung neuer Nanostrukturen zum Ersatz 
der konventionellen goldbasierten Strukturen verbessern lässt. Eine Untersuchung möglicher Labels unter 
Verwendung eines Biotin-Streptavidin Systems wurde für die vier gebräuchlichsten Detektionslabels 
durchgeführt: gold- und silberbeschichtete Goldnanopartikel, Polystyrenpartikel und carbon black (CB). Die 
mit einem Immunospotassay (ISA) erzielten Ergebnisse zeigen, dass der Einsatz von CB die niedrigsten 
Detektionsschwellen (DL) aller Labels ermöglicht. Aus diesem Grund wurde es im Folgenden als 
Detektionssystem für DF in LFIA eingesetzt und erzielte eine DL, welche 50-mal geringer (10ng/L) ist als das 
kommerzielle Verfahren mit normalen Goldnanopartikeln (500ng/L). Wegen der hohen Empfindlichkeit 
fluoreszenzbasierter Verfahren wurden darauf basierende Labels genutzt, um Immunospotassays, welche die 
Prinzipien von LFIA, FLISA (fluorophore linked immunosorbent assay) und ELISPOT (enzyme linked 
immunospotting) verbinden, als Alternative zu den zeitaufwändigen ELISA (enzyme linked immunosorbent 
assay) zu produzieren. Das dadurch entstandene System benötigt nur ein Zehntel der ursprünglichen 
Serummenge (4µL) und lässt sich um 2-4h schneller durchführen als ELISA (45-60min). Dabei bleibt das 
Detektionslimit für NS1 mit 5,2ng/mL vergleichbar zu ELISA. Die Überprüfung und der Vergleich des 
Verfahrens mit einem kommerziellen ELISA Test, durchgeführt mit 83 Serumproben, zeigte eine 
Empfindlichkeit von 81% und eine Spezifität  von 88%. Die Methode erlaubt eine schnellere, billigere und 
einfachere Erkennung auch bei Einsatz normaler Laborausstattung. Um das Problem der Agglomerierung der 
lumineszierenden Polymerpartikel während des Flusses zu umgehen, wurden Poly[styren-co-(2-hydroxyethyl 
methacrylat)] Kern/Hülle- Partikel, die lumineszierende [Ru(4,4’-dicarboxilate-2,2’-bpy)3]-Komplexe 
enthielten, synthetisiert und als alternative Labels für ISA verwendet. Diese Partikel zeigen durch ihre geringe 
Aggregation, Monodispersität, Biokompatibilität und leichte Funktionalisierung vielversprechende 
Eigenschaften für mögliche Diagnosen, welche über Zell-Tracking und Bildgebung hinausgehen. Die besten 
Ergebnisse für LFIA und ISA wurden durch Kombination von Kolorimetrie und Fluoreszenzdetektion unter 
Verwendung von Clustern von Gold- und fluoreszierenden NPs erzielt. Die Cluster konzentrieren Gold-NPs, 
  
dies reduziert das NS1 DL (10ng/L) auf 1/50  im Vergleich zu Goldlabels. Die Verwendung von tragbaren 
Fluoreszenzlampen ermöglicht eine weitere Reduktion des NS1 DL auf 2,5ng/L, womit sich in Summe eine 
Verbesserung um den Faktor 200 ergibt. Die Empfindlichkeitsverbesserungen, welche bei Verwendung von 
CB und Nanopartikelclustern beobachtet wurden, werden die DF Diagnose am ersten Tag der Erkrankung 
ermöglichen. Dies war bisher erst am dritten Tag möglich. Billige, schnelle und zuverlässige Methoden 
wurden auch mit Einsatz von Fluoreszenzdetektion gezeigt. Der in dieser Arbeit erzielte wissenschaftliche 
Erkenntnisgewinn ist ein wichtiger Schritt zur Entwicklung zuverlässigerer und empfindlicherer 
Diagnoseverfahren zum Einsatz abseits der führenden Industrienationen, da die nötige Einfachheit der Assays 
beibehalten wird. Die Verbesserungen sind dabei nicht nur für die DF-Diagnostik relevant, sondern lassen 
sich auch auf alle vernachlässigten Krankheiten weiteren und andere Analyten, welche LFIA einsetzen, 
übertragen um point-of-care Unterstützung zu gewährleisten. 
  
Acknowledgements 
First and above all, I praise God for providing me this opportunity and granting me the capability to 
proceed successfully. Thank for the wisdom and perseverance that has been bestowed upon me 
during this research project, and indeed, throughout my life. The more I delve into science, the more 
I realize His existence and presence. 
This thesis appears in its current form due to the assistance and guidance of several people. I would 
like to extend my sincere appreciation to all of them. In particular, I want to thank… 
 … Prof. Jens Michaelis for accepting the invitation to be the first supervisor and for the 
careful corrections and important comments to improve my thesis. 
 … PD. Dr. Stefan Thalhammer for giving me the opportunity to develop my thesis at his lab 
and encouraging me to perform my own ideas. Thank for all support with DAAD-Capes 
project and for the precious advices to develop and improve writing and presentation skills. 
No words can say my immense gratitude to his help. 
 … Prof. Lauro Kubota for allowing me to be part of his group and all support during my 
experiments in Brazil. 
 … Prof. Claudio Pannuti for opening the doors of his laboratories and providing me Dengue 
serum samples. 
 … Staff from Biophysics group at Helmholtz Zentrum Munich for the nice dairy moments 
and especially to our group meetings and retreats. Thank you for the friendly and helpful 
environment. In particular, I would like to thank Bárbara Miranda, Anahí Philippart and 
Cátia Correa who worked direct with me for all valuable discussions. This showed me 
science develops faster when minds work together.  
 … Norbert Menzel for being always ready to help in the lab. I greatly appreciate his 
assistance that made some of my experiments possible. 
 … Prof. Walch for allowing me to use the transmission electron microscope, which 
provided me important information for my thesis. 
 … Marilena Pinto for the support in Munich even before arriving in Germany. I would like 
to thank for her efforts to organize the IDK program so brilliantly. 
 … All my friends (near or far) for listening to me and giving me support. In particular, I 
would like to thank Anahí Philippart, Bárbara Miranda, Luciana Afonso, Martin Schmid and 
Willian Portes for the support and encouragements. 
 … My special friends, Heloísa and Paulo Schumacher, for the friendship. One only knows 
who is a real friend when difficult moments appear and these two friends showed me the 
real meaning of a friendship, even with the distance. 
  
 … Elite  Network  of  Bavaria for the fellowship and the International Doctorate Program 
NanoBioTechnology (IDK-NBT) for the interdisciplinary lectures and environment. 
 … Stefan Fikar for the support, patience and encouragement during the last and hardest 
moments of my doctorate work. I am thankful for having you in my life.  
 … Last but not least, my family for believing me. I thank my parents, Alceu and Enedir, and 
my brother, Alceu Júnior, for all unconditional support and help during these three years far 
away from them. Even with the distance, they shared the happiest moments and supported 
me in the difficult situations. This achievement was only possible because you stand by my 
side and made me see further. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Preface 
 
This thesis was prepared as a cumulative thesis and it was divided in 5 chapters: 
 
 Chapter 1: Introduction and summary of the most relevant results described in the next 
chapters. 
 Chapter 2: it is a publication in Journal of Immunological Methods, volume 375, 264 – 270, 
2012. The article is named “Enhancement of the detection limit for lateral flow immunoassays: 
Evaluation and comparison of bioconjugates”.  
 Chapter 3: it is a publication in Biosensors and Bioelectronics, in press, under the DOI 
number: 10.1016/j.bios.2012.08.005, named “Immunospot assay based on fluorescent nanoparticles 
for Dengue fever detection”.  
 Chapter 4: it is a publication in Journal of Materials Chemistry B, under DOI: 
10.1039/c3tb00316g, titled “One step synthesis of polymer core-shell particles with carboxylated 
Ruthenium complex: potential tool for biomedical applications”. The article was published after the 
thesis submission and therefore it is presented in the same format as the submission template from 
the journal. 
 Chapter 5: it is a manuscript prepared for submission to a journal, but the results are 
described in a patent requisition and they could not be published up to the time of the thesis 
submission. A letter from the technology transfer office of the Helmholtz Zentrum München is 
attached to this thesis in Appendix A1.  
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CHAPTER 1 
1. Introduction 
 
1.1 Nanoparticles in diagnostics 
 
The use of nanotechnologies for diagnostic applications shows great promise to meet the 
rigorous demands of the clinical laboratories for sensitivity and cost-effectiveness (Azzazy et 
al., 2006). Nanodiagnostics, defined as the use of nanotechnology for clinical diagnostic 
purposes (Jain, 2005), are promising to provide higher sensitivity, lower sample volume and 
faster analysis than conventional diagnostic tools (Azzazy et al., 2006).  
Numerous nanostructures have been investigated to determine their properties and 
possible applications in diagnostics (Jianrong et al., 2004). Nanoparticles (NPs), defined as 
structures with lengths in two or three dimensions between 1 nm and 100 nm (Web ref. 1 
ASTM 2456, 2006), are successfully used as probes in biosensing applications. A variety of 
NPs has been described for this purpose, including metal NPs (Parolo et al., 2012), silica NPs 
(Xie et al., 2009), polymer NPs (Juntunen et al., 2012) and quantum dots (Yang et al., 2011).  
While NPs have their own intrinsic properties, it is generally necessary in diagnostic 
applications to impart additional properties or functions through physical or chemical 
coupling between a NP and one or more molecules. Nanostructures can be conjugated to 
biological molecules, including enzymes, antibodies, affinity proteins, cell receptor ligands 
and drugs, producing a measurable signal characteristic of the target biomolecules (Fortina et 
al., 2007). The association of one or more biologically relevant molecules at the interface of a 
NP defines a NP-bioconjugate and combines the unique optoelectronic or physicochemical 
properties of NP with biological activity such as selective binding (Algar et al., 2011). 
Among the diagnostic tools that use NP-bioconjugates, the immunoassays are especially 
interesting due to the combination of high specificity of antibodies with the variety of NP 
properties. In these assays, an analyte is determined by an immune reaction with an antibody 
that binds specifically to the analyte. This type of reaction involves the binding of one type of 
molecule, the antigen, with a second type, the antibody. The immune reaction is signalized by 
a detectable label. Herein a label is defined as every molecule/structure responsible by 
developing a signal (light absorption, luminescence, magnetism etc), which indicates the 
interaction between the antigen and the antibody. Thus, a large variety of labels have been 
used, including enzymes, fluorophores, chemiluminescent dyes, radioactive elements and 
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recently nanoparticles.  
 
1.2 Nanoparticle-bioconjugates and antibodies 
 
NP-bioconjugates can be prepared via the formation of new chemical bonds between 
functional groups associated with a NP and a biomolecule or a small molecule of interest. NPs 
may also offer the potential for association through coordinate bonding, electrostatic 
interactions, and van der Waals interactions (Algar et al., 2011). The choice of the binding 
mechanism of a biomolecule to the NPs depends on the biomolecule and the nature of the NPs. 
Main characteristics of antibodies and bioconjugation with particles are detailed in the next 
sections (1.2.1-1.2.4). 
 
1.2.1 Antibodies 
 
An antibody, also known as an immunoglobulin (Ig), is a globular plasma 
protein produced by B-cells that is used by the immune system to identify and neutralize 
foreign bodies, such as bacteria and viruses. The antibody recognizes a unique part of the 
foreign target, called antigen. The antibodies have a specific part, paratope, which binds 
specifically to a defined structure, epitope, of the antigen, allowing these two structures to 
bind together with precision. Using this binding mechanism, an antibody can interact with a 
microorganism or an infected cell to activate other parts of the immune system, or can 
neutralize its target directly (Cole et al., 1984). For example, an antibody can bind to a 
specific part (or to some parts) of a microorganism, which is essential for its invasion and 
survival, and inactivate it. 
Antibodies exist in different varieties known as isotypes. In mammals, there are five 
antibody isotypes (Figure 1a) known as IgA, IgD, IgE, IgG and IgM. They differ in their 
structure, biological properties, functional locations and ability to deal with different antigens. 
The antibody monomer is composed of two different parts: heavy and light chain (Figure 1b). 
In mammals, there are five types of mammalian Ig heavy chain denoted by α, δ, ε, γ, and μ.  
These chains are found in IgA, IgD, IgE, IgG, and IgM antibodies, respectively. Distinct 
heavy chains differ in size and composition. Each heavy chain has two regions, the constant 
region and the variable region. The constant region is identical in all antibodies of the same 
isotype, but differs in antibodies of different isotypes. The variable region of each heavy chain 
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is approximately 110 amino acids long and is composed of a single Ig domain (Cole et al., 
1984). Recently, small fragments of naturally occurring heavy-chain antibody, named 
nanobody, have been successfully used in biomedical applications. Nanobodies are strictly 
monomeric, very stable, and highly soluble entities, produced in camelids and sharks (Cortez-
Retamozo et al., 2004). Although they show promising characteristics, their production has 
been done by a restricted number of companies, and therefore they are only available for a 
few antigens. 
The light chain contains one constant domain and one variable domain. The approximate 
length of a light chain is 211 to 217 amino acids. Each antibody contains two light chains that 
are always identical; only one type of light chain, κ or λ, is present per antibody in mammals. 
 
 
Figure 1. Scheme of mammal antibody isotypes and monomer structure. There are five different isotypes of 
antibodies in mammals (a): monomer (IgD, IgE, IgG), dimmer (IgA) and pentamer (IgM). A monomer (b) is 
formed by a heavy (blue) and a light (green) chain and two different regions: antigen-binding fragment (Fab) 
and crystallisable fragment (Fc). Adapted from Cole et al. (1984). 
 
The region on an antibody that binds to the antigen is called antigen-binding fragment, 
Fab region. It is composed of one constant and one variable domain of each of the heavy and 
the light chain. These domains shape the paratope. The two variable domains bind 
the epitope on the specific antigen (Cole et al., 1984). 
The crystallisable fragment region, Fc region, is the tail region of the antibody that 
interacts with cell surface receptors, called Fc receptors, and some proteins of the complement 
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system. This property allows the antibodies to activate the immune system. The Fc region is 
composed of two heavy chains that contribute two or three constant domains depending on 
the class of the antibody. Thus, the Fc region ensures that each antibody generates an 
appropriate immune response for a given antigen, by binding to a specific class of Fc 
receptors, and other immune molecules, such as complement proteins. By doing this, it 
mediates different physiological effects including lysis of cells, and degranulation of mast 
cells, basophils and eosinophils (Cole et al., 1984). 
The antibodies can cross react with similar epitopes on other antigens, usually with less 
affinity, due to the relatively small component recognized by them on the antigen. The 
specificity of an antibody refers to its ability to recognize a specific epitope in the presence of 
other epitopes. An antibody with high specificity would result in less cross-reactivity. The 
binding affinity of most antibodies is influenced by conformational determinants, and 
antibodies may not bind to the same protein in a denatured state. Conformation may be altered 
by many factors, including association with other proteins, temperature, pH, salt 
concentration, and fixation. The measure of the binding strength of an antibody for a 
monovalent epitope is defined as affinity. The interaction follows the thermodynamic 
principles of any reversible bimolecular interaction and is described by the affinity constant 
KA. The affinity constant describes the amount of antigen-antibody complex forming at 
equilibrium: 
                             AgAb
AgAbK A
                                                         (1) 
 
where KA is the affinity constant, Ab and Ag are the molar concentrations of unoccupied 
binding sites on the antibody or antigen respectively, and Ab–Ag is the molar concentration 
of the antibody-antigen complex (Lipman et al., 2005).  
The time taken to reach equilibrium is dependent on the rate of diffusion and the affinity 
of the antibody for the antigen, and can vary widely. The affinity constant for antibody-
antigen binding can span a wide range, extending from below 105 L/mol to above 1012 L/mol. 
The specific association of antigens and antibodies is dependent on hydrogen bonds, 
hydrophobic interactions, electrostatic forces, and van der Waals forces. Although these 
bonds are non-covalent, some of the associations between antigen and antibody can be very 
strong. Affinity constants can be affected by temperature, pH and solvent. (Lipman et al., 
2005; Web ref. 2, Millipore tutorial, 2012).  
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Most antigens are highly complex and present numerous epitopes that are recognized by a 
large number of lymphocytes. Each lymphocyte is activated to proliferate and differentiate 
into plasma cells, producing antibodies that bind to different epitopes of the antigen, called 
polyclonal antibodies. In contrast, monoclonal antibodies (mAbs) are produced by a single B 
lymphocyte clone. The main differences between monoclonal and polyclonal antibodies are 
described in the Table 1. The mAbs were first recognized in sera of patients with multiple 
myeloma in which clonal expansion of malignant plasma cells produce high levels of an 
identical antibody resulting in a monoclonal gammopathy. In the mid-1970s, Köhler and 
Milstein devised the technique for generating monoclonal antibodies of a desired specificity, 
for which they were awarded the Nobel prize (Köhler and Milstein, 1975). They fused splenic 
B cells with myeloma cells with the resulting immortal hybridomas, each producing a unique 
mAb (Lipman et al., 2005) 
 
Table 1. Comparison between the main characteristics of monoclonal and polyclonal antibodies 
(Liddell E. et al., 1995; Web ref. 3, Abcam tutorial, 2012) 
Monoclonal antibodies Polyclonal antibodies 
 Expensive to produce;  Inexpensive to produce; 
 High technology required;  Technology required is low; 
 Training is required for the technology 
use; 
 Skills required are low;  
 Time scale is long for hybridomas;  Time scale is short; 
 Can produce large amounts of specific 
antibodies; 
 Produces large amounts of non-specific 
antibodies; 
 Recognizes only one epitope on an 
antigen; 
 Recognizes multiple epitopes on any 
one antigen; 
 Once a hybridoma is made it is a 
constant and renewable source and all 
batches will be identical. 
 Can show batch to batch variability. 
 
The use of antibodies produced in animals (mouse, rabbit, goat) and immobilized on NPs 
allows the development of assays, which are specific to the analyte. For analytical purposes, 
monoclonal antibodies are the preference in order to avoid cross-reaction with other analytes. 
The procedure adopted to immobilize an antibody on a particle depends on the nature of each 
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particle. As a protein, an antibody has side groups from the aminoacid sequence (-SH, -NH2, -
COO-) that provides the anchors for the bioconjugation. The following sections describe the 
bioconjugation with biomolecules for gold, carbon black and polymer particles, which are of 
interest to this thesis. 
 
1.2.2 Gold nanoparticles 
 
Gold NPs, ranging from 1-100 nm, are characterized by their strong optical absorption 
and light scattering. In imaging applications, gold NPs are potentially a very sensitive probe 
that can provide elastically scattered light intensities that are orders of magnitude larger than 
the fluorescence emission of dyes. Nanoparticles composed of gold offer good 
biocompatibility, facile synthesis, and conjugation to a variety of biomolecular ligands, 
antibodies, and other targeting moieties. The predominant chemistry for modifying gold NPs 
is the interaction with thiol groups. Small molecules, polymers, and a variety of biomolecules 
can be anchored to gold NPs through thiol-terminated linkers. Bifunctional thiol ligands that 
display, for example, carboxyl or amine groups also enable further modifications using 
standard techniques to prepare gold NP bioconjugates (Jain et al., 2008, 2011; Algar et al., 
2011). In this thesis, gold NPs were conjugated to proteins by chemisorption on the particle 
surface. 
 
1.2.3 Carbon black particles 
 
Carbon black NPs labeled with reporter molecules can serve as signaling labels in rapid 
diagnostic assays as an alternative to gold, colored latex, silica, quantum dots, or up-
converting phosphor NPs. Carbon black can be obtained from soot, commercially available 
from different sources, and shows variable sizes ranging from tens of nanometers to a few 
micrometers. These preparations are intended for other uses, such as in toner or ink for 
printers or in automobile tires. The number of functional groups on these NPs is very small, 
precluding the possibility of the covalent attachment of proteins or DNA. Bioconjugation 
mainly occurs by physical adsorption. Covalent attachment between biomolecules on carbon 
black particles can be achieved by the adsorption of the biomolecules on the particle surface 
followed by glutaraldehyde coupling (Rayev et al., 2008). This procedure produces very 
stable bioconjugates and it was the procedure adopted in this thesis. 
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1.2.4 Polymer particles 
 
Polymer and amphiphile-based NPs are currently the most prominent materials being 
utilized in biomedical applications. These include polymer NPs, dendrimers, liposomes, 
polymersomes, and micelles (Guo et al., 2003; Torchilin, 2006; Discher et al., 2006; Peer et 
al., 2007). The interest in these materials arises from the combination of nanoscale or 
microscale size with the nearly infinite diversity of physical properties and chemical 
functionality that can be obtained through organic chemistry. Different properties are tailored 
through the selection of the polymer chemical composition. Bioconjugates of polymer NPs 
are typically prepared to assist targeting-antibody conjugates. While there is no characteristic 
surface chemistry due to the diversity of materials, the introduction of carboxyl or amine 
groups into the polymer composition for purposes of bioconjugation is standard procedure. 
Overall, the bioconjugation chemistry of these NPs is generally dictated by the functional 
groups associated with the material (Algar et al., 2011). 
The most common method to bind a polymer NP to an antibody is the cross-linking 
reaction between amines and carboxylic acids using carbodiimide activation with 1-ethyl-3-
(3-dimethylaminopropyl)carbodiimide, EDC. The polymer NPs are commonly prepared with 
carboxylic acid groups. Then, the target biomolecule of interest has one or more primary 
amines that allow binding to the carboxylated NP. During the reaction, a reactive o-
acylisourea intermediate is produced through the activation of carboxylic acids, followed by 
the peptide bond formation with the biomolecule. In some cases, it is necessary to increase the 
reaction efficiency by producing a more stable reactive intermediate with N-
hydroxysuccinimide (NHS) or a sulfonated derivative. Although the succinimidyl ester 
intermediate is not resistant toward hydrolysis, it hydrolyzes more slowly than the o-
acylisourea intermediate, increasing the reaction efficiency (Algar et al., 2011). The 
carbodiimide procedure was adopted in this thesis to bind antibodies and spacers to polymer 
particles. It produced stable and functional bioconjugates for an efficient performance in 
immunoassays, especially in point-of-care assays. 
 
1.3 Point-of-care testing: assays on paper 
 
Point-of-care is defined as a medical testing at or near the site of patient care. Accurate 
point-of-care diagnosis required for effective medical treatments often calls for 
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qualitative/quantitative measurements of metabolites, enzymes, and other biomarkers. For 
urban and rural populations in developing countries, the need for such assessments is as 
pressing as in the developed world. However, practical methods for detecting and quantifying 
analytes in the developing world must be robust, lightweight, simple to operate, and above all, 
low-cost (Ellerbee et al., 2009). As suggested by the World Health Organization, WHO, an 
ideal test for impoverished environments has to be ASSURED: Affordable, Sensitive, Specific, 
User-friendly, Rapid and Robust, Equipment-free and Delivered to those who need it (Web ref. 
4, WHO, 2008). 
Due to the lack of convenient accurate point-of-care assessment tools in the developing 
world, many health risks and illnesses remain poorly defined and receive inappropriate 
treatment.  In addition, little information about the burden of disease is available to guide 
population health decisions. There is an increase necessity for point-of-care tools that provide 
(Ellerbee et al., 2009): 
 unequivocal identification of pathogen type and subtype and drug sensitivity profile; 
  rapid assessment of susceptibility and immunity to health threats; 
  rapid diagnosis of exposure and disease; 
 rapid detection of emerging pathogens; 
 rapid parallel diagnosis of multiple infectious agents; 
  accurate assessment of disease stage and prognosis; 
  reliable detection and management of outbreaks, emerging acute and chronic 
health threats. 
To overcome the problems related to costs, necessity of equipment and laboratory 
exhausting routines, paper-based analytical devices have been widely used since the 60’s for 
many applications (Carrilho et al., 2009; Cheng et al., 2010; Haeberle et al., 2007; Mark et al., 
2010; Martinez et al., 2010), mostly for biological assays and diagnosis as point-of-care 
devices (Gubala et al., 2012). Many advantages can be listed by using paper as a supporting 
substrate for diagnostic tools (Leung, 2011): 
 paper is widely manufactured from renewable resources and it is inexpensive; 
 it is combustible and biodegradable; 
 the porous structure of paper enables wicking of liquid which is important for lateral 
flow assays and chromatography applications; 
 paper is also suitable for biological applications since cellulose (and derivatives) is 
compatible with biological samples; 
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 paper surface can be easily manipulated through printing, coating and impregnation 
and can be fabricated in large scale; 
 it can be easily stored, transported and disposed; 
 paper properties can be easily altered to fulfill the requirements of different 
applications 
Recently, many works have focused on the development of low-cost paper based medical 
diagnostic devices, especially lateral flow immunoassays (LFIAs). These test strips have been 
well-established diagnostic tool in laboratory by combining the mentioned advantages of 
paper based tests with the specificity of antibodies. This technology offers additional 
advantages when compared to the conventional detection methods: it is rapid, simple and 
cost-effective.  
 
1.4 Lateral flow immunoassay 
 
The technological basis for the development of lateral flow immunoassays, also called 
strip tests, was created in 1980, when Leuvering and col. (1980a) reported the use of colloidal 
particles as labels for immunoassays (Schubert-Ullrich et al., 2009). The first and most 
popular application to this test format was the use of human chorionic gonadotropin for the 
detection of pregnancy (Leuvering et al., 1980b, 1983). 
LFIA follows the same principles of an enzyme linked immunosorbent assay (ELISA). 
Therefore, it is important to understand this technique before a complete description of LFIA. 
Different approaches can be used for ELISA: sandwich, competitive and indirect. The most 
used approach for pathogen detection is based on sandwich ELISA (Figure 2). 
 
 
Figure 2. Scheme of a sandwich enzyme linked immunosorbent assay. Antibodies are immobilized on the 
microplate and the antigens from the sample are captured by the antibodies on the surface. The detection 
proceeds with antibodies that bind to the antigen (sandwich) and contain enzymes that catalyze a reaction with a 
colored product. 
 
A capture antibody specific to the protein of interest is immobilized on a solid phase of an 
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ELISA microplate (e.g.microtiter plate or multiple well strips). The analytes in the sample are 
captured by the immobilized antibody and detected by a second analyte-specific antibody, 
which is enzyme-labeled and binds to the protein of interest by forming a “sandwich”. The 
light absorption of the product formed after adding the substrate is directly proportional to the 
analyte concentration. For sandwich ELISA, the antigen has to show more than one epitope, 
therefore this format is only applicable to large molecules such as proteins. Thus, the 
sandwich assay is the most common format for pathogen detection (Schubert-Ullrich et al., 
2009). 
Similar to sandwich ELISA, LFIA has antibodies that capture and detect the analyte 
(Figure 3a), but it has as principle the movement of a liquid sample along a strip made of 
different membranes. The LFIA is assembled by different components, including: 
 Sample pad 
 Conjugate pad 
 Reaction membrane 
 Absorbent pad 
 Backing material 
 The membranes are assembled as shown in the Figure 3b. 
 
 
Figure 3. Scheme with the components of a lateral flow immunoassay. (a) The assay has two lines (test and 
control) that appear when a positive sample is added to the sample pad and it indicates that an antibody coated 
label bound to the antigen captured by the antibody immobilized on the nitrocellulose membrane. (b) The strip 
test is composed by 5 membranes: sample (1) and conjugate (2) pads, reaction membrane (3), absorbent pad (5) 
and backing material (6). The visible detection is based on detection labels (7) and the flow of liquid is assured 
by capillary forces (4). 
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 In order to run the test, a liquid sample (whole blood, serum, urine, food extract) is added 
on the sample pad to remove solid materials and possible contaminants (Figure 4a). The 
volume used to run a LFIA usually ranges from 50 to 500 µL. Then, the liquid containing the 
analyte flows into the conjugate pad, where antibodies coupled to particles were previously 
deposited. The gold nanoparticles are the “gold standard” for LFIA. When the analytes 
interact with the particle coupled antibodies, they produce complexes consisting of analyte-
antibody-particles (Figure 4b). These complexes move to the reaction membrane, where 
antibodies that bind specifically to the analyte (test line) and to the particle coupled antibodies 
(control line) are immobilized in the line geometry (Figure 4c). The analyte-antibody-particle 
complexes are trapped at the test line due to the analyte-antibody interactions. Thus, the final 
complex consists of antibody (immobilized)-antigen-antibody-particle. The positive result is 
indicated by the signal provided by the particles. In the case of gold nanoparticles, it is 
produced a red line and its color intensity is proportional to the analyte concentration.  
 
Figure 4. Operation of the lateral flow immunoassay. First, the sample is added to the sample pad (a) and 
starts to flow through the membrane due to capillary forces. The analyte molecules move to the second 
membrane, conjugate pad, where particles containing antibodies specific for the analyte are deposited. The 
analyte interacts with the antibody coated particle, producing the complex: analyte-antibody-particle. The 
complexes flow into the reaction membrane (b), where antibodies specific to the analyte (test line) and to the 
antibody from the particles (control line) are immobilized in line format. In the first line, the analyte-antibody-
particle complexes are trapped by antigen-antibody interactions and develop a signal, which is characteristic of 
the particles (c). Most of the commercial tests are based on gold nanoparticles, developing red line as a positive 
result. The antibody coated particles that do not bind to the analyte are trapped in the control line by antibody-
antibody interactions. The excess of liquid is absorbed in the absorbent pad. 
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This sandwich format is also only applicable for analytes with more than one epitope 
(high-molecular mass analytes) (Schubert-Ullrich et al., 2009). The antibodies coupled to a 
particle that did not bind to the antigens pass through the test line and achieve the control line, 
where they are trapped by antibody-antibody interactions. The signal response at the control 
line confirms the proper flow of the liquid through the strip and it works as the positive 
control (Posthuma-Trumpie et al., 2009). More test lines can be applied, allowing 
multianalyte testing (Snowden et al., 1991; Zhang et al., 2006) or for semi quantitative 
evaluation of the response (Laitinen et al., 1996a; Cho et al.; 2001). The various elements will 
be discussed in more detail in the section 1.6. 
When the analyte has low molecular weight and only one epitope, the format is restricted 
to the competitive design. In this layout, antibody is sprayed at the test line, and then a 
mixture of sample analyte and labeled analyte is applied at the conjugate pad. The sample 
analyte and labeled analyte compete for binding sites on the antibody at the test line (Laitinen 
et al., 1996b). In the competitive LFIA format the response is negatively correlated to the 
analyte concentration (i.e. more analyte present, less signal; no analyte gives the highest 
signal). For analytes with more than one epitope, the sandwich format is applicable. The 
response is directly proportional to the amount of analyte in the sample (O’Keeffe et al., 
2003). The preferred layout is dependent on the particular application (Posthuma-Trumpie et 
al., 2009). 
LFIA technology is currently widely applied in different fields, including diagnostics, 
detection of specific pathogens such as biowarfare agents, presence of toxic compounds in 
food, feed or environment and abuse of (illicit) drugs. They are especially designed for single 
use at point of care/need, i.e. outside the laboratory. Applications are often designed where an 
on/off signal is sufficient and the results are usually provided within 10–30 min (Posthuma-
Trumpie et al., 2009). 
 
1.5 Immunospot assay 
 
The principle of an immunospot assay is similar to the LFIA, but without a mobile phase 
moving up the test strip. The term immunospot has been used to refer to a method, where 
capture antibody is immobilized on the membrane. After the incubation with the liquid 
sample, the membrane is immersed in the solution containing the detection antibodies. The 
detection antibodies are usually labeled with an enzyme which subsequently reacts with a 
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substrate to form a colored product (Bathoorn et al., 2011; Franci et al., 1986). NPs can be 
also used as detection labels. In such “sandwich” assays, the absorbance of the product is 
directly proportional to the concentration of the analyte present in the sample.  
 
 
Figure 5. Scheme of an immunospot assay. The antigen from the sample is spotted on the nitrocellulose surface 
and interacts with the fibers. The detection proceeds with antibodies that bind to the antigen and contain 
enzymes that catalyze a reaction with a colored product. 
 
An immunospot assay can also be performed by depositing the sample directly at the 
membrane (Figure 5). The use of paper, such as nitrocellulose membranes, has provided a 
useful and simple base for fast and low cost tests (Liu et al., 2011; Martinez et al., 2010). This 
format is similar to indirect ELISA and it is used when the analyte has high molecular weight 
like proteins. The analysis time for such immunospot assay ranges from 10 min up to 3 h and 
depends on the number of incubation cycles involved and the time needed for all incubations.  
Similar to LFIAs, immunospot assays provide qualitative or semi quantitative results 
(Schubert-Ullrich et al., 2009) and do not include flow steps. In the next section, a detailed 
explanation of LFIA components is described. Many characteristics required for LFIA are 
also necessary for ISA, although flow requirements are dispensable. 
 
1.6 Components of lateral flow immunoassay 
 
The function and characteristics of each component is described in the next sections with 
numeric references from the Figure 3. 
 
1.6.1 Sample pad: blood filter matrices 
 
The sample pad is a membrane that stores chemicals to increase the wettability and it also 
filtrates solids and contaminants from the sample. For analytes found in serum, a highly 
desirable performance assigned to a LFIA would be its ability to accommodate whole blood 
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as a sample. The sample pad should be capable of separating cells from serum or plasma so 
that enough volume of sample is generated to run the test. Efficient separation of blood cells 
from serum is extremely difficult. Blood contains 35% to 45% solids, mostly as red blood 
cells, meaning that a 200 μL aliquot of blood would be expected to yield at most 130 μL if the 
separation was 100% efficient. The filter material must be capable to work over the full range 
of blood variability, yielding enough serum to fill the bed volume of the entire test strip 
reproducibly and with the same flow kinetics. Nowadays, the most efficient sample pad 
consists of glass fiber (Ponti et al., 2009; Web ref. 5, Millipore protocol, 2008). 
 
1.6.2 Antibodies and conjugate pad 
 
Antibodies used in LFIA must have sufficient sensitivity, specificity, purity, and stability 
to accomplish the performance requirements of the test. Depending on the assay design, 
antibodies may be used as the capture reagent at the test line, as the conjugate on the detector 
particle, or both. Minimally, the antibody must remain reactive after being adsorbed to a solid 
surface, retain its structural integrity when completely dried, and then be instantly reactive 
when rehydrated by the sample. While the formation of an immunocomplex at the test line is 
most commonly used as the result indicator, it is theoretically possible to achieve a result 
using any ligand recognition system where a detector particle becomes bridged to a capture 
reagent on the membrane. In such systems the reagents employed, whether purified from a 
natural source or prepared as a synthetic construct, are subject to the same requirements for 
sensitivity and stability as antibodies (Ponti et al., 2009; Web ref. 5, Millipore protocol, 2008). 
The membrane and buffer used for dilution of the capture reagents have to be optimized to 
allow high protein immobilization, maintenance of reagent reactivity, and no alteration of the 
membrane flow properties. The most common membrane is constituted of glass fiber, but also 
polyester pad can be chosen with good results. Some capture reagent may show many 
possibilities in the buffer formulation, but certain antibodies and synthetic constructs may 
require a specific formulation to maintain structural stability and reactivity. Problems can 
arise from chemical interactions that occur during evaporation, when the concentration of the 
salts from the buffer becomes transiently very high. For example, if the reagent solution is 
buffered with a primary amine such as tris(hydroxymethyl)aminomethane (TRIS) or glycine, 
salt bridging can occur between acidic amino acid residues (glutamic acid and aspartic acid) 
in the capture reagent and the –NH3+ group of the buffer molecule, reducing the capture 
Chapter 1 
 
15 
 
reagent ability to bind analyte. The ionic strength of the buffer should be reduced as much as 
possible. Ions in solution can interfere with electrostatic interactions between the membrane 
and the capture reagents. In addition, physiological concentrations of buffer salts and sodium 
chloride promote the solubility of most proteins and reduce the hydrophobic attraction of the 
nitrocellulose membrane (Ponti et al., 2009; Web ref. 5, Millipore protocol, 2008).  
 
1.6.3 Reaction membrane 
 
For lateral flow test strips, the membrane must irreversibly bind capture reagents at the 
test and control lines. The polymer from which the membrane is made determines most of its 
binding characteristics. If the membrane undergoes a secondary process that chemically alters 
the polymer or buries it under a second polymer, protein binding properties may be 
dramatically altered. Typical polymers are nitrocellulose, polyvinylidene fluoride, nylon and 
polyethersulfone. For the most part, the membrane protein binding capacity is determined by 
the amount of polymer surface area available for immobilization. The membrane surface area 
is determined by pore size, porosity (amount of air in the three dimensional structure), 
thickness, and, to a minor extent, structural characteristics unique to the polymer (Ponti et al., 
2009; Web ref. 5, Millipore protocol, 2008). 
Membranes made from nitrocellulose and nitrocellulose/cellulose acetate blends are 
hydrophobic. They easily wet in water because detergents or surfactants have been added to 
the membrane during production. A minimum concentration of surfactant or detergent is 
needed to make the membrane wettable. Once this concentration is reached, further increases 
have little impact on wettability. Surfactants and detergents can affect protein adsorption, 
whether derived from the membrane or included in the reagent buffer. If their concentration in 
the membrane is too high, they will prevent adsorption by masking the nitrocellulose. Tween 
20, Triton X-100, glycerin, polyvinyl alcohol (PVA), polyvinylpyrrolidone (PVP), and 
polyethylene glycol (PEG) can reduce protein binding by adsorbing to the membrane 
preferentially or forming a complex with a protein molecule before it adsorbs. Their use 
should be minimized or avoided completely after the capture reagents have been immobilized 
and fixed. If they are applied to the membrane as part of a blocking process, their 
concentrations should be kept as low as possible to prevent displacement of the capture 
reagent (Ponti et al., 2009; Web ref. 5, Millipore protocol, 2008). 
Membrane thickness has mainly three impact aspects on the LFIA performance:  
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 Impact on the bed volume: the bed volume is directly related to the thickness. As the 
thickness increases, the bed volume increases, since the three dimensional space equals the 
length of the strip times the width times the thickness. The bed volume can be increased by 
the use of an absorbent pad at the end of the membrane strip. Under these circumstances, the 
total volume of sample taken up by the strip is governed mainly by the bed volume of the 
absorbent pad (Ponti et al., 2009; Web ref. 5, Millipore protocol, 2008); 
 Impact on the width of the test and control lines: since the bed volume increases with 
thickness, the width of the test and control lines can be influenced. In most instances, the 
capture reagents are applied to the membrane at a constant volume per unit distance. The 
liquid is absorbed into the membrane, displacing the air from a comparable volume within the 
pores. The liquid usually penetrates down into the membrane and then moves laterally. 
Spreading of the reagent on relatively thinner membranes will be greater than on relatively 
thicker membranes because there is less depth to allow downward penetration of the liquid. If 
the same mass of capture reagent is spread out over a wider area, the detector reagent will be 
similarly diffused, the net result being less color intensity and lower sensitivity (Ponti et al., 
2009; Web ref. 5, Millipore protocol, 2008); 
 Impact on signal visibility: thicker membranes absorb more sample, thereby 
increasing the mass of analyte that passes by the capture line. The signal should also be 
intrinsically stronger. Both of these potential advantages are negated by a physical limitation 
of the membrane. Due to the opacity of the nitrocellulose, detector reagent bound at the test 
and control lines is visible only if it is located near the surfaces of the membrane. In some 
cases, the antibody may be more concentrated on the side to which it is applied; but for the 
most part, no discernible gradient is observed. Consequently, detector reagent is captured 
evenly through the depth of the membrane. Relative to visualization, however, any detector 
reagent bound deeper than ~10 μm from the surface becomes invisible to the user, as its color 
is masked by the membrane opacity. Since the visible depth is constant for a given membrane, 
the amount of visible signal is inversely proportional to membrane thickness (Ponti et al., 
2009; Web ref. 3, Millipore protocol, 2008). 
 
1.6.4 Capillary flow rate 
 
In LFIA, the sample solution is absorbed by the membranes as a result of capillary action. The 
lateral flow in the membranes can be modeled by Darcy’s law (Masoodi et al., 2010), 
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L
PAKQ 
                                                                 (2) 
 
where Q is the volumetric flow rate, K is the permeability of the paper, A’ is the cross-              
sectional area perpendicular to flow, ΔP is the pressure gradient,  is the viscosity of the 
solution and L is the height of the liquid. Assuming that there are no applied pressures and 
neglecting gravitational terms, ΔP can be calculated using the Laplace equation,      
 
                                                             
r
P  cos2                                                              (3) 
 
where  is the surface tension of the solution,  is the contact angle and r is the effective pore 
radius of the filter paper. Capillary forces are responsible for the speed, or capillary flow rate, 
at which a sample front moves along a membrane strip when liquid is introduced at one end. 
This value is very difficult to measure accurately since the rate decays exponentially as the 
liquid moves further along the membrane. An easier parameter to measure is the capillary 
flow time, the time required for liquid to move along and fill completely a strip of defined 
length. The flow rate of a membrane depends on the aggregate properties of the porous 
structure. Ultimately, the capillary flow rate is determined by the overall distribution of pore 
sizes and not of the single largest pore. As the aggregate pore size increases, the flow rate of 
the membrane increases. All other parameters (pore size, pore size distribution, thickness) 
being equal, capillary flow rate increases linearly with increasing porosity. Capillary flow rate 
is the most critical performance parameter of the membrane due to the effective concentration 
of analyte in the sample being inversely proportional to the change in flow rate. In a lateral 
flow test strip, the antigen is unable to bind once its passes the immobilized antibody, because 
test strips are designed to flow in only one direction. As a consequence of this strip property, 
the effective antigen concentration decreases with the increase in flow rate because of the 
reduced length of time that the components of the reactive pair are close enough to bind to 
each other. The amount of complex formed is a relation among the rate constant related to the 
affinity of the antibody for the antigen and the concentrations of the reactants (Ponti et al., 
2009; Web ref. 5, Millipore protocol, 2008): 
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        R = k[Ab][Ag]                                                             (4) 
 
where R is the amount of formed complex, k is the rate constant related to the affinity of the 
antibody for the antigen, [Ab] and [Ag] are the concentration in mol/L of the antibody and the 
antigen. 
The capillary flow rate decreases exponentially as the distance of the sample front from 
the origin increases. This means that the placement of the test line has a significant impact on 
achievable sensitivity. As the capture line is placed further from the origin, the flow rate at 
which the analyte passes the capture reagent line is slower; and the effective concentration of 
analyte in the sample is higher. For this reason, it is advantageous to locate the test line 
relatively far up the strip. Furthermore, a given volume of liquid spreads out further on the 
membrane when the capillary flow rate increases, maintaining other physical properties 
constant. Reagent lines applied to faster flowing membranes will be wider than the same lines 
applied to slower flowing membranes. This causes the signal to be spread out over a wider 
area, making it more difficult to visualize a weak signal (Ponti et al., 2009; Web ref. 5, 
Millipore protocol, 2008). 
 
1.6.5 Absorbent Pad 
 
Absorbent pads, when used, are placed at the distal end of the test strip. The primary 
function of the absorbent pad is to increase the total volume of sample that can be allowed to 
enter the test strip. This increased volume can be used to wash out unbound detector particles 
from the test and control lines, thereby lowering the background and enhancing assay 
sensitivity. Since the volume of sample that contributes to the signal is controlled by the 
volume required to solubilize the detector particles, the addition of the absorbent pad may not 
have a dramatic impact on overall assay sensitivity. If the strip design does not include an 
absorbent pad, the volume of sample analyzed in the strip is determined solely by the bed 
volume of the membrane. 
 
1.6.6 Backing material  
 
The reaction membrane is often thin and fragile, so it is attached to a plastic or nylon basic 
layer to allow cutting and handling, besides supporting the other membranes. The film 
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provides a high level of mechanical strength, making it nearly impossible to break the 
membrane during routine processing operations. Membranes without a backing card, in 
comparison, are extremely fragile and can be very difficult to manipulate during test strip 
assembly. Using backing card, it is common to provide an additional treatment to the 
nitrocellulose membrane with a thin film that acts as a barrier to chemical contamination from 
adhesives that are used to mount the membrane on cards. Although adhesives typically do not 
penetrate into a microporous membrane more than a few microns, volatile organic solvents 
released from the adhesive during long term storage may adsorb to the nitrocellulose. This 
can alter the membrane wetting properties and adversely affect lateral flow properties (Web 
ref. 3, Millipore protocol, 2008). 
 
1.6.7 Particles used as detection labels 
 
Various types of detector reagents can be used for the visualization of the signal in LFIA. 
Particles ranging from 10 nm to 1µm are commonly used in commercially available tests. 
Gold nanoparticles are the most used detection particle due to their optical properties and they 
are considered “gold standard” in LFIA (Verheijen et al., 1998). Some other examples are 
latex (Gussenhoven et al., 1997), selenium (Lou et al., 1993), carbon (Lonnberg et al., 2001) 
and liposomes (Zaytseva et al., 2004). Latex particles and liposomes incorporate dyes or 
fluorophores, which allow visualization and, when applicable, quantitation of the response. 
The newest labels contain or are composed of quantum dots (Goldman et al., 2004). Other 
possibilities include enzyme conjugates, other colloidal metals, dye sacs, fluorescent particles, 
and magnetic particles (Posthuma-Trumpie et al., 2009).  
 
1.7 Detection techniques 
 
The detection limit in LFIA is related to the detection particles, which must be 
inexpensive and provide a high signal (absorption, fluorescence, phosphorescence, magnetic 
field). Particles that provide a colorimetric signal are preferable due to the ease of 
visualization and no need for equipment, according to ASSURED criteria. The coupling of 
colored nanoparticles to the detection molecule is one of the most powerful techniques for an 
immediate readability of the tests. The production of a stable and sensitive immunosensor 
based on real color appearance requires a criterious screening of possible colored labels. 
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Fluorescent particles are also a promising option for LFIA owing to the high sensitivity. In 
addition, inexpensive apparatus can be used to excite the fluorophores, such as fluorescent 
lamps or LED, and visually read the emission in the visible spectral range. In the next section, 
the basic theories of light absorption and luminescence are described. 
 
1.7.1 Colorimetric detection 
 
Absorption of electromagnetic radiation is the way in which the energy of a photon is 
taken up by matter, typically the electrons of an atom. The absorption of light during wave 
propagation attenuates the beam in accordance to the absorption law, Beer-Lambert law. This 
law quantitatively describes how the attenuation depends on the concentration of the 
absorbing bodies and the path length over which the absorption occurs. Due to the interaction 
between the photons and absorbing particles, the radiant power of the beam decreases (Skoog 
et al., 2004). The transmittance of the solution is the fraction of incident radiation transmitted 
by the solution and it is expressed as: 
    
oP
PT                                                                        (6) 
 
where T is the transmittance, P is the beam after passing through the absorbing solution and 
Po is the initial beam. 
The absorbance of a solution is related to the transmittance in a logarithmic manner: 
 
bc
P
PA o  log                                                            (7) 
 
where A is the absorbance, ɛ is a proportionally constant named molar absorptivity, b is the 
path length and c is the molar concentration of the absorbing structure (Skoog et al., 2004). 
Gold nanoparticles at 40 nm are the standard labels for LFIA and show high optical 
absorption at 528 nm. This optical property arises from the phenomenon of surface plasmon 
resonance (SPR), wherein the conduction band electrons of a gold NP oscillate collectively 
and in resonance with certain wavelengths of incident light (Jain et al., 2008) The 
wavelength-dependent intensity of the SPR is very sensitive to changes in the dielectric 
environment surrounding the gold NP, as well as plasmonic coupling between NPs (Algar et 
al., 2011).  
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Carbon black is a refractory and most strongly light-absorbing component of soot, a 
nearly omnipresent by-product of inefficient combustion (Schwarz, et al., 2008). Carbon 
black is highly extended fused benzene rings terminated with quinone groups and phenol 
groups. This structure allows the  electrons to delocalize over large areas absorbing all light 
at the visible region. 
 
1.7.2 Fluorescence detection 
 
Fluorescence is an emission process in which atoms or molecules are excited by the 
absorption of an electromagnetic radiation beam. The excited species then relax to the ground 
state, giving up their excess of energy as photons. Fluorescence occurs rapidly and it is 
generally complete in about 10-5s from the time of excitation. The lifetime of an excited 
specie is brief due to several mechanisms that an excited molecule gives up its excess of 
energy and relaxes to its ground state. Two of the most important mechanisms are 
nonradioative relaxation and fluorescence emission (Figure 6).  
 
Figure 6. Partial energy diagram for a hypothetical molecular species. Three electronic energy states are 
shown, Eo, E1, E2. Eo is the ground state, and E1 and E2 are excited states. Each state is shown as having four 
excited vibrational levels. The diagram also indicates the nonradiative relaxation and fluorescence phenomena. 
 
Vibration relaxation, depicted by the short wavy arrows between vibrational energy levels, 
occurs during collisions between excited molecules and molecules of the solvent. During the 
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collisions, the excess of vibrational energy is transferred to solvent molecules in a series of 
steps. The average lifetime of an excited vibrational state is only about 10-15s. Nonradiative 
relaxation between the lowest vibrational level of an excited electronic state and the upper 
vibrational level of another electronic state can also occur. This type of relaxation is called 
internal conversion, depicted by the two longer wavy arrows, and it is less efficient that 
vibrational relaxation with a life time between 10-9 and 10-6 s. The effect of both nonradiative 
relaxations is a rise in the temperature of the medium (Skoog et al., 2004). 
Irradiation of a fluorophore between the wavelengths λ1 to λ5, as shown in the Figure 6, 
results in the momentary population of the vibrational levels of the first excited state E1. 
When higher energy is used (λ’1 to λ’5), the vibrational levels of the higher energy electronic 
state E2 become populated. Bands of radiation are produced when molecules relax from the 
lowest vibrational state of an excited state E1 to the many vibrational levels of the ground 
state E0. Like molecular absorption bands, molecular fluorescence bands are formed by a 
large number of closely spaced lines that are usually difficult to resolve. The transition from 
E1 to the lowest vibrational state of the ground state (λ1) has the highest energy of all the 
transitions in the band. As a result, all the other lines that terminate in higher vibrational 
levels of the ground state are lower in energy and produce fluorescence emission at longer 
wavelength than λ1. Thus, molecular fluorescence bands consist of longer wavelengths than 
the band of absorbed radiation responsible for their excitation, the Stokes shift (Skoog et al., 
2004). 
The power of fluorescence radiation (F) is proportional to the radiant power of the 
excitation beam absorbed by the system: 
               F = K’(P0 – P)                                                           (8) 
 
where P0 is the power of the beam incident on the solution and P is its power after it passes 
through the medium. The constant K’ depends on the quantum efficiency of the fluorescence. 
To relate F to the concentration c of the fluorescent structure, equations (7) and (8) are 
combined: 
                                              )101(0
' bcPKF                                (9) 
 
In fluorescence, the radiation power emitted is directly proportional to the source intensity, 
but absorbance is essentially independent of source intensity, because it is related to the ratio 
of radiant powers. Fluorescence is recognized as one of the most sensitive detection methods 
Chapter 1 
 
23 
 
because the emission signal is measured above a low background level. It is inherently more 
sensitive (~1000 times) than absorption methods.  
Therefore, fluorescence based detection systems are very promising for immunoassays in 
order to produce assays with lower detection limits than obtained with colorimetric detection 
based tests. The only concern of fluorophores is the easy decomposition in presence of 
oxygen molecule, a photobleaching phenomenon. Thus, the incorporation of fluorophores 
inside a particle decreases this effect due to the limited oxygen diffusion. In addition, the 
incorporation of fluorophores within a particle allows enhancing the sensitivity of assays. In 
this case, when an antibody coated fluorescent particle binds to the antigen, numerous 
fluorophore molecules contribute to the signal. On the other hand, in conventional assays 
using antibodies labeled with fluorophore molecules, only a few fluorophores per analyte 
contribute to the signal (Linares et al., 2012b). 
 
1.7.3 Charge-transfer absorption and phosphorescence 
 
For high sensitivity purposes, charge-transfer absorption is particularly interesting due to 
the usual high molar absorptivities (> 10,000 L mol-1 cm-1). Many inorganic complexes 
exhibit this type of absorption and are named charge-transfer complexes. A charge-transfer 
complex consists of an electron-donor group bonded to an electron acceptor. When the light is 
absorbed, an electron from the donor is transferred to an orbital that is largely associated with 
the acceptor. The excited state is thus the product of a kind of internal oxidation/reduction 
process. Due to the high absorptivity, particles containing inorganic complexes have been 
successfully used for biomedical application (Lin et al., 2011). 
In this thesis, [Ru(4,4’-dicarboxilate-2,2’-bipyridine)3].13 complex was incorporated in 
polymer particles and used in ISA as the detection label. The carboxylated bipyridine ligand 
contributes to the stability of the complex by having empty  orbitals that can bond with the 
metal d orbital subshell and by being a chelating ligand. Each derivative bipyridine bonds 
twice to the metal center through the donation of the single pair electrons on both nitrogen 
atoms. If one of the metal-nitrogen bonds is broken, the other metal-nitrogen bond will hold 
the ligand in place long enough for the broken bond to reform (Watts 1984; Web ref. 6). 
Optical transitions result from the absorption of photons and transfer of electrons to higher 
energy molecular orbitals. The degree of allowedness depends on the symmetry and the 
multiplicity (or electron spin count) of the different states. Allowed transitions have no 
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change in electron spin (ΔS = 0). Forbidden transitions have a difference in electron spin 
between the ground and excited states. This means that only transitions from the singlet 
ground state, i.e. all electrons paired, to singlet excited states are allowed. Transitions from 
the singlet ground state to triplet excited states with two unpaired electrons, are forbidden. 
The allowedness of a transition can be inferred from the magnitude of the extinction 
coefficient for a given band in the optical absorbance spectrum. Allowed transitions have 
values of molar extinction coefficient in the thousands (L mol-1 cm-1), forbidden transitions 
have much smaller values (Watts 1984; Web ref. 6). 
The lowest energy excited state of ruthenium(II) tris-bipyridine (Figure 7) is a metal-to-
ligand charge transfer state, MLCT. This state is formed by the promotion of an electron from 
the filled metal highest occupied molecular orbital, HOMO, to an empty ligand π* lowest 
unoccupied molecular orbital, LUMO. This transition is fully allowed by the laws of quantum 
mechanics (symmetry and spin selection rules) and the transition has a large extinction 
coefficient. The value of the extinction coefficient is in the thousands for MLCT transitions 
and much smaller for d-d or metal centered transitions. The MLCT excited state is not 
strongly anti-bonding with respect to the metal-ligand bond. The π* character of the LUMO is 
primarily with respect to internal ligand pi bonds and not metal-ligand bonds. Creation of the 
MLCT excited state does not lead to the decomposition or photolysis of the complex to an 
appreciable degree (Watts 1984; Web ref. 6). 
 
Figure 7. Molecular orbital diagram for ruthenium (II) polypyridine diagram. Scheme (a) of the molecular 
orbitals and electron distribution at the ground state (GS). After light absorption (b), allowed electron 
transitions occur (solid vertical arrows), but intersystem crossing (ISC) takes place in which singlet states 
convert to triplet states. A forbidden process (long lived emission) generates phosphorescence emission (dashed 
diagonal arrows). Adapted from Web ref. 6. 
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This state is formed by the promotion of an electron from the filled metal HOMO to the 
higher energy d* orbital. This excited state is forbidden by the symmetry selection rules of 
quantum mechanics and a transition of this type will have a small extinction coefficient. In 
this case the anti-bonding character of the orbital is with respect to the metal-ligand bond. The 
probability of ligand loss (photolysis of the complex) increases with the formation of the 
ligand field (LF) excited state (Watts 1984; Web ref. 4). 
After the allowed singlet ground state to singlet excited state transition, the excited 
molecule relaxes to lower energy states. One possible relaxation is called intersystem crossing 
and results in the relaxation of a singlet state to a lower energy triplet state. For quantum 
mechanical reasons, primarily due to exchange integrals, triplet states are at lower energy than 
the singlet states of the same orbital parentage. On the state diagram above this is clearly seen. 
The singlet and triplet MLCT excited states have the same occupied orbitals, they only differ 
in energy due to the differences in electron spin pairings (Watts, 1984; Web ref 6). 
For ruthenium polybipyridine, the intersystem crossing efficiency is approximately 100%. 
This means that all singlet MLCT created upon absorption of a photon by the ground state 
become triplet MLCT states through intersystem crossing. The triplet MLCT is a long lived 
luminescent excited state, because relaxation to the singlet ground state is a slow process due 
to the difference in spin states. The relaxation process has a partially forbidden character. 
Ruthenium tris-bipyridine has a quantum yield of emission of about 8%. Only a small fraction 
of molecules go from the triplet excited state to the singlet ground state through the radiative 
mechanism. The majority of molecules relax to the ground state through non-radiative, 
vibrational relaxation processes. Release of a photon with an accompanying spin change is 
called phosphorescence (Watts 1984; Web ref. 6). 
 
1.8 Dengue fever 
 
Dengue fever (DF) is a tropical disease caused by a virus and transmitted mainly by Aedes 
aegypti, a species of mosquito with a global distribution. DF has emerged as a rapidly 
spreading vector-borne disease affecting mainly poor, urban populations and it is also the 
leading cause of hospital admissions in several countries (web ref. 7, WHO, 2010). The 
incidence of DF has dramatically grown over the world in recent decades. Over 2.5 billion 
people are now endangered from dengue. The World Health Organization (web ref. 8, WHO, 
2012) currently estimates 100 million cases of DF. About 500,000 cases are dengue 
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hemorrhagic fever (DHF), resulting in 5% of annual mortality. The disease is now endemic in 
more than 100 countries in Africa, America, Eastern Mediterranean, South-east Asia and 
Western Pacific. The threat of a possible outbreak of DF now exists in Europe and local 
transmission of DF was reported for the first time in 2010. For DHF, early medical care can 
save lives, decreasing mortality rates to less than 1% (Allwinn, 2011).  
The virus belongs to the family Flaviviridae and comprises four (DV-1–DV-4) distinct 
serotypes. The virus is composed of a nucleocapsid that is surrounded by a lipid membrane 
and covered by glycoproteins. Its genome consists of a single-stranded RNA that encodes a 
polyprotein precursor of viral proteins. This precursor is cleaved by host and viral proteases, 
which generates three structural proteins (C, capsid; prM, premembrane; and E, envelope) and 
seven nonstructural proteins (NS1, NS2a, NS2b, NS3, NS4A, NS4B and NS5). The structural 
proteins are incorporated into the mature infective virus, while the nonstructural proteins are 
involved in the replication and assembly of the virus. 
Once the mosquito bites a person and the virus is carried into the body, it binds to 
Langerhans cells, which are in the skin and identify pathogens. The virus enters the cells 
through an interaction between the viral proteins and the membrane proteins on the 
Langerhans cell. The membrane proteins are specifically the C-type lectins, called dendritic 
cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) and 
mannose receptors. The DC-SIGN, as a non-specific receptor for foreign material on dendritic 
cells, seems to be the main point of entry. The dendritic cell moves to the nearest lymph node. 
Meanwhile, the virus genome is translated in membrane-bound vesicles on the endoplasmic 
reticulum of the cell, where the cell protein synthesis apparatus produces new viral proteins 
that replicate the viral RNA, forming viral particles. Immature virus particles are transported 
to the Golgi apparatus, the part of the cell where some of the proteins receive necessary sugar 
chains (glycoproteins). The new mature viruses bud on the surface of the infected cell and are 
released by exocytosis. They are then able to enter other white blood cells, such as monocytes 
and macrophages (Rodenhuis-Zybert et al., 2010).  
The initial reaction of infected cells is to produce interferon, signaling molecule that raises 
a number of defenses against viral infection through the innate immune system by increasing 
the production of a large group of proteins. Interferon also activates the adaptive immune 
system, which leads to the generation of antibodies against the virus as well as T cells that 
directly attack any cell infected with the virus. Various antibodies are generated and most of 
them bind closely to the viral proteins and target them for phagocytosis (ingestion by 
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specialized cells and destruction) (Rodenhuis-Zybert et al., 2010). 
1.8.1 Disease stages 
 
After the incubation time of 4-9 days, the first symptoms appear, including abrupt onset 
fever, severe headache, muscle pain, joint pain and retro-orbital pain (Figure 8).  
 
 
Figure 8. Characteristics of Dengue fever infection. Variation of temperature, potential clinical issues, 
laboratory changes and serology/virology with time dependence after the outbreak of the infection. The critical 
stage occurs from the third to the sixth day and it is marked by intense bleeding in case of hemorrhagic fever 
(Adapted from Web ref. 9). 
 
 Due to the severe musculoskeletal pain, DF is also referred as “breakbone fever”. The 
neutrophils (white cells related to inflammatory processes) count starts falling from day 1 and 
the thrombocyte (blood platelet responsible for blood coagulation) count starts falling from 
day 3. The thrombocyte count will keep on falling until patient temperature returns to normal. 
Those dengue patients who have DHF start to show bleeding in skin, nose and even 
gastrointestinal tract (Dengue, 2012). The critical phase starts on day 3 to 7 after onset of 
illness at the time of defervescence when temperature is returning to normal. There is an 
increase in capillary permeability associated with plasma leak from intravascular 
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compartment to interstitial compartment which marks the beginning of critical period and 
lasts for 24 to 48 hours after which plasma leak stops. Although, majority of dengue patients 
do not develop plasma leak, those who indeed develop worsens with fall in blood pressure 
and hypoproteinemia, low level of proteins in the blood. The hematocrit, volume percentage 
of red cells in the blood, starts rising as protein leak is accompanied by loss of water from 
blood making blood thicker with lower volume. Dengue shock syndrome is fatal, if it is not 
treated promptly. This plasma leakage is transient lasting for 24 to 48 hours and if circulatory 
blood volume can be maintained during these critical 48 hours, life can be saved. Then it 
starts the recovery phase. If the patient survives the 24 to 48 hours of critical phase, a gradual 
reabsorption of extravascular interstitial fluid takes place in 48 to 72 hours.  Patient general 
condition improves and hemodynamic stabilizes (Web ref. 9). 
 
1.8.2 Serology 
 
Following the initial infection, the dengue virus replicates to high titers in the blood 
before patients present enough symptoms to go to a physician, with viremia peaking at the 
time or shortly after the onset of symptoms, as depicted in Figure 8. Virus remains detectable 
in the blood for up to 2 to 12 days after the onset of symptoms (Vaughn et al., 2000; Gubler et 
al.; 1981). 
During the viremic phase where the virus has access to the bloodstream and starts the 
dengue infection, NS1 antigen is produced concomitantly during the virus replication process 
(Figure 9).  
 
 
Figure 9. Target biomolecules for detection of Dengue fever infection. Antibody/Antigen level of NS1 protein 
and antibodies IgM and IgG in the blood stream after the outbreak of the symptoms (Adapted from Blacksell, 
2012). 
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The NS1 antigen is a 46- to 50-kilodalton glycoprotein highly conserved for all dengue 
serotypes and is expressed in either membrane-associated or secreted forms (Flamand et al., 
1999; Falconar et al., 1991). Soluble NS1 circulates in the serum of patients during the 
viremic phase of dengue virus infections and hence it is an excellent diagnostic target for 
acute dengue diagnosis. Difference in the persistence of soluble NS1 antigen in serum 
between primary (5-6 days post-onset of illness) and secondary dengue infections (6–12 days) 
has been noted. It is hypothesized that the presence of anti-NS1 antibodies, that are more 
frequently detected in dengue secondary infection (Koraka et al., 2003), modulates the 
formation of antibody-antigen complexes which impede the ability of the test to detect free 
NS1 antigen (Libraty et al., 2002; Young et al., 2000; Blacksell, 2012). 
Dengue IgM antibodies are a reliable marker of recent infection but not necessarily acute 
infection. In primary dengue virus infections, IgM antibodies are detected following the 
decline of viremia between days 3–5 after the onset of infection using very sensitive detection 
methods, reaching peak levels approximately 2 weeks later. In dengue endemic settings, IgM 
antibodies may be detectable as soon as after 2-3 days of the infection and peak IgM antibody 
levels are usually lower than in primary infections. The IgG antibody response develops a few 
days after the onset of the IgM antibody response and is serotype specific. The IgG antibodies 
may persist for many years following a single infection. Secondary dengue virus infections 
generate IgG antibody response that is characterized by a rapid rise in IgG antibodies 
detectable at days 4-5 of illness. This production is much sooner than the normal IgG 
antibody response of a primary infection (Blacksell, 2012). 
 
1.8.3 Lateral flow immunoassay based on viral NS1 protein 
 
The most important development in dengue diagnostics in recent years is the advent of the 
dengue virus NS1 antigen detection. Dengue tests that detect NS1 antigen employ a number 
of serotype-specific anti-NS1 monoclonal antibodies to capture and detect soluble NS1 
antigen in serum, plasma, or blood. ELISA is the most used method to detect NS1 protein, but 
LFIA is the most appropriate technology when point-of-care is necessary. 
Although LFIA has been successfully used in numerous systems, its application is limited 
when high sensitivity is required, especially in early stage disease diagnostics. A current 
limitation for LFIA application related to detection limit has been reported for early stage 
detection of Dengue fever infection. Twelve studies evaluated a commercial strip test (Biorad) 
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for the diagnosis of acute dengue infection using admission samples, and the results 
demonstrated considerable variation in sensitivity (49.8%–98.7%) but the specificities 
reported were consistent for all (>90%). For 25% of the studies, the sensitivity was >89%. 
However, all of these studies used a skewed comparator of virus isolation, real-time 
polymerase chain reaction, RT-PCR, or NS1-ELISA and did not examine the possibility of 
false-negative results by testing paired serum samples to examine for dynamic rise in 
serological assays such as IgM or IgG capture ELISAs. Studies that used a more 
representative combination of virus or antigen detection and serology as reference 
comparators gave sensitivities for the Biorad strip test between 49.4% (Najioullah et al., 
2011) and 78.9% (Pok et al., 2010).  
The Standard Diagnostic Bioline Dengue Duo NS1 antigen detection strip was evaluated 
for acute dengue diagnosis in four studies with consistently high specificity estimates (96.7–
100%) and sensitivities that ranged from 48.5% (Blacksell et al., 2011) to 65.4% (Wang et al., 
2010) with the studies either using a combination of virus detection and serology (Wang et al., 
2010; Osorio et al., 2010) as comparators or serology alone (Blacksell et al., 2011; Blacksell, 
2012).  
Similar limitations have been observed for other diseases, including HIV (Gray et al., 
2007), influenza (Gavin et al., 2003), malaria (Murray et al., 2008), among other diseases. 
 
1.9 Aim and structure 
 
Based on the necessity of sensitivity improvement, this thesis aims to enhance the 
performance of paper based immunoassays by screening and developing nanostructures to 
replace the conventional gold nanoparticles in the detection system.  
A brief summary of the results is presented in the next sections of this chapter: 
  Section 2.1 (Chapter 2): Investigation of the most commonly used detection 
labels for LFIA based on colorimetry and comparison of their performance in terms of 
detection limit (section 2.1.1). The best label, carbon black, was used to develop an 
immunospot assay and a lateral flow immunoassay for Dengue fever detection. These last 
results are described in the Chapter 5, but it was placed in this section to facilitate the 
comprehension (section 2.1.2); 
 Section 2.2 (Chapter 3): Development of an immunospot assay based on 
fluorescence for Dengue fever detection, addressing the challenge of fast and reliable tests for 
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low resources laboratories in epidemic periods; 
 Section 2.3 (Chapter 4): Development of core-shell polymer particles as a 
detection label to overcome particle agglomeration for paper based tests; 
 Section 2.4 (Chapter 5): Development of novel detection label for LFIA by 
combining colorimetry and fluorescence in order to produce test with high sensitivity. 
A diagram summarizing the thesis structure is shown in the Figure 10. 
 
 
Figure 10. Diagram of the thesis organization. Description of the challenges and strategies of immunoassays 
based on paper for impoverished environments discussed in the thesis. 
 
2. Results and Discussion 
 
In the second part of this chapter, the main results are briefly described in four sections 
according to the detection method used (colorimetry, fluorescence, phosphorescence and 
colorimetry combined to fluorescence). 
 
2.1 Optical based detection systems 
 
2.1.1 Enhancement of the detection limit for lateral flow immunoassays: evaluation and 
comparison of bioconjugates 
 
As described, LFIAs show limitations in applications that require high sensitivity, such as 
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early stage disease detection. In order to produce sensitive assays, a careful screening of 
detection labels has to be done during LFIA development. Although numerous particles have 
been already used as detection labels, there is a lack of studies to compare their sensitivties. 
Based on this necessity, this section compares the performance of the four commonly used 
labels in LFIA (more details are described in the Chapter 2): 
 colloidal gold nanoparticles 
 silver coated gold nanoparticles 
 polystyrene beads 
 carbon black 
Each system was chosen according to the literature, using the most appropriate label 
characteristics for LFIA. For instance, gold nanoparticles with 40 nm diameter provides the 
most efficient flow through the membranes and high signal to noise ratio in comparison to 
bigger gold particles. On the other hand, due to low density, carbon black is used in bigger 
diameters without prevent dramatically its flow through the membranes in which pore size is 
8-12 times the carbon black agglomerate diameter. The biomolecule immobilization was 
optimized for each particle and excess of labels was used in the experiments to ensure 
saturation in the nitrocellulose.  
In order to compare the signal intensity for the four labels in comparable experimental 
conditions observed in LFIA, spot tests on nitrocellulose membrane were performed. 
Bioconjugates of those particles were prepared by functionalization with streptavidin and they 
were evaluated using the biotin-streptavidin system. Dilution series of biotinylated-bovine 
serum albumin (BSA) were spotted from 10 mg/mL to 0.01 µg/mL onto the nitrocellulose 
membrane. Streptavidin coated particles flowed through the membranes and interacted with 
the biotinylated-BSA spots (more experimental details are described in the Chapter 2).  
Curves comparing signal intensity for each label are presented in Figure 11. Carbon black 
presents the highest blackness percentage in comparison to the other labels and the difference 
becomes more pronounced at higher concentrations. The silver coated gold nanoparticle was 
the second label in signal intensity, followed by gold nanoparticle and blue-polystyrene bead. 
The expanded area in the graph of the Figure 12 shows the variation of gold, silver coated 
gold and blue polystyrene particle intensity with biotinylated-BSA concentration.  
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Figure 11. Comparison of blackness percentage for four different labels. Curves of blackness intensity for gold, 
silver coated gold, blue polystyrene beads and carbon black were acquired according biotinylated-BSA 
concentration after 20 minutes of label exposition. Expanded area within the graph shows blackness variation 
for all labels excluding carbon black. 
 
Silver enhancement method provides an intensity superior to bare gold particles and 
detection limits of 1µg/mL and 100ng/mL for biotinylated-BSA, respectively. Carbon black 
has a visible signal until 10ng/mL of biotinylated BSA. On the other hand, blue polystyrene 
beads showed the lowest intensity, visually almost imperceptible when observed in low 
biotinylated BSA concentration (up to 100µg/mL). The summary of label performance is 
shown in the table 2. 
 
Table 2. Comparison of labels for LFIA based on biotin-streptavidin system. 
Particles Diameter (nm) 
Detection limit for 
biotin (µg/mL) 
carbon black 
100-200 
Agglomerates: 500-2000 
0.01 
silver coated gold nanoparticles < 200 0.1 
gold nanoparticles 39 ± 5 1 
polystyrene beads 239 ± 9 100 
 
Carbon black provides unmistakably the best signal to noise ratio and an imcomparable 
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performance in relation to the other tested labels. In addition, it is readly available in several 
forms and particle sizes useful for different detection ranges (Lönnberg et al., 2001). Based on 
these results, carbon black was chosen as label for Dengue fever detection, using Dengue 
virus NS1 glycoprotein as the biomarker. As prevously described (section 1.8.2), early 
detection of Dengue fever can be perfomed by detecting NS1 protein. LFIA based on gold 
nanoparticles (section 1.8.3) as standard labels provide limited sensitivity for diagnosis in the 
first days of the disease and carbon black can overcome this limitation by lowering the 
detection limit of the assay. 
The performance of gold and carbon black nanoparticles coated with anti-NS1 
monoclonal antibodies were compared in terms of visual signal provided by each label and it 
is described in the next section 2.2. More details about label comparison are described in the 
Chapter 2. 
 
2.1.2 Lateral flow immunoassay based on carbon black particles 
 
In this section, the use of carbon black particles as detection labels is investigated with 
particular emphasis on viral NS1 protein in LFIA. Again gold NPs served as the reference for 
comparison in terms of sensitivity. The results described in this section are detailed in the 
Chapter 5, but they were summarized here to facilitate the work comprehension. 
 The employed assay follows the principles of lateral flow tests already described in the 
Section 1.4. However, owing to the fact that carbon black particles tend to agglomerate, some 
modifications were required. The conjugate pad was removed and the LFIA basically 
consisted of three parts: (i) the absorbent pad (glass fiber) to filter the serum, (ii) the 
nitrocellulose membrane and (iii) the absorbent pad. The test and control lines are composed 
of monoclonal anti-NS1 antibody and anti-streptavidin antibody, respectively.  
In the actual experiment, the glass fiber pad was first immersed in the serum containing 
the NS1 proteins Figure 12. As the liquid flowed through the membrane, the anti-NS1 
antibodies captured and immobilized the NS1 proteins from the seum. After five minutes, the 
pad was immersed in a dispersion containing a mixture of two differently coated carbon black 
detection labels, one with anti-NS1 antibodies, the other with streptavidin. On arrival at the 
test line, the anti-NS1 antibody coated particles were captured by interaction with the NS1 
proteins. Accumulation of the captured carbon particles produced a visible black line, which 
provided evidence that the serum was infected with the Dengue virus. The detection limit was 
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determined by repeating the procedure with a series of differently diluted serum samples from 
an infected patient. The streptavidin coated carbon black particles were captured at the control 
line. The detection sensitivity could be improved by passing a washing buffer through the 
assay. The purpose was to transfer unbound carbon black particles from the membrane to the 
absorbent pad. The LFIA format with test immersion was preferred in relation to a 
conventional lateral flow test due to the formation of carbon black agglomerates during the 
drying step in the conjugate pad. This format avoids the formation of structures that block the 
membrane pores and consequently the flow. 
 
 
Figure 12. Scheme of lateral flow immunoassay based on carbon black. LFIA in a microplate after dipping 
one extremity in the serum, carbon black dispersion and washing buffer solution. The zoom of the test line shows 
the carbon black aggregate bound to the NS1 protein previously immobilized on the nitrocellulose membrane. 
 
To compare the carbon black performance in LFIA, an assay based on standard gold NPs 
was developed for NS1 protein detection. The assay has the conventional set up of a LFIA 
with four membranes (see section 1.4). The test and control lines consist of anti-NS1 
antibodies and biotinylated-albumin, respectively. Anti-NS1 protein capture antibody-gold 
NPs and streptavidin-gold NPs are the responsible labels for the color development. 
For the LFIA based on gold NPs, the test line is visible until 500 ng/mL (Figure 13a), and 
below this concentration, the test lines are inconsistent. As observed in the last section (2.1.1) 
for the immunospot experiments, the carbon black particles show a lower detection limit, 10 
ng/mL, than the gold nanoparticles (Figure 13b).  
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Figure 13. Pictures of the lateral flow immunoassay for Dengue virus NS1 protein. LFIA based on gold 
nanoparticles (a) and carbon black (b) for different concentrations of NS1 protein. The detection limits for gold 
nanoparticles and carbon black (indicated by the black arrows) are 500 ng/mL and 10 ng/mL, respectively. 
 
The sensitivity enhancement indicated by 50 times lower detection limit is decisive for 
early Dengue fever detection based on NS1 protein. Libraty and colleages (Libraty et al., 
2002) showed that plasma levels of free Dengue-2 virus secreted NS1 protein by day of 
illness variate between 150-250ng/mL for the second day of the disease for patients infected 
with secondary infections and Dengue hemorrhagic fever. Differently than colloidal gold, 
carbon black particles are able to provide visual signal below the NS1 concentration existent 
in infected patients on the first days of the disease, which can be vital for the rapid assesment 
of pacients developing more severe cases of the disease. 
 
2.2 Fluorecence based detection system 
  
2.2.1 Immunospot 
 
The work described in this section was driven by the current limitations to combine speed 
of analysis, ease of use and sensitivity for Dengue fever detection in laboratories with low 
resources. Currently, ELISA is the method of choice to detect Dengue virus NS1 protein in 
laboratories. However, this is a time consuming method, requiring 3-5 hours, and it is the 
bottleneck for routine of clinical analysis laboratory in epidemic periods, when hundreds of 
samples should be tested. This section describes an easy method combining principles of 
fluorophore linked immunosorbent assay (FLISA) and enzyme linked immunospotting 
(ELISPOT). FLISA follows the same principles of ELISA, but replacing the enzyme by a 
flurophore, which provides faster results with comparable sensitivity. ELISPOT is a method, 
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where antibodies are immobilized on a membrane, compounds secreted by cells are captured 
and an enzyme conjugated antibody provides the colorimetric detection. The advantage of 
combining the fluorescence detection of FLISA with the sample deposition on a membrane of 
ELISPOT is the development of a sensitive and fast assay.  
In the proposed test, a low volume of serum sample is applied onto a nitrocellulose 
membrane and mouse anti-NS1 IgG labeled with fluorescent nanoparticles are used for 
dengue detection. The test takes less time and the results can be qualitative/quantitative. The 
possibility of applying the sample directly to the nitrocellulose membrane with high protein 
affinity allows the use of low volume of samples and avoids the necessity of two antibodies 
for capture and detection. It reduces the costs, besides the time consuming incubation and 
washing steps. The use of fluorescent nanoparticles provides lower detection limit in 
comparison to conventional FLISA, additionally avoiding bleaching effects. As a general 
view, the immunospot test allows diagnosing DF in less than one hour with high specificity 
and sensitivity, less complexity and using conventional apparatus in clinical analysis 
laboratories. Detailed information about this section is described in the Chapter 3. 
In order to select a suitable particle, three commercial fluorescent particles with 40 nm of 
diameter were evaluated. Fluorophores incorporated in polymer particles were chosen to 
overcome bleaching effects generally observed with fluorescent dyes. The particles consisted 
of polystyrene containing multiple carboxylic acids for covalent ligand attachment. The 
chosen particles showed highest fluorescence emission, peaking at 567 nm and mean diameter 
of 37 ± 5 nm.  
Single and multiple tests were developed using commonly available materials and 
equipment in clinical laboratories. The single tests, or strip tests, were constructed combining 
cellulose and nitrocellulose membranes in a layer-by-layer structure, following LFIA 
principles (section 1.4). The test requires only 4 µL of serum sample, in contrast with 50-100 
µL for ELISA. In case of multiple sample analysis, parallel tests can be performed by 
applying the samples directly on the same nitrocellulose membrane with sufficient 15 mm 
spacing between each spot to avoid contamination. The molecules in the spot are pulled out of 
solution by the membrane and stick to the paper avoiding cross contamination between 
neighboring spots. This also remains stable after several washing steps. After adding the 
sample and blocking unspecific sites with albumin, fluorescent NPs coated with anti-NS1 
antibody is added and incubated during 15 min. The results of the test can be read after 
washing the membrane with washing buffer (more experimental details are explained in the 
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Chapter 3). 
Experiments comparing the fluorescence intensity of the same samples analyzed in single 
and multiple tests revealed a variation lower than 16%. The presented direct sample 
application is analogous to indirect ELISA tests, with the advantage of a shorter incubation 
time and no further washing steps. By using nitrocellulose, the high membrane-protein 
affinity assures the retention of the analyte into the membrane. 
Versatility was also achieved for the fluorescence measurement. Considering that 
laboratories around the world have varying amount of equipment availability and sometimes 
even lack of instruments altogether, three different instruments were used and evaluated: a 
simple fluorometer coupled to an optical fiber; an ELISA reader, which allows the 
measurement placing the membrane in a ELISA microplate; and a UV-lamp that can be used 
in unequipped laboratories providing qualitative results. Although, UV-lamp can only 
perform qualitative tests, it is a very cheap apparatus and can be easily obtained. The 
importance of such instrumentation is stressed by the fact that many tests only need a yes/no 
diagnostics. A lamp in the UVB range was chosen for the fact that they are mostly used in 
clinical laboratories and the emission is capable to excite the tail of the fluorophore excitation 
band. 
To compare the performance and consequently the detection limits for measurements 
performed with these three aparatus, a NS1 protein dilution series starting from 1 until 500 
ng/mL was analyzed by all of them (Figure 14).  
 
Figure 14. Comparison of detection instruments and conventional method. Fluorescent spots from serum 
dilution from an infected patient with anti-NS1 coated fluorescent particles measured under UV-lamp (a), by 
fluorometer coupled with optical fiber (black) and ELISA reader (red) (b). Positive (left) and negative (right) 
controls are shown in (c). Sandwich fluorescent immunosorbent assay (d) using fluorescent nanparticles and 
fluorescent dye molecules. 
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The fluorescent spots under UV-lamp (Figure 14a) can be easily visualized from 200 
ng/mL NS1 protein. Below this concentration, it is not possible to precisely confirm the 
positive NS1 protein serum signal. A positive and negative control is used to provide the 
limits for yes/no decision by comparison with the sample spot (Figure 14c). The negative 
control consists of a serum sample from a patient never infected with the virus. The positive 
control is a serum sample from a patient in the third day of the infection (highest NS1 
concentration during the infection, Figure 9), which was confirmed by NS1-ELISA and RT-
PCR.  
The measurements performed by the fluorometer coupled to an optical fiber showed a 
lower detection limit compared to the ELISA reader (Figure 14b). The detection limits were 
calculated, showing 5.2 and 11.5 ng/mL for optical fiber coupled to fluorometer and ELISA 
reader measurements, respectively. The relative standard deviation of the proposed method 
was evaluated by performing ten successive determinations of two serum samples. The 
calculation was performed dividing the standard deviation by the mean of the measurements. 
The values, 17% and 12%, were low considering that the tests are performed on membranes, 
where the pore structure is not so homogeneous as ELISA substrate. 
Although these two instruments showed different sensitivities for NS1 protein detection, 
both are adequate to be used for diagnosis. The immunospot is indeed capable of providing a 
reliable diagnostic below the NS1 concentration that exists in infected patients on the first-
second day of the infection. The low detection limit is decisive for early Dengue fever 
detection based on the NS1 protein and it is important for the rapid assessment of patients. 
When an UV-lamp is the only available tool, Dengue fever can be detected on the third day of 
infection. Lateral flow immunoassay tests are faster than the presented immunospot assay, but 
they require 25 times more sample volume and two antibodies (capture and detection). Thus, 
immunospot assay may be more appropriate for laboratory analyses of numerous samples.  
In order to evaluate the gain in performance of the proposed method in comparison to 
classical FLISA, analytical curves for NS1 antibody coated fluorescent particles and anti-
mouse IgG-fluorescein isothiocyanate (IgG-FITC) antibodies were obtained on nitrocellulose. 
Figure 14 shows that higher signals were recorded when particles were used, resulting 
therefore in a more sensitive assay. Besides avoiding bleaching effects, the use of particles 
permits to concentrate the fluorophores and contribute to a higher fluorescence signal per 
antibody bound to the antigen, unlike FLISA. Precisely, considering the concentration range 
between 2 and 100 ng/mL, the particles used as enhancers resulted in a curve slope of 0.758 
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a.u. mL/ng, which is higher than the assay using only IgG-FITC (0.539 a.u. mL/ng). It means 
that the proposed assay is more sensitive to detect variations on the concentration axis. 
In order to verify the potential of the proposed methodology in the biological analysis, 83 
blood serum samples from infected patients were analyzed and compared to a commercial 
NS1 ELISA. ELISA reader and UV-lamp were chosen as detection, because they are more 
commonly available in laboratories. Analysis provided satisfactory results compared to the 
commercial test (Table 3). The fluorescence measurements performed in ELISA reader 
revealed sensitivity of 81% and specificity of 88%. However, the qualitative measurements 
using UV-lamp showed low sensitivity, 59%, and specificity of 83%. Although, they showed 
low sensitivity, it is still acceptable as a diagnostic tool due to its sensitivity be superior to 
50%. The low sensitivity is justified by the difficulty to establish visual limits for considering 
a positive or a negative result. The limit was defined by the negative control, in which non-
infected serum was analyzed and non-specific interaction provided background intensity. 
Thus, the diagnostic was obtained by comparing visually the sample spots with the 
established limit. After comparing the values obtained with commercial NS1 ELISA and 
fluorescent measurements in ELISA reader (paired t-test), no significant statistical differences 
were found.  
 
Table 3. Dengue NS1 detection using the proposed method with reference to a commercial 
NS1 ELISA in 83 serum samples from infected patients. 
NS1 status 
Immunospot 
(ELISA reader) 
Immunospot 
(UV-lamp) Total 
 Positive Negative Positive Negative 
Positive 48 11 35 24 59 
Negative 3 21 4 20 24 
Total 51 32 39 44 83 
Sensitivity 81% 59%  
Specificity 88% 83%  
 
The newly developed test has the advantage of being performed during 45 to 60 minutes 
in comparison to classical ELISA or FLISA, which usually take 3-5 hours. The use of 
fluorescent nanoparticles allowed high sensitivity and ease detection using different 
laboratory equipment. In addition, the application of reagents and samples on nitrocellulose 
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membrane provided easy manipulation, low volume samples and lower costs. The 
combination of principles of different assays can produce a fast and high sensitive test to be 
applied to Dengue fever detection, mainly in impoverished environments and epidemic areas, 
where sensitivity, speed and simplicity are essentials. 
 
2.3 Phosphorescence based detection system 
 
2.3.1 Polymer core-shell particles of poly(styrene-co-hydroxyethylmethacrylate), PSHEMA, 
containing luminescent ruthenium complex  
 
Polymer particles are very promising as labels for diagnostic applications due to their 
property and functionality diversities. A current problem of polymer particles is the 
aggregation during synthesis or agglomeration after storage. For LFIA and ISA, the flow of 
particles through tortuous pathways inside the membranes is essential to assure 
reproducibility and reliability. The particle agglomeration can limit the label performance, and 
consequently the entire assay. Therefore, the work described in this section deals with the 
synthesis of polymer particles with low agglomeration, which can be used as labels in paper 
based immunoassays.  
Polystyrene particles (PS) are predominantly applied to biomedical purposes, including 
LFIA. Unfortunately, PS particles show low colloidal stability resuling in agglomeration and 
instability during bioconjugation steps. Accordingly, poly[styrene-co-(2-hydroxyethyl 
methacrylate)] (PSHEMA) polymer particles may be a suitable material for bioapplications 
substituting PS particles. PSHEMA particles consist of a hydrophilic/hydrophobic 
heterogeneous surface with high colloidal stability, insensitive non-specific agglutinability, 
free-emulsifier polymerization and high monodispersity. The particles are characterized as 
core-shell structures, where the HEMA richer chains are more concentrated at the particle 
periphery, stabilizing the hidrophobic core. The colloidal stabilization is provided by strong 
electrostatic repulsion with contributions of steric stabilization (Cardoso et al., 1998; 1999; 
2001; Okubo et al., 2003; Martin-Rodriguez et al., 1996).  
Due to their numerous advantages, PSHEMA particles were synthesized and used as 
detection labels in immunospot assay for Dengue fever detection. Ru complexes with 
carboxylated ligands were incorporated into the particles during the synthesis in order to 
produce luminescent structures. The carboxylated groups enabled the conjugation with 
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biomolecules and consequently allowed biomedical application. More details about the 
synthesis and Ru complex are described in the Chapter 4. 
The particle morphology was characterized using atomic force and transmission electron 
microscopies (Figure 15).  
 
 
Figure 15. Microscopic characterization of PSHEMA-Ru particles using AFM and TEM. AFM topography 
image (a) and histogram (b) of diameter distribution of the film surface of PSHEMA-Ru, showing a 
monodispersed size distribution evidenced by the hexagonal packing. Bright-field and energy loss images at 40 
eV (N shell of Ru) for PSHEMA (c and d) and Ru-PSHEMA (e and f). Line profiles of the particles at 40 eV 
without and with Ru complex, indicating a slight higher contrast between shell and core in presence of Ru than 
the particles without the complex.  
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Hexagonal packing caused by high uniformity of particle sizes is observed with low 
deformation of the particles (Figure 15a). The size distribution of 150 particles yields a 
diameter of 185 ±15 nm (Figure 15b). Energy filtered transmission electron microscopy 
(EFTEM) in combination with electron spectroscopy imaging (ESI-TEM) were used to 
investigate the Ru complex distribution in the particle (Linares et al., 2011; Valadares et al., 
2008). Bright-field images for PSHEMA and Ru-PSHEMA particles (Figure 15c and e) show 
spherical particles that present slight deformations as necks between the particles, more 
evident for PSHEMA-Ru. Energy loss TEM images were obtained at 40 eV, which is the N 
absorption threshold region of Ru (Figures 15d and f). PSHEMA core-shell structure has been 
already described in the literature using molecular maps at the low energy loss range (0-80eV) 
(Linares et al., 2009). The images at 40 eV show that the shell of PSHEMA particles with Ru 
complexes present a slight higher contrast in relation to the core in comparison to PSHEMA 
particles without Ru complexes, as shown by the line profiles (Figure 16g). More details of 
image analysis are described in the Chapter 4. 
The PSHEMA polymerization is described as a process where monomers are added to the 
growing chains inside of the polymer swollen particles and the HEMA richer chains are more 
concentrated at the particle periphery. X-ray photoelectron spectroscopy also indicated that 
the HEMA component is localized at the shell (Okubo et al., 1989). Thus, considering the 
hydrophilic structure of Ru complex, it can be expected that the complexes accumulate in the 
HEMA richer domains, the particle shell. Cardoso and col. (Cardoso et al., 1998) investigated 
the elemental distribution within PSHEMA particles and showed that the initiator counter ions, 
K+, concentrate in a thin outer particle surface. The positive layer around the particles can 
have an important role to keep the ruthenium complex in the particle shell.  
The Ru complexes concentrate at the particle shell and contribute for further conjugation 
with biomolecules. In order to demonstrate the potential of the nanoparticles for 
bioconjugation, biomolecules immobilized on the particle surface and the bioconjugates were 
applied as detection system for fluorescence microscopy. Monoclonal Dengue virus 
antibodies for a viral non-structural glycoprotein, NS1, were immobilized on the particle 
surface and they were used to analyze infected serum samples. A dilution series of the NS1 
protein was deposited on the nitrocellulose membrane, forming spots of 0.5 µL of serum. The 
resulting analytical curve and the respective luminescent spots (Figure 16a) show a linear 
range from 200 to 400 ng/mL and a detection limit of 187 ng/mL. More experimental details 
are described in the chapter 4.  
Chapter 1 
 
44 
 
 
Figure 16. Anti-NS1 coated PSHEMA-Ru particles used to detect Dengue virus NS1 protein. Analytical curve 
(a) for Dengue virus NS1 performed on nitrocellulose membrane and digital images of serum spots, where NS1 
protein was detected by anti-NS1 coated PSHEMA-Ru particles. Values were obtained by subtracting the 
background intensity from the spot signal. Images from serum positive samples (b) from the second (second row) 
and third day (first row) of infection from a group of 10 patients. Images were recorded at 10x of magnification. 
 
Serum positive samples (Figure 16b) from the second and third day of the infection of 10 
patients were analyzed using PSHEMA-Ru particles and a fluorescence microscope. The test 
was positive for all samples, proving that the luminescent particles are indeed capable of 
providing a reliable diagnostic for Dengue fever. The morphology of the serum spots show 
that the particles tend to accumulate on the edges of the serum spots, where the proteins also 
concentrate. When a solution of proteins is deposited on a nitrocellulose membrane, the 
proteins tend to accumulate on the edges of the spot. This is also observed in the Chapter 3, 
Figure 2g. For the samples from the third day of the infection (Figure 16b, second row), when 
the NS1 protein concentration is higher, the central part of the spots are also luminescent. It 
indicates that the particles flowed through the membrane with 450nm of porous size and 
interacted with the proteins adsorbed in that area. 
The PSHEMA-Ru particles showed to have a high potential to be successfully used in 
biomedical applications. The low agglomeration of the particles allows easy particle flow in 
the paper based assays, avoiding membrane obstruction and influence in the test performance. 
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2.4  Colorimetry and fluorescence based detection system 
 
2.4.1 Gold and fluorescent nanoparticle clusters 
 
In the last section (Chapter 5), the detection limit improvement of LFIAs and ISAs is 
taken up by the combination of colorimetry and fluorescence methods. Gold and fluorescent 
nanoparticles (emission maximum: 605 nm) were combined in small clusters and used as 
labels for immunoassays. The strategy increases the colorimetric signal because each analyte 
is recognized by several colored nanoparticles instead of a single nanoparticle. Furthermore, 
the combination of fluorescent NPs allow decreasing the detection limit by using a simple UV 
lamp to excite the fluophores, which also produces an enhanced signal in comparison to 
single fluorescent NPs used as detection labels. The fluorescence emission is only used in 
case that the colorimetric signal is not enough to provide a convincing result.  
The clusters were prepared by coating the particles with albumin and then combining 
them by peptide bonds between the albumin layers. The structures were characterized using 
transmission electron microscopy (Figure 17).  
 
Figure 17. Microscopic characterization of nanoparticles and clusters. Bright-field images of (a) gold 
nanoparticles, (b) fluorescent beads and (c) cluster of gold and polystyrene nanoparticles. Carbon map (d) of 
the clusters with red arrows indicating the gold nanoparticles and blue arrows point to the polymer particles. 
Spectra (e) of the background and the polymer particles. 
Gold 
NPs 
Polymer NPs 
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Bright field image of gold nanoparticles (Figure 17a) shows well dispersed structures with 
average diameter of 39 ± 5 nm. Image of fluorescent nanoparticles (Figure 17b) shows 
particles with a mean diameter of 38 ± 8 nm. In the bright field image of the clusters (Figure 
17c), the darker particles consist of gold due to its higher atomic number in comparison to 
fluorescent polystyrene nanoparticles. It is possible to observe small agglomerates consist of 
gold-gold, gold-fluorescent and fluorescent-fluorescent particles. The carbon map (Figure 
17d) indicates all materials containing carbon in their composition as intense bright signal. 
This image is obtained by an arithmetic procedures on images acquired above and below the 
energy threshold for the excitation of K shell electrons of carbon (303 eV). Hence, it 
demonstrates that there is organic material around the gold nanoparticles formed by 
biomolecules conjugated to the particle surface. The bare gold nanoparticles do not show the 
bright shell (image not shown here). The fluorescent nanoparticles are evidenced by 
undefined borders around the particles. The agglomerates consisted of gold and polystyrene 
show their organic shell of biomolecules in contact, suggesting interactions between them. 
The carbon map is confirmed by the electron energy loss spectroscopy (EELS) at the K 
absorption threshold region of carbon. It shows the high intensity of carbon signal for the 
polystyrene nanoparticles in comparison to the background formed by parlodium, which is a 
thin film that supports the sample and has carbon in its composition. 
Lateral flow immunoassays were developed using gold-fluorescent clusters as labels for 
Dengue fever detection (Figure 18a).  
 
Figure 18. Scheme and pictures of a lateral flow immunoassay based on clusters for Dengue virus NS1 
protein. Lateral flow immunoassay (a) based on gold-polystyrene nanoparticles clusters and zoom of the test 
line showing the cluster bound to the NS1 protein previously immobilized on the nitrocellulose membrane. LFIA 
pictures at different concentrations of NS1 protein (b) and under UV lamp (c). The detection limits for gold 
nanoparticles and carbon black alone (indicated by the red arrows) are 500 and 10 ng/mL, respectively. 
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The test and control lines consist of anti-NS1 capture antibody and biotinylated-albumin. 
The clusters were separately coated with anti-NS1 detection antibody and streptavidin. A red-
fluorescent line indicates positive serum sample for Dengue fever. 
Tests were performed with different NS1 protein concentration and the picture of them is 
shown in the Figure 18b and c. The detection limit of colorimetric signal is 10 ng/mL, but 
when the strip tests are under UV light, the detection limit is lowered down to 2.5 ng/mL 
(Figure 18c). Accordingly, gold-fluorescent nanoparticle cluster provides comparable 
colorimetric sensitivity of the best colored labels, carbon black, and shows additional 
sensitivity due to the fluorescent nanoparticles, contributing to a more reliable assay. 
 
2.5 Detection limit comparison 
 
In this work, different detection systems based on nanostructures were used in order to 
develop reliable, sensitive and fast immunoassays for early Dengue fever infection detection 
based on the viral protein NS1. A summary of the detection systems is described in the Table 
4, including characteristics of each system. A comparison between both colored labels 
indicates that an immunoassay produced with carbon black shows the highest colorimetric 
signal and represents an interesting option to replace gold nanoparticles (Chapter 2 and 5). 
Fluorescence is a very sensitive method that provides lower detection limits than colorimetry, 
as observed for the immunospot assay based on commercial fluorescent nanoparticles 
(Chapter 3). PSHEMA-Ru particle (Chapter 4) has a core-shell structure and also shows good 
performance with low particle agglomeration. Although fluorescent labels generally provide 
lower detection limit, it requires the use of fluorescence readers, which is contrary to the 
conception of producing a simple assay for impoverished environments. Therefore, clusters 
with colored and fluorescent nanoparticles were developed. The detection is based on 
colorimetric signal provided by gold nanoparticles, but an additional signal enhancement can 
be obtained by using a simple UV lamp or LED. As described above, the detection limit for 
the cluster showed comparable detection limit to carbon black, but lower values were 
obtained by exciting fluorescent particles.  
In terms of Dengue fever disease detection, all investigated labels detect the DF from the 
first to the second day of the infection, except for the PSHEMA-Ru particles, which can be 
used to diagnose from the second to the third day. The performance of those labels is superior 
to the standard gold nanoparticles currently in use in commercial available assays and the 
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progress achieved by this thesis in terms of LFIA sensitivity is shown in the Figure 20. 
 
 
Figure 19. NS1 concentration vs. infection time after symptom onset and detection limits of LFIA. Detection 
limit of commercial LFIA kits based on gold nanoparticles and the achievements of the detection labels obtained 
in this thesis (Adapted from Libraty et al., 2002) 
  
The graph clearly shows that commercial tests can only detect the disease from third of 
the infection, when the patient with hemorrhagic fever is already on risk to develop shock 
bleeding. However, the proposed labels allow the detection of DF days before than the 
commercial kits (1st-2nd day). The anticipated diagnostic is essential to provide correct 
treatment and avoids the progress of the infection. The high sensitivity in immunoassays can 
be very useful for the development of point-of-care tools that provide early stage diagnostic of 
other diseases. 
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Table 4. Summary of the detection systems for Dengue fever diagnostics based on nanoparticles. 
Detection system Assay type Detection limit (ng/mL) 
Duration 
(min) 
Day after 
the outbreak References 
Gold 
nanoparticles 
(“gold standard”)  
 
Lateral flow 
immunoassay 
 
 
500 20 3rd Chapter 2 
Carbon black 
 
 
 
Lateral flow 
immunoassay 
 
 
10 25 1st-2nd Chapter 2 and 5 
Fluorescent 
nanoparticles 
 
Immunospot 
assay 
 
Optical fiber reader: 5 
ELISA reader: 15 
UV lamp: 200 
 
45-60 1st-2nd Chapter 3 
Luminescent 
PSHEMA-Ru 
particles 
 
 
 
Immunospot 
assay 
 
Microscope: 190 25 3rd Chapter 4 
Gold-fluorescent 
nanoparticles 
clusters 
 
 
Lateral flow 
immunoassay 
 
 
Visible: 10 
Under UV: 2.5 25 1st-2nd Chapter 5 
Chapter 1 
 
 50
3. References 
Algar, W.R.; Prasuhn, D. E.; Stewart, M. H.; Jennings, T. L.; Blanco-Canosa, J. B.; Dawson, P. E.; 
Medintz, I. L. The controlled display of biomolecules on nanoparticles: a challenge suited to 
bioorthogonal chemistry. Bioconjugate Chem. 2011, 22, 825–858. 
Allwinn, R. Significant increase in travel-associated dengue fever in Germany. Med. Microbiol. 
Immunol. 2011, 200, 155–159. 
Azzazy, H. M. E.; Mansour, M. M. H.; Kazmierczak, S. C. Nanodiagnostics: A New Frontier for 
Clinical Laboratory Medicine Clin. Chem. 2006, 52, 1238–1246. 
Bathoorn, E.; Limburg, A.; Bouwman, J. J.; Bossink, A. W.; Thijsen, S. F. Diagnostic potential of 
an enzyme-linked immunospot assay in tuberculous pericarditis. Clin. Vaccine Immunol. 2011, 
18, 874–877. 
Blacksell, S. D.; Jarman, R. G.; Bailey, M. S.; Tanganuchitcharnchai, A.; Jenjaroen, K.; Gibbons, R. 
V.; Paris, D. H.; Premaratna, R.; Janaka de Silva, H.; Lalloo, D. G.; Day, N. P. J. Evaluation of 
six commercial point-of-care tests for diagnosis of acute dengue infections: the need for 
combining NS1 antigen and IgM/IgG antibody detection to achieve acceptable levels of 
accuracy. Clin. Vaccine Immunol. 2011, 18, 2095–2101. 
Blacksell, S. D. Commercial Dengue Rapid Diagnostic Tests for Point-of-Care Application: Recent 
Evaluations and Future Needs? J. Biomed. Biotechnol. 2012, 2012, 1–12. 
Cardoso, A. H.; Leite, C. A. P.; Zaniquelli, M. E. D.; Galembeck, F. Easy polymer latex self-
assembly and colloidal crystal formation: the case of poly[styrene-co-(2-hydroxyethyl 
methacrylate)]. Colloids Surf., A 1998, 144, 207–217. 
Cardoso, A. H.; Leite, C. A: P.; Galembeck, F. Latex particle self-assembly and particle 
microchemical symmetry: ps/hema latex particles are intrinsic dipoles. Langmuir 1999, 15, 
4447–4453. 
Cardoso, A. H.; Leite, C. A. P.; Galembeck, F. Latex macrocrystal self-assembly dependence on 
particle chemical heterogeneity. Colloids Surf., A 2001, 181, 49–55. 
Carrilho, E.; Phillips, S.T.; Vella, S.J.; Martinez, A.W.; Whitesides, G.M. Paper Microzone Plates. 
Anal. Chem. 2009, 81, 5990–5998. 
Cheng, C.-M.; Martinez, A.W.; Gong, J.; Mace, C.R.; Phillips, S.T.; Carrilho, E.; Mirica, K.A.;  
Cho, J-H.; Paek, S-H. Semiquantitative, bar code version of immunochromatographic assay system 
for humam serum albumin as model analyte. Biotechnol. Bioeng. 2001, 75, 725–732. 
Cole, S. P. C.; Campling, B. G.; Atlaw, T.; Kozbor, D.; Roder, J. C. Human monoclonal antibodies. 
Mol. Cell. Biochem. 1984, 62, 109–120. 
Chapter 1 
 
 51
Cortez-Retamozo, V.; Backmann, N.; Senter, P. D.; Wernery, U.; Baetselier, P. D.; Muyldermans, 
S.; Revets, H. Efficient cancer therapy with a nanobody-based conjugate. Cancer Res. 2004, 
64, 2853–2857. 
Discher, D. E.; Ahmed, F. Polymersomes. Ann. Rev. Biomed. Eng. 2006, 8, 323–341. 
Ellerbee, A. K.; Phillips, S. T.; Siegel, A. C.; Mirica, K. A.; Martinez, A. W.; Striehl, P.; Jain, N.; 
Prentiss. M.; Whitesides. G. M. Quantifying colorimetric assays in paper-based microfluidic 
devices by measuring the transmission of light through paper. Anal. Chem. 2009, 81, 8447–
8452. 
Falconar, A. K. I.; Young, P. R. Production of dimerspecific and dengue virus group cross-reactive 
mouse monoclonal antibodies to the dengue 2 virus non-structural glycoprotein NS1.  J. Gen. 
Virol.  1991, 72, 961–965. 
Flamand, M.; Megret, F.; Mathieu, M.; Lepault, J.; Rey, F. A.; Deubel, V. Dengue virus type 1 
nonstructural glycoprotein NS1 is secreted from mammalian cells as a soluble hexamer in a 
glycosylation-dependent fashion. J. Virol. 1999, 73, 6104–6110.  
Fortina, P.; Kricka, L. J.; Graves, D. J.; Park, J.; Hyslop, T.; Tam, F.; Halas, N.; Surrey, S.; 
Waldman, S. A. Applications of nanoparticles to diagnostics and therapeutics in colorectal 
cancer. Trends Biotechnol. 2007, 25, 145-152. 
Franci, C.; Ingles, J.; Castro, R.; Vidal, J. Further studies on the ELISA-spot technique. Its 
application to particulate antigens and a potential improvement in sensitivity. J. Immunol. 
Methods 1986, 88, 225–232. 
Gavin, P. J.; Thomson, Jr., R. B. Review of rapid diagnostic tests for influenza. Clin. Appl. 
Immunol. Rev. 2003, 4, 151–172. 
Goldman, E. R.; Clapp, A. R.; Anderson, G. P.; Uyeda, H. T.; Mauro, J. M.; Medintz, I. L.; 
Mattoussi, H. Multiplexed toxin analysis using four colors of quantum dot fluororeagents. Anal. 
Chem. 2004, 76, 684–688. 
Gray, R. H.; Makumbi, F.; Serwadda, D.; Lutalo, T.; Nalugoda, F.; Opendi, P.; Kigozi, G.; 
Reynolds, S. J.; Sewankambo, N. K.; Wawer, M. J. Limitations of rapid HIV-1 tests during 
screening for trials in Uganda: diagnostic test accuracy study. Brit. Med. J. 2007, 335, 188–190. 
Gubala, V.; Harris, L. F.; Ricco, A. J.; Tan, M. X.; Williams, D. E. Point of care diagnostics: status 
and future. Anal. Chem. 2010, 84, 487–515. 
Gubler, D. J.; Suharyono, W.; Tan, R. Viraemia in patients with naturally acquired dengue 
infection,” Bulletin of the World Health Organization 1981, 59, 623–630. 
Guo, X.; Szoka, F. C. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. 
Acc. Chem. Res. 2003, 36, 335–341. 
Chapter 1 
 
 52
Gussenhoven, G. C.; van der Hoorn, M. A.; Goris, M. G.; Terpstra, W. J.; Hartskeerl, R. A.; Mol, B. 
W.; van Ingen, C. W.; Smits, H. L. LEPTO dipstick, a dipstick assay for detection of 
Leptospira-specific immunoglobulin M antibodies in human sera. J. Clin. Microbiol. 1997, 35, 
92–97. 
Haeberle, S.; Zengerle, R. Microfluidic platforms for lab-on-a-chip applications. Lab on a Chip 
2007, 7, 1094–1110. 
Jain, K. K.  Nanodiagnostics: application of nanotechnology in molecular diagnostics. Expert. Rev. 
Mol. Diagn. 2003, 3,153– 161. 
Jain, K.K. Nanotechnology in clinical laboratory diagnostics. Clin. Chim. Acta. 2005, 358, 37–54. 
Jain, P. K.; Huang, X.; El-Sayed, I. H.; El-Sayed, M. A. Noble metals on the nanoscale: Optical and 
photothermal properties and some applications in imaging, sensing, biology and medicine. Acc. 
Chem. Res. 2008, 41, 1578–1586. 
Jianrong, C.; Yuqing, M.; Nongyue, H.; Xiaohua, W.; Sijiao, L. Nanotechnology and Biosensors. 
Biotechnol. Adv. 2004, 22, 505–518. 
Juntunen, E.; Myyryläinen, T.; Salminen, T.; Soukka, T.; Pettersson, K. Performance of fluorescent 
europium(III) nanoparticles and colloidal gold reportersin lateral flow bioaffinity assay. Anal. 
Biochem. 2012, 428, 31–38. 
Köhler, G.; Milstein, C. Continuous cultures of fused cells secreting antibody of predefined 
specificity. Nature 1975, 256, 495–497. 
Koraka, P.; Burghoorn-Maas, C. P.; Falconar, A.; Setiati, T. E.; Djaniatun, K.; Groen, J.; Osterhaus, 
A. D. M. E. Detection of immune-complex-dissociated nonstructural-1 antigen in patients with 
acute dengue virus infections. J. Clin. Microbiol. 2003, 41, 4154–4159. 
a Laitinen, M. P. A.; Sojakka, K. M.; Vuento, M. Thin-Layer Affinity Chromatography in Analysis 
of Protein-Ligand Affinity.  Anal. Biochem. 1996, 243, 279–282. 
b Laitinen, M. P. A.; Vuento, M. Affinity immunosensor for milk progesterone: identification of 
critical parameters. Biosens. Bioelectron. 1996, 11, 1207–1214. 
Leung, V. Development of Paper-based Devices for Diagnostics and Biosensing. Master thesis, 
University Hamislton, Ontario 2011. 
a Leuvering, J. H. W.; Thal, P. J. H. M.; Van Der Waart, M.; Schuurs, A. H. W. M. Sol particle 
immunoassay (SPIA). J. Immunoassay 1980, 1, 77–91. 
b Leuvering, J. H. W.; Thal, P. J. H. M.; Waart, M.; Schuurs, A. H. W. M. Sol particle agglutination 
immunoassay for human chorionic gonadotrophin. Fresenius’ J. Anal. Chem. 1980, 301, 132. 
Leuvering, J. H. W.; Goverde, B. C.; Thal, P. J. H. M.; Schuurs, A. H. W. M. A homogeneous sol 
particle immunoassay for human chorionic gonadotrophin using monoclonal antibodies. J. 
Chapter 1 
 
 53
Immunol. Meth. 1983, 60, 9–23. 
Libraty, D. H.; Young, P. R.; Pickering, D.; Endy, T. P.; Kalayanarooj, S.; Green, S.; Vaughn, D. 
W.; Nisalak, A.; Ennis, F. A.; Rothman, A. L. High circulating levels of the dengue virus 
nonstructural protein NS1 early in dengue illness correlate with the development of dengue 
hemorrhagic fever. J Infect. Dis. 2002, 186, 1165–1168. 
 Liddell, E.;  Weeks, I. In Antibody technology; Therapeutic application of antibodies, Chapter 7. 
Bios Scientific Publisher: Oxford, United Kingdom, 1995; pp. 103–119. 
Lin, W.; Zheng, Y.; Zhang, J.; Wan, X. Fabrication of core shell nanostructures from near-infrared 
electrochromic amphiphilic diblock copolymers containing pendant dinuclear ruthenium group 
through assembly and their optical, electrochemical, and electroptical properties. 
Macromolecules 2011, 44, 5146–5154. 
Linares, E. M.; Valadares, L. F.; Silva, C. A.; Rezende, C. A.; Galembeck, F. Molecular mapping 
by low-loss-energy EFTEM imaging. Anal. Chem. 2009, 81, 2317–2324. 
Linares, E. M.; Jannuzzi, S. A. V.; Galembeck, F. Electrostatic contributions in the increased 
compatibility of polymer blends. Langmuir 2011, 27, 15199–15205. 
a Linares, E. M.; Kubota, L. T.; Michaelis, J.; Thalhammer, S. Enhancement of the detection limit 
for lateral flow immunoassays: evaluation and comparison of bioconjugates J. Immunol. 
Methods 2012, 375, 264–270. 
b Linares, E. M.; Pannuti, C.S.; Kubota, L.T.; Thalhammer, S. Immunospot assay based on 
fluorescent nanoparticles for Dengue fever detection. Biosens. Bioelectron.  2012, in press. 
Lipman, N. S.; Jackson, R. L.; Trudel, L. J.; Weis-Garcia, F. Monoclonal versus polyclonal 
antibodies: distinguishing characteristics, applications, and information resources. ILAR J. 2005, 
46, 258–268. 
Liu, C.; Jia, Q.; Yang, C.; Qiao, R.; Jing, L.; Wang, L.; Xu, C.; Gao, M. Lateral flow 
immunochromatographic assay for sensitive pesticide detection by using fe3o4 nanoparticle 
aggregates as color reagents. Anal. Chem. 2011, 83, 6778–6784. 
Lönnberg, M.; Carlsson, J. Quantitative detection in the attomole range for 
immunochromatographic tests by means of a flatbed scanner. Anal. Biochem. 2001, 293, 224–
231. 
Lou, S.; Patel, C.; Ching, S.; Gordon, J. One-step competitive immunochromatographic assay for 
semiquantitative determination of lipoprotein(a) in plasma. Clin. Chem. 1993, 39, 619–624. 
Mark, D.; Haeberle, S.; Roth, G.; von Stetten, F.; Zengerle, R. Microfluidic lab-on-a-chip 
platforms: requirements, characteristics and applications. Chem. Soc. Reviews 2010, 39, 1153-
1182. 
Chapter 1 
 
 54
Martin-Rodriguez, A.; Cabrerizo-Vilchez, M. A.; Hidalgo-Alvarez, R. Surface characterization of 
latexes with different interfacial Properties Colloids Surf., A 1996, 108, 263–271. 
Martinez, A.W.; Phillips, S.T.; Whitesides, G.M.; Carrilho, E. Diagnostics for the Developing 
World: Microfluidic Paper-Based Analytical Devices. Anal. Chem. 2010, 82, 3–10. 
Masoodi, R.; Pillai, K. M. Darcy's law-based model for wicking in paper-like swelling porous 
media. AIChE Journal 2010, 56, 2257–2267. 
Mukhopadhyay, S.; Kuhn, R. J.; Michael Rossmann, M. G. A structural perspective of 
the flavivirus life cycle. Nat. Rev. Microbiol. 2005, 3, 13–22.  
Murray, C. K.; Gasser, Jr., R. A.; Magill, A. J.; Miller, R. S. Update on Rapid Diagnostic Testing 
for Malaria. Clin. Microbiol. Rev. 2008, 21, 97–110. 
Najioullah, F.; Combet, E.; Paturel, L.; Martial, J.; Koulmann, L.; Thomas, L.; Hatchuel, Y.; Cabié, 
A.; Cesaire, R. Prospective evaluation of nonstructural 1 enzyme-linked immunosorbent assay 
and rapid immunochromatographic tests to detect dengue virus in patients with acute febrile 
illness. Diagn. Microbiol. Infect. Dis. 2011, 69, 172–178. 
Näreoja, T.; Vehniäinen, M.; Lamminmäki, U.; Hänninen, E. P.; Härmä, H.; Study of nonspecific of 
an immunoassy using Eu-doped polystyrene nanoparticle labels. J. Immunol. Methods 2009, 
345, 80–89. 
O’Keeffe, M.; Crabbe, P.; Salden, M.; Wichers, J.; van Peteghem, C.; Kohen, F.; Pieraccini, G.; 
Moneti, G. Preliminary evaluation of a lateral flow immunoassay device for screening urine 
samples for the presence of sulphamethazine. J. Immunol. Methods 2003, 278, 117–126. 
Okubo, M.; Suzuki, T.; Fukuhara, Y. Estimation of heterogeneous surface structure of submicron-
sized, composite polymer particles consisting of hydrophobic and hydrophilic components by 
atomic force microscopy. Colloid Polym. Sci. 2003, 281, 569–574. 
Osorio, L.; Ramirez, M.; Bonelo, A.; Villar, L. A.; Parra, B. Comparison of the diagnostic accuracy 
of commercial NS1- based diagnostic tests for early dengue infection. Virol. J. 2010, 361. 
Parolo, C.; Escosura-Muñiz, A.; Merkoçi, A. Enhanced lateral flow immunoassay using gold 
nanoparticles loaded with enzymes. Biosens. Bioelectron. 2012, in press. 
Peer, D.; Karp, J. M.; Hong, S.; Farokhzad, O. C.; Margalit, R.; Langer, R. Nanocarriers as an 
emerging platform for cancer therapy. Nat. Nanotechnol. 2007, 2, 751–760. 
Pok, K. Y.; Lai, Y. L.; Sng, J.; Ng, L. C. Evaluation of nonstructural 1 antigen assays for the 
diagnosis and surveillance of dengue in Singapore. Vector-Borne Zoonotic Dis. 2010, 10, 1009–
1016. 
Ponti, J. S.; Brown, M. C.; Chun, P.; Mansfield, M. A. In Lateral flow immunoassay. Wong, R.; Tse, 
H., Ed.; Material platform for the assembly of LFIA test strips/ Antibodies: key to a robust 
Chapter 1 
 
 55
LFIA/ Colloidal gold and other labels for LFIA/ Nitrocellulose membrane for LFIA: a technical 
treatise. Chapters 3-6; Human Press: New York, US, 2009; pp 51–114. 
Posthuma-Trumpie, G. A.; Korf, J.; van Amerongen, A. Lateral flow (immuno)assay: its strengths, 
weaknesses, opportunities and threats. A literature survey. Anal. Bioanal. Chem. 2009, 
393,569–582. 
Posthuma-Trumpie, G. A.; Wichers, J. H.; Koets, M.; Berendsen. L. B. J. M.; van Amerongen, A. 
Amorphous carbon nanoparticles: a versatile label for rapid diagnostic (immuno)assays. Anal. 
Bioanal. Chem. 2012, 402, 593–600. 
Rayev, M.; Shmagel, K. Carbon-protein covalent conjugates in non-instrumental immunodiagnostic 
systems. J. Immunol. Methods 2008, 336, 9–15. 
Rodenhuis-Zybert, I. A.; Wilschut, J.; Smit, J. M. Dengue virus life cycle: viral and host factors 
modulating infectivity". Cell. Mol. Life Sci. 2010, 67, 2773–86. 
Schubert-Ullrich, P.; Rudolf, J.; Ansari, P.; Galler, B.; Führer, M.; Molinelli, A.; Baumgartner, S. 
Anal. Bioanal. Chem. 2009, 395, 69–81. 
Schwarz, J. P.; Spackman, J. R.; Fahey, D. W.; Gao, R. S.; Lohmann, U.; Stier, P.; Watts, L. A.; 
Thomson, D. S.; Lack, D. A.; Pfister, L.; Mahoney, M. J.; Baumgardner, D.; Wilson, J. C.; 
Reeves, J. M. Coatings and their enhancement of black carbon light absorption in the tropical 
atmosphere.  J. Geophys. Res. 2008, 113, D03203.  
Skoog, D. A.; West, D. M.; Holler, F. J.; Crouch, S. R. In Fundamentals of Analytical Chemistry, 
Introduction to spectrochemical methods; Instruments for optical spectrometry; Molecular 
absorption spectrometry; Molecular fluorescence spectroscopy, Chapter 24-27, 8th ed Thomson, 
Brooks/Cole: Toronto, Canada, 2004; pp 710–838. 
Snowden, K.; Hommel, M. Antigen detection immunoassay using dipsticks and colloidal dyes.  J. 
Immunol. Methods 1991, 140, 57–65.  
Torchilin, V. P. Multifunctional nanocarriers. Adv. Drug Delivery Rev. 2006, 58, 1532–1555. 
Valadares, L. F.; Linares, E. M.; Braganca, F. C.; Galembeck, F. Electrostatic adhesion of 
nanosized particles: the cohesive role of water. J. Phys. Chem. C 2008, 112, 8534–8544. 
Vaughn, D. W.; Green, S.; Kalayanarooj, S.; Innis, B. L.; Nimmannitya, S.; Suntayakorn, S.; Endy, 
T. P.; Raengsakulrach, B.; Rothman, A. L.; Ennis, F. A.; Nisalak, A. Dengue viremia titer, 
antibody response pattern, and virus serotype correlate with disease severity,” J. Infect. Dis. 
2000, 181, 2–9. 
Verheijen, R.; Stouten, P.; Cazemier, G.; Haasnoot, W. Development of a one step strip test for the 
detection of sulfadimidine residues. Analyst 1998, 123, 2437–2441. 
Xia, X.; Xu, Y.; Zhao, X; Li, Q. Lateral flow immunoassay using europium chelate-loaded silica 
Chapter 1 
 
 56
nanoparticles as labels. Clin. Chem. 2009, 179–182. 
Zaytseva, N. V.; Montagna, R. A.; Lee, E. M.; Baeumner, A. J. Multi-analyte single-membrane 
biosensor for the serotype-specific detection of Dengue virus. Anal. Bioanal. Chem. 2004, 380, 
46–53. 
Zhang, C.; Zhang, Y.; Wang, S. Development of Multianalyte Flow-through and Lateral-Flow 
Assays Using Gold Particles and Horseradish Peroxidase as Tracers for the Rapid 
Determination of Carbaryl and Endosulfan in Agricultural Products. J. Agric. Food Chem. 2006, 
54:2502–2507. 
Yang, Q.; Gong, X.; Song, T.; Yang, J.; Zhu, S.; Li, Y.; Cui, Y.; Li, Y.; Zhang, B.; Chang, J. 
Quantum-dot based immunochromatography test strip for rapid, quantitative and sensitive 
detection of alpha fetoprotein. Biosens. Bioelectron. 2011, 30, 145–150. 
Young, P. R.; Hilditch, P. A.; Bletchly, C.; Halloran, W. An antigen capture enzyme-linked 
immunosorbent assay reveals high levels of the dengue virus protein NS1 in the sera of infected 
patients. J. Clin. Microbiol. 2000, 38, 1053–1057. 
Watts, R.J. Ruthenium Polypyridyls: A Case Study. J. Chem. Educ. 1983, 60, 834–842. 
Whitesides, G.M. Paper-Based ELISA. Angew. Chem. Int. Ed. 2010, 49, 4771–4774. 
 
Web references: 
(Last access:December 2012)  
 
Web ref. 1, ASTM E2456 
http://www.astm.org/Standards/E2456.htm 
Web ref.2, Millipore tutorial: 
http://www.millipore.com/immunodetection/id3/antibodiestutorial  
Web ref. 3, Abcam protocol: 
http://www.abcam.com/index.html?pageconfig=resource&rid=11269&pid=11287 
Web ref. 4, WHO: 
http://www.who.int/tdr/publications/documents/bl7-annual-report-2008.pdf 
Web ref. 5, Millipore protocol:  
http://www.millipore.com/techpublications/tech1/tb500en00 (last access date: 9/2012). 
Web ref. 6: 
http://www.lasalle.edu/~prushan/IC-articles/IC%20exp%204.pdf 
Web ref. 7:  
WHO: http://whqlibdoc.who.int/publications/2010/9789241564090_eng.pdf (last access date: 
Chapter 1 
 
 57
9/2012). World Health Organization, 2010.  
Web ref. 8:  
WHO: http://www.who.int/mediacentre/factsheets/fs117/en/ -(last access date: 9/2012). World 
Health Organization, 2012. Fact Sheet 117. 
Web ref. 9: 
 http://drrajivdesaimd.com/290/drrajivdesai/dengue/ 
 
 
 
 
Chapter 2 
 
 58
 
 
 
 
 
 
 
   
 
 
 
CHAPTER 2 
Enhancement of the detection limit for lateral 
flow immunoassays: Evaluation and comparison 
of bioconjugates 
 
 
 
 
 
 
  
 
 
 
 
 
Journal of Immunological Methods 375 (2012) 264–270
Contents lists available at SciVerse ScienceDirect
Journal of Immunological Methods
j ourna l homepage: www.e lsev ie r .com/ locate / j im
Chapter 2Technical note
Enhancement of the detection limit for lateral ﬂow immunoassays:
Evaluation and comparison of bioconjugates
Elisângela M. Linares a, Lauro T. Kubota b, Jens Michaelis c, Stefan Thalhammer a,⁎
a Helmholtz Zentrum München, German Research Center for Environmental Health, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany
b Institute of Chemistry, University of Campinas, Cidade Universitária s/n, 13083-970, Campinas, São Paulo, Brazil
c Department of Chemistry, Ludwig-Maximilians-Universität München, Butenandtstr. 11, Haus E, 81377 München, Germanya r t i c l e i n f o⁎ Corresponding author at: Helmholtz Zentrum Mü
13084-971, München, Germany. Tel.: +49 89/3187 28
3323.
E-mail address: stefan.thalhammer@helmholtz-mu
(S. Thalhammer).
0022-1759/$ – see front matter © 2011 Elsevier B.V. A
doi:10.1016/j.jim.2011.11.003a b s t r a c tArticle history:
Received 25 September 2011
Received in revised form 2 November 2011
Accepted 3 November 2011
Available online 10 November 2011There is an increasing demand for convenient and accurate point-of-care tools that can detect and
diagnose different stages of a disease in remote or impoverished settings. In recent years, lateral
flow immunoassays (LFIA) have been indicated as a suitable medical diagnostic tool for these en-
vironments because they require little or no sample preparation, provide rapid and reliable results
with no electronic components and thus can be manufactured at low costs and operated by un-
skilled personnel. However, even though they have been successfully applied to acute and chronic
disease detection, LFIA based on gold nanoparticles, the standard marker, show serious limita-
tions when high sensitivity is needed, such as early stage disease detection. Moreover, based on
the lack of comparative information for label performance, significant optimization of the systems
that are currently in use might be possible. To this end, in the presented work, we compare the
detection limit between the four most used labels: colloidal-gold, silver enhanced gold, blue
latex bead and carbon black nanoparticles. Preliminary results were obtained by using the bio-
tin–streptavidin coupling as a model system and showed that carbon black had a remarkably
low detection limit of 0.01 μg/mL in comparison to 0.1 μg/mL, 1 μg/mL and 1 mg/mL for silver-
coated gold nanoparticles, gold nanoparticles and polystyrene beads, respectively. Therefore, as
a proof of concept, carbon black was used in a detection system for Dengue fever. This was
achieved by immobilizing monoclonal antibodies for the nonstructural glycoprotein (NS1) of
the Dengue virus to carbon black. We found that the colorimetric detection limit of 57 ng/mL
for carbon black was ten times lower than the 575 ng/mL observed for standard gold nanoparti-
cles; which makes it sensitive enough to diagnose a patient on the first days of infection. We
therefore conclude that, careful screening of detection labels should be performed as a necessary
step during LFIA development in order to enhance the detection limit in a final test system.
© 2011 Elsevier B.V. All rights reserved.Keywords:
Lateral flow immunoassay
Dengue fever
Carbon black
Gold nanoparticles1. Introduction
There is an increasing demand for convenient and accu-
rate point-of-care tools that can detect and diagnose differ-
ent stages of a disease in remote or impoverished settings.nchen, P.O. Box 6154-
93; fax: +49 89/3187
enchen.de
ll rights reserved.In recent years, lateral flow immunoassays (LFIA) have been in-
dicated as a suitable medical diagnostic tool for these environ-
ments and are used as an appropriate technology for a wide
variety of point-of-care or field applications ranging from:
uses in the health sector to diagnose diseases and prove the ab-
sence of pathogenic organisms in food or feed, to aiding lawen-
forcement in the fight against drugs of abuse and bio-warfare
(Posthuma-Trumpie et al., 2009). This chromatographic device
contains labeled detection proteins, e.g. nanoparticle–antibody
conjugates, whichwill reactwith a specific analyte. Thismobile
phase is pulled through the stationary by the capillary effect59
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molecules, where the trapped labels accumulate in concentra-
tion until visually detectable. The advantages of such a system
are numerous and mostly lie in its compact design, speed, sim-
plicity of use and long and robust storage time. Indeed, they re-
quire little or no sample preparation, have no electronic
components and can solely rely on a binary visual detection.
This presents the needed result in a rapid and reliable form,
so that an unskilled operator can interpret it, at a low
manufacturing cost. However, even though LFIA have been suc-
cessfully applied to numerous systems, including acute and
chronic disease detection, they show serious limitations in
high sensitivity applications; which is especially important in
the early stage diagnostics of diseases. Here, the detection
limit is related to the labels used for detection, and in many
cases coupling nanoparticles to the detection molecule is con-
sidered to be one of the most powerful techniques for an im-
mediate and clearly resolved test. While colloidal gold is
currently the most commonly used label, other detection sys-
tems mainly based on fluorescent nanoparticles, dyed latex,
and carbonblack have been used in an effort to improve the de-
tection limit (Näreoja et al., 2009; Lönnberg and Carlsson,
2001).
Recent works have compared and evaluated LFIA with dif-
ferent detection systems for a variety of applications (Gordon
and Michel, 2008; Posthuma-Trumpie et al., 2009). However,
a systematic evaluation of the label performance in depen-
dence on the detection limit was not presented. For instance:
Colloidal gold was used as detection system for pesticide resi-
dues of carbaryl and endosulfan in extracts of cereals and veg-
etables, showing a detection limit of 100 μg/L and 10 μg/L
respectively (Zhang et al., 2006). On the other hand, the same
label was applied to detect human serum albumin in urine
and it showed a detection limit of 30 mg/L (Cho and Paek,
2001). Furthermore, colloidal carbon labels were used in LFIA
to detect the residue of antibiotic sulfametazine (O'Keffe et
al., 2003) and erythropoietin (Lönnberg et al., 2008) in 200 μL
of urine, revealing detection limits of 6.3 μg/L and 0.035 ng/L,
respectively. Nevertheless, the sample for erythropoietin de-
termination was pretreated with filtration and desalting
steps, whereas the urine for sulfametazine determination was
used without pretreatment. So, although the characteristics of
many tests can be found, they are performed in different sys-
tems, device structures, sample pretreatments and volumes.
Therein, a comparison of the performance and sensitivities of
different labels could be used to significantly optimize the de-
tection limit of the end product.
A current example related to the inadequate detection limit
for LFIA has been reported for early stage detection of Dengue
fever (DF). DF is a mosquito-borne viral infection that, in recent
decades, has become a major international public health con-
cern. Denguehemorrhagic fever (DHF), a potentially lethal com-
plication, has become a leading cause of hospitalization and
death. Indeed, theWorld Health Organization (2009) estimated
that two fifths of the world's population was at risk with an an-
nual 50million reported cases worldwide. For DHF, early detec-
tion and medical care can decrease mortality rates from more
than 20% to less than 1%. More than 20 rapid tests based on
LFIA principles for DF are commercially available, but most of
them show limited application due to their low sensitivity and
specificity. This was recently exemplified when 8 commercialkits for DF based on IgG/IgM detection were evaluated and
only one showed the necessary specificity (97.6%) and sensitiv-
ity (65.3%) to be considered of clinical use (>50%) (Blacksell et
al., 2006). It means that only one test had the proportion of ac-
tual positives correctly identified (sensitivity) higher than 50%
and the proportion of negatives correctly identified (specifici-
ty) higher than 50%. Currently, a highly conserved viral non-
structural glycoprotein (NS1) of the Dengue virus has been
used as a high potential analyte target for early Dengue de-
tection (Datta and Wattal, 2010). During the acute phase,
the virus produces high NS1 levels in membrane-associated
and secretory forms, which are both demonstrated to be im-
munogenic (Alcon et al., 2002; Lima et al., 2010). Commer-
cial LFIA tests based on NS1 detection are available and
show a high variability in sensitivity (between 37% and
98.9%), which can be partially explained by the fact that the
sensitivity has been reported to decreasewith time both during
the infection and with secondary infections (Osorio et al.,
2010).
Based on the lack of comparative information available for
label performance, in the light that optimization could yield
the necessary sensitivity for LFIA to be used as an early stage di-
agnostic tool, we identified and evaluated the fourmost used la-
bels: gold, silver-enhanced gold, dyed latex bead and carbon
black nanoparticles. Preliminary results, in the terms of a sys-
tematic comparison of the detection limit, were obtained by
using the well-known biotin–streptavidin coupling as a model
system. Once established, a proof of concept was made by com-
paring carbon black against the standard colloidal gold to diag-
nose DF.
2. Materials and methods
2.1. Chemicals and materials
Streptavidin-labeled carboxylate-modified polystyrene
blue latex beads with a mean diameter of 250 nm, bovine
serum albumin (BSA) powder, biotin-NHS, streptavidin,
boric acid, glycine, anti-mouse IgG antibody-alkaline phos-
phatase, nitrotetrazolium blue chloride, 5-bromo-4-chloro-
3-indolyl phosphate disodium salt, potassium phosphate
mono- and dibasic were purchased from Sigma-Aldrich
(Milwaukee, USA). Glutaraldehyde 25% was obtained from
Calbiochem (Darmstadt, Germany). Gold nanoparticles
with a mean diameter of 40 nm, streptavidin-labeled gold
nanoparticles and a silver enhancer kit were purchased
from British Biocell International (Cardiff, United Kingdom).
Carbon black 100 and nitrocellulose AC99 membranes were
obtained from Degussa (Essen, Germany) and Whatman
(Maidstone, United Kingdom), respectively. Purified Den-
gue virus NS1 glycoprotein and Dengue Virus NS1 glycopro-
tein mouse monoclonal antibody (NS1mAb) supernatant
were obtained from Abcam (Cambridge, United Kingdom)
and Thermo Scientific (Rockford, United States), respective-
ly. 1 mL Hitrap protein G HP column for affinity chromatog-
raphy and a PD10 desalting columnwere purchased from GE
Healthcare (Uppsala, Sweden). Sample of DF serum was
provided by Clinical Hospital at State University of Campi-
nas in Brazil and the presence of the DF virus NS1 protein
was confirmed by the use of a sandwich ELISA from Stan-
dard Diagnostics (Hagal-Dong, Korea).60
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The NS1mAb was purified by protein G affinity chroma-
tography. The supernatant was slowly passed through the
protein G column using an ÄKTApurifier 100 (GE Healthcare,
Uppsala, Sweden). The NS1mAb was eluted from the column
in a total volume of 10 mL of 0.1 mol/L glycine at pH 2.8. The
volume was additionally reduced to 1 mL by ultrafiltration,
using a 100 k Amicon ultra-4 centrifugal filter (Millipore, Bil-
lerica, USA), centrifuged at 4000 rpm for 13 min and then the
buffer was exchanged to 1× PBS using a desalting column.
2.3. Nanoparticle–protein conjugate preparation
Blue latex bead nanoparticles were purchased with strep-
tavidin covalently bound in a buffered aqueous suspension
and, therefore, only needed to be diluted.
Carbon black–streptavidin and carbon black–NS1mAb co-
valently bound particle-conjugates were prepared according
to Rayev et al. (Rayev and Shmagel, 2008). Purifying the
protein-coated nanoparticles was achieved through centrifu-
gation at 13000 rpm for 10 min, carefully removing the clear
supernatant and dispersing. This washing step was repeated
5 times. Protein-coated nanoparticles were stored in 0.01 M
phosphate buffer solution containing 5% BSA and 20% glycer-
ol at pH 7.5 and stored at 4 °C. In order to optimize the immo-
bilization reaction, the buffer concentration and pH were
varied from 1 to 0.001 M and from 6 to 8, respectively. For
all other reactions 0.01 M borate buffer, pH 8, and phosphate
buffer were used. The final solid content was 1% (w/w).
Gold nanoparticles were purchased with streptavidin al-
ready covalently bound in a buffered aqueous suspension
and, therefore, only needed to be diluted.
Gold nanoparticle–NS1mAb conjugate preparation was
performed according to the following protocol: Gold nano-
particle dispersions were adjusted to pH 8 with a 0.01 M so-
lution of NaOH. 10 μL of 0.01 mg/mL NS1mAb solution was
added to 0.1 mL of the adjusted gold dispersion and stirred
for 30 min. Purification of the gold nanoparticle–NS1mAb
conjugates was achieved by centrifugation at 5000 rpm for
15 min at 4 °C. The clear supernatant was carefully removed,
and the precipitated gold conjugates were dispersed in
100 μL of phosphate buffer and stored at 4 °C, containing 1%
(w/w) of solid contents. The optimum pH for conjugation
was found by making a series composed of solutions adjusted
to pH 7, 8, and 9 and evaluated by dot blot tests.
2.4. Streptavidin coated nanoparticle characterization by atomic
force microscopy (AFM)
Topographical analysis of the different nanoparticle labels
was performed by AFM. Each particle-dispersion was sonicat-
ed for 10 min at room conditions and deposited on glass
slides resulting in a 0.01% (w/v) dispersion of solid compo-
nents. Particles were analyzed using an AFM (JPK Nanowi-
zard 1, Berlin Germany) in intermittent contact mode with
100 μm xy-scan range and 15 nm z-scan range and Si tips
NSC 15 (40 N/m spring constant) (Mikromasch, Las Rozas
de Madrid Spain). Images were processed and analyzed
using JPK SPM v3.1 and Gwyddion v2.19. Size distributionhistograms were obtained by measuring the diameter of
150 particles of each material.
2.5. Dot blot tests
2.5.1. The streptavidin–biotin system
BSA was biotinylated according to Guesdon et al. (1979)
and purified by dialysis. Biotin functionalization of the nitro-
cellulose membrane was achieved by slowly pipetting 2 μL
spots, each of different concentrations ranging from
0.01 μg/mL to 10 mg/mL of the biotinylated BSA onto differ-
ent locations of the membrane. The remaining non-specific
sites were blocked by submersing the membrane into a deac-
tivation solution 5% (w/v) BSA in 0.1 M phosphate buffer at
pH 7. Washing steps were performed by dipping the mem-
branes 3 times during 5 min each into a 0.01 M phosphate
buffer solution, at pH 7.4. Gold, blue latex and carbon black
particle–streptavidin conjugate dispersions were diluted in
0.01 M phosphate buffer at pH 7.4 to a content of 0.5%
(w/v) solids. Each of the biotin functionalized membranes
was submerged into different particle–streptavidin conjugate
dispersions for 20 min. The particles passed through the
membranes and particles in excess were absorbed by a cellu-
lose absorbent pad located on the other membrane extremi-
ty. Subsequently, the membranes were washed with 0.01 M
phosphate buffer at pH 7.4, air-dried and scanned.
2.5.2. Silver enhancement
The gold nanoparticle labeled membrane was additionally
enhanced by submerging it into silver solution with reducing
agent. A curve of gold nanoparticle-conjugates being en-
hanced with silver was obtained by adding a 2 μL droplet of
gold nanoparticle–streptavidin solution, containing 0.5%
(w/v) of solids, onto an untreated nitrocellulose membrane.
This was in turn submerged into silver solution with reducing
agent and the signal enhancement was measured by taking
consecutive pictures with a Sony 230 of 7.3 megapixel
camera and analyzing the results with Gwyddion v2.19.
2.5.3. Antibody–protein system
NS1 protein concentration was determined, from a serum
sample of a patient with clinical diagnosis of acute DF, by en-
zyme linked immunosorbent assay. NS1 protein functionali-
zation of the nitrocellulose membrane was achieved by
diluting the serum samples in 0.01 M phosphate buffer at
pH 7.4 and then slowly pipetting 2 μL spots, each of different
concentrations ranging from 0.06 to 5.75 μg/mL, of the NS1-
protein onto different locations of the membrane. The
remaining non-specific sites were blocked by submersing
the membrane into a solution 5% (w/v) BSA in 0.1 M phos-
phate buffer at pH 7. Each of the NS1 functionalized mem-
branes were submerged into either carbon black-NS1mAb
or gold-NS1mAb conjugate dispersions with a concentration
of 1% (w/v) solids in 0.01 M phosphate buffer at pH 7.4 and
incubated at RT for 20 min. The particles flowed through
the membranes and particles in excess were absorbed by a
cellulose absorbent pad located on the other membrane ex-
tremity. Subsequently, the membranes were washed with
0.01 M phosphate buffer at pH 7.4 and air-dried. Gray scale
optical analysis was performed from scanned images.61
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48-bit images of the dot blot tests, that included a gray scale
reference chart in each scan, where acquired with a Hewlett–
Packard 3800 Scanjet scanner (Palo Alto, USA). The images
were processed with Image-J v1.42 where a 5×1.2 mm area
was selected for analysis of each image and the mean back-
ground, calculated from three different points in close proxim-
ity to the relevant dot blot, was subtracted. The processed
image RGB channels were then split using Adobe Photoshop
CS3, and the most intense channel was converted into 8-bit
gray scale. Each dot blot was now represented by a number
from 0 to 255, corresponding to white and black, respectively,
and the data quantified in blackness percentage.
3. Results and discussion
An initial study, by topographical analysis, of the different
nanoparticle labels was performed to make a firsthand com-
parison of the systems. This was of particular importance
since the silver-enhanced gold particle system was uncharac-
terized. The AFM micrographs are depicted in Fig. 1 togetherFig. 1. Particle characterization using AFM. Topography images and line profiles wer
ticles, b) silver enhanced gold nanoparticles, c) blue latex beads and d) carbon black
gold nanoparticles added to silver reducer solution. f) Size distribution curve calcula
reducer solution.with the corresponding cross section graph defined by a
white line. The gold nanoparticles, shown in Fig. 1a, have a
very sharp size distribution with a mean diameter of 39±
5 nm. This particle size was chosen since it is well-known
to provide the best performance for gold nanoparticles in
LFIA (Posthuma-Trumpie et al., 2009). Moreover, silver en-
hancement is a well-practiced method of additionally improv-
ing the signal from gold nanoparticle systems. To this end, the
autometallography method (Danscher et al., 1993), which is
based on the reduction of a silver salt at the surface of gold par-
ticles, was used to enlarge the gold particle size by forming a
core–shell structure. As it transpired, the resulting silver coated
gold nanoparticles had grownup to 5 times larger than the gold
core, which can be seen in Fig. 1b. The size distribution curve
can be seen in Fig. 1e and reveals a bimodal mean diameter
distribution of 55±9 nm and 187±22 nm. This inhomoge-
neity in growth may be caused by the steric hindrance of
neighboring particles. In order to find the optimum exposure
time in dependence on visual signal enhancement, gold
nanoparticle-conjugates were deposited onto a nitrocellu-
lose membrane and exposed to silver reducing solution.
The measured Δ blackness was plotted in dependence one obtained for particle dispersions dried on glass slides for: a) gold nanopar-
. e) The variation of blackness is plotted in dependence on exposure time for
ted form AFM images of gold nanoparticle after 20 min of exposure to silver
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best choice since it is the shoulder value between a fast in-
crease in intensity and the start of non-specific silver reduc-
tion increasing the background signal. Blue latex beads,
Fig. 1c, were found to have a slightly larger average diame-
ter, than the 250 nm defined by the manufacture, of 293
±9 nm and form strip like agglomerates. Carbon black,
Fig. 1d, has a large distribution with an average particle di-
ameter of 150±50 nm and form extensive aggregates rang-
ing between 0.5 and 2 μm.
It can be seen that the labels show different degrees of ag-
glomeration that even occur after ultrasonic treatment, as a re-
sult of thehigh affinity of similar particles and the differences in
structure. The density and size of these agglomerates could im-
pede a direct comparison of performance among the labels for
LFIA, due to the difficulty of attributing the signals to differ-
ences in absorptivity, particle concentration in agglomerates
or density of immobilized biomolecules. However, each system
was chosen according to the literature, using the most appro-
priate label characteristics for LFIA, optimized biomolecule im-
mobilization and particle excess to ensure saturation in the
nitrocellulose. For instance, gold nanoparticles with 40 nm di-
ameter provides the most efficient flow through the mem-
branes and high signal to noise ratio in comparison to bigger
gold particles. On the other hand, due to its low density, carbon
black can be used with larger diameters without dramatically
preventing its flow through the membranes in which pore
size is 8–12 times the carbon black agglomerate diameter.
Evaluation of the nanoparticles as labelswas done by dot blot
tests. Here, the nanoparticles were directly bound to the detec-
tion proteins as represented in Fig. 2a. In this work we usedFig. 2. Illustration of the system and a comparison of the blackness after 20 min of
ferent labels: carbon black, silver coated gold, gold, and blue polystyrene bead nano
lustration of a target protein functionalized membrane exposed to labeled detection
different labels; carbon black showing by far the strongest signal. d) The same data
threshold for the different systems (a dashed line shows the visible limit observedboth NS1mAb and streptavidin to target the NS1 protein and bi-
otin, respectively. A nitrocellulose membrane was functiona-
lized with a concentration series of the target molecules in
the form of 2 μL dots placed in different locations along the
membrane. The remaining non-specific sites were blocked
and then the membrane was exposed to a solution of the la-
beled detection proteins, as depicted in Fig. 2b, and the signal
intensity interpreted.
Preliminary results, in the terms of a systematic com-
parison of the detection threshold and saturation values,
were obtained by using the well-known biotin–streptavi-
din coupling as a model system. To this end, dot blot tests
were prepared with a dilution series of biotinylated-BSA
spots ranging from 10 mg/mL to 0.01 μg/mL and exposed
to the nanoparticle–streptavidin conjugates. Curves com-
paring the signal intensity, for each label in dependence
on the concentration of deposited biotinylated-BSA, are
presented in Fig. 2c–d. Absorbance saturation curves are pre-
sented in Fig. 2c showing plateau values of 3, 6, 17 and 58%
for blue latex bead, gold, silver enhanced gold and carbon
black nanoparticles, respectively. The same data set is plotted
in Fig. 2d with the concentration on a log10 scale to identify
the visible detection thresholds of 1 mg/mL, 1 μg/mL,
0.1 μg/mL and 0.01 μg/mL for blue latex bead, gold, silver en-
hanced gold and carbon black nanoparticles, respectively.
Spots were visible by naked eye above 5% of blackness percent-
age (represented by the dashed line in Fig. 2d). Thus, carbon
black has unmistakably the highest signal performance in rela-
tion to the other tested labels with 100 times greater detection
limit and 10 times higher signal intensity than the standard
gold system. In addition, it is readily available in several formsexposure in dependence on biotinylated-BSA concentration for the four dif-
particles. a) An illustration of a nanoparticle labeled detection protein. b) Il-
protein conjugates. c) A linear plot emphasizing the saturation point of the
set is plotted with the concentration on a log10 scale to identify the detection
by naked eye).
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(Lönnberg and Carlsson, 2001).
Based on these results, carbon black was chosen as detec-
tion label for DF using the viruses NS1 glycoprotein, which is
used in early detection methods, as a target molecule. Since
the standard LFIA tests are based on gold nanoparticles and
are clinically known to provide limited sensitivity for diagno-
sis during the first days of the disease: Carbon black was di-
rectly compared with the gold system to find out if it can
overcome this limitation.
Thus, dot blot tests were prepared with a dilution series of
NS1 protein spots ranging from 0.06 to 5.75 μg/mL and sepa-
rately exposed to the nanoparticle–NS1mAb conjugates pre-
pared at the same solid contents. Fig. 3a shows an image of
the scanned spots and the carbon black–antibody conjugates
are clearly visible at 57 ng/mL, whereas the gold nanoparticle
signal can only be clearly interpreted at 575 ng/mL. This detec-
tion limit is according to the concentration that is required to
produce a signal greater than three times the standard devia-
tion of the noise level. The difference in detection threshold is
more clearly shown in Fig. 3b–c. The blackness and the spot
area reduce when the protein concentration is decreased and
the detection limit depends on the compromise of both param-
eters. The area reduction is due to the high affinity of theprotein
to the nitrocellulosemembrane, avoiding the protein spreading
during the solution deposition. The results reveal that carbon
black conjugates are approximately 10 times more sensitive
than gold nanoparticles for NS1 protein detection. According
to Libraty et al. (2002), plasma levels of secreted NS1 protein
from free Dengue-2 virus may vary between 150 andFig. 3. Detection limit for the Dengue virus NS1 protein based on gold and carbon bla
blot tests showing the dilution series of NS1 protein after being exposed to carbon b
data set as blackness intensity and spot area in dependence on concentration.250 ng/mL per day of illness for the second day of contracting
the disease for patients that are both DHF and secondary infec-
tions. Therein, the carbon black system is indeed capable of pro-
viding a visual signal bellow the NS1 concentration that exists
in infected patients on the first days of the disease. This sensitiv-
ity enhancement is decisive for early DF detection based on the
NS1protein and can be vital for the rapid assessment of patients
developing more severe cases of the disease.
4. Conclusion
We compared the detection limit and signal intensity
between the four most used labels: gold, silver enhanced
gold, blue latex bead and carbon black nanoparticles. Prelimi-
nary resultswere obtained by using the biotin–streptavidin cou-
pling as a model system and showed that carbon black had a
remarkably lower detection limit of 0.01 μg/mL in comparison
to 0.1 μg/mL, 1 μg/mL and 1 mg/mL for silver-enhanced gold,
gold, and latex bead nanoparticles, respectively. Moreover, car-
bon black was used as a detection system for Dengue fever
where a colorimetric detection limit of 57 ng/mL for carbon
black was found to be ten times lower than the 575 ng/mL for
standard gold nanoparticles. This improvement, that makes
the system sensitive enough to diagnose a patient on the first
day of infection, can be crucial to overcome the limitations of
LFIA in regard to early diagnosis of Dengue fever. We therefore
conclude that, careful screening of detection labels should be
performed as a necessary step during LFIA development in
order to enhance the detection limit in a final test system and
we hope that these results can facilitate the development ofck nanoparticles coated with anti-NS1 monoclonal antibodies. a) Scanned dot
lack and gold nanoparticle NS1mAb detection conjugates. b) Shows the same
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tem in order to achieve a specific sensitivity.Acknowledgments
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Dengue fever is one of the most neglected tropical diseases and of highest international public health
importance, with 50 million cases worldwide every year. Early detection can decrease mortality rates
from more than 20% to less than 1% and the relevant early diagnosis analyte is the viral non-structural
glycoprotein, NS1. Currently, enzyme linked immunosorbent assay (ELISA) is the method of choice to
detect NS1. However, this is a time consuming method, requiring 3–5 h, and it is the bottleneck for
routine of clinical analysis laboratory in epidemic periods, when hundreds of samples should be tested.
Here we describe an easy method combining principles of ﬂuorophore linked immunosorbent assay
(FLISA) and enzyme linked immunospotting (ELISPOT). For detection, we used mouse anti-NS1 IgG
labeled with ﬂuorescent nanoparticles. The presented procedure needs only 4 mL of serum samples and
requires 45–60 min. The detection limit, 5.2 ng/mL, is comparable to ELISA tests. The comparison of 83
samples with a commercial ELISA revealed a sensitivity of 81% and speciﬁcity of 88%. The use of
ﬂuorescent nanoparticles provides a higher sensitivity than an assay using usual ﬂuorescent dye
molecules, besides avoiding bleaching effects. Based on the results, the proposed method provides fast,
speciﬁc and sensitive results, and proves to be a suitable method for Dengue NS1 detection in
impoverished regions or epidemic areas.
& 2012 Elsevier B.V. All rights reserved.1. Introduction
Neglected tropical diseases (NTD) are a multiple of diverse
diseases strongly associated with poverty, ﬂourishing in impo-
verished environments and thriving best in tropical areas. Due to
these characteristics, they have low visibility in the rest of the
world and limited access to support services. Among the NTD,
Dengue fever (DF) has emerged as a rapidly spreading vector-
borne disease affecting mainly poor, urban populations and it is
also the leading cause of hospital admissions in several countries
(WHO, 2010). DF results from infection with a virus transmitted
mainly by Aedes aegypti, a species of mosquito with a global
distribution. The incidence of DF has dramatically grown over the
world in recent decades. Over 2.5 billion people are now endan-
gered from Dengue. The World Health Organization (WHO, 2012)
currently estimates 100 million cases of Dengue fever, 500,000ll rights reserved.
764 Neuherberg, Germany.
enchen.de (E.M. Linares),
.br (L.T. Kubota),
hammer).
t al., Biosensors and Bioelecases of Dengue hemorrhagic fever (DHF) and resulting in 2.5% of
annual mortality. The disease is now endemic in more than 100
countries in Africa, America, Eastern Mediterranean, South-east
Asia and Western Paciﬁc. The threat of a possible outbreak of DF
now exists in Europe and local transmission of DF was reported
for the ﬁrst time in 2010. For DHF, medical care can save lives,
decreasing mortality rates from more than 20% to less than 1%
(Allwinn, 2011).
To provide medical care, DF diagnosis should be fast, speciﬁc,
sensitive and with low cost. Nowadays, there are different tools
used for diagnosis by isolating the virus, detecting viral antigen or
RNA in serum or tissues (Levi et al., 2007), and detecting speciﬁc
antibodies or proteins in the serum (Guzman and Kouri, 1996).
Serologic tests have been routinely used for diagnosis of DF due to
their simplicity and rapidity in comparison to the other methods.
Enzyme linked immunosorbent assay, ELISA, has become the
most widely used serologic test for DF diagnosis in the past few
years due to its simplicity and little sophisticated equipment
(Gubler, 1998). These assays are predominantly based on the
detection of immunoglobulin, which consists of IgM and IgG
antibodies produced against the virus at day 5 or 6 of illness
(Vaughn et al., 1997). Due to the necessity of diagnosing DF inctronics (2012), http://dx.doi.org/10.1016/j.bios.2012.08.005
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8early stages, a highly conserved viral non-structural glycoprotein
(NS1) of the Dengue virus has been used as a high potential
analyte target for early Dengue detection (Datta and Wattal,
2010; Linares et al., 2012). Dengue NS1 antigen has been detected
in the serum of DF infected patients as early as one day post onset
of symptoms. During acute phase, high NS1 level exists as
membrane-associated and secretory forms by the virus; both
forms are demonstrated to be immunogenic (Lima et al., 2010).
NS1 detection using ELISA is based on the principle of a solid
phase sandwich enzyme-linked immunosorbent assay with col-
orimetric detection. A monoclonal antibody is adsorbed on the
solid phase and works as capture antibody for binding the
antigen. Another monoclonal antibody conjugated to an enzyme
is used to detect the antigen through a colorimetric enzymatic
reaction (Najioullah et al., 2011). Although Dengue NS1 ELISA
offers a sensitive approach with detection in the low ng/ml range,
the technique also shows some disadvantages. ELISA tests require
a large number of incubation and washing steps. These make the
procedure difﬁcult to automate for screening large sample num-
ber, and signiﬁcantly prolong the time up to 5 h to get the results
(Alcon et al., 2002; Young et al., 2000). In addition, in many cases,
efﬁcient antibody adsorption on microplates requires overnight
incubation time. For routine tests in clinical analysis laboratories
during epidemic periods, the test duration is relatively long, as
hundreds of samples should be tested at the same day (Liu et al.,
2003; Velappan et al., 2008).
Analogous to ELISA principles, another technique has been used
for DF detection, which are based on enzyme-linked immunospot
(ELISPOT). The term immunospot has been used to refer to a
method, where antibodies are immobilized on membrane, com-
pounds secreted by cells are captured and an enzyme conjugated
antibody provides the colorimetric detection (Bathoorn et al.,
2011; Franci et al., 1986). The use of paper, such as nitrocellulose
membranes, has provided an useful and simple base for fast and
low cost tests (Liu et al., 2011; Martinez et al., 2010). Cardosa et al.
(1988, 1995) reported the development of a dot enzyme immu-
noassay for the detection of Dengue antibodies. This formed the
basis of a commercial Dengue blot kit in which the viral antigens
are bound to nitrocellulose membranes instead of microplates. The
antibodies are visualized using protein A, which is labeled with
horseradish peroxidase (Lam et al., 1996). Although this assay
allows ﬁeld application with diagnosis in peripheral health settings
due to the use of membrane as solid support, the tests also involve
several time consuming steps, which turns to the same practical
disadvantages observed for ELISA.
While efforts have been described to overcome ELISA limita-
tions (Chunglok et al., 2011; Pi~ao et al., 2009; Piletsky et al., 2001;
Wan et al., 2012), ﬂuorophore linked immunosorbent assays
(FLISAs) have been proven to be a powerful alternative that uses
ﬂuorescence rather than enzymatic activity for detection and thus
overcome some of the disadvantages of ELISA (Cummins et al.,
2006; Liu et al., 2003; Velappan et al., 2008). Compared to
sandwich ELISA, this assay has several advantages: rapidity (the
time is reduced from 5 to 1.5 h), simplicity and lower costs due to
the use of fewer reagents. FLISA still shows similar speciﬁcity and
sensitivity as the sandwich ELISA (Liu et al., 2003). New
approaches have also been described to improve FLISA perfor-
mance. Miller et al. (2006) used ﬂuorescent dyes conjugated to
antibody coated polystyrene beads to detect the analyte on the
focus plane by confocal laser scanning microscopy. High sensitive
assays have been also described using quantum dot-based ﬂuor-
escence-linked immunosorbent assays, enhancing the ﬂuores-
cence signal provided by high intensity of a particle in
comparison to a dye (Zhu et al., 2011; Peng et al., 2009).
In this work, we present an immunospot test for Dengue
detection, combining FLISA advantages with principles of ELISPOTPlease cite this article as: Linares, E.M., et al., Biosensors and Bioeleas an alternative method to replace sandwich ELISA in impover-
ished regions or epidemic areas. The advantage of combining both
techniques is the development of a sensitive and fast sensor. Spot
tests based on ﬂuorescence detection have already shown useful
combinations of high sensitivity and low complexity (Linares
et al., 2007). In the proposed test, a low volume of serum sample
is applied onto a nitrocellulose membrane and mouse anti-NS1
IgG labeled with ﬂuorescent nanoparticles are used for Dengue
detection. The test takes less time and the ﬂuorescent signal
can be measured with a ﬂuorometer or alternatively with an
UV-lamp. The possibility of applying the sample directly to a high
surface area nitrocellulose membrane allows the use of low
volume of samples and avoids the necessity of two antibodies
for capture and detection. The use of ﬂuorescent nanoparticles
provides lower detection limit in comparison to conventional
FLISA, additionally avoiding bleaching effects. As a general view,
the immunospot test allows diagnosing DF in less than one hour
with high speciﬁcity and sensitivity, less complexity and using
conventional apparatus in clinical analysis laboratories.2. Materials and methods
2.1. Chemicals and materials
Bovine serum albumin (BSA), glycine, N-(3-Dimethylamino-
propyl)-N0-ethylcarbodiimide hydrochloride (EDC), anti-mouse
IgG–FITC antibody, dialysis membranes (MWCO 100 kDa and
130 kDa), Tween 20, sodium carbonate and bicarbonate, potas-
sium phosphate mono- and dibasic were purchased from Sigma-
Aldrich (Munich, Germany). FluoSpheres carboxylate-modiﬁed
microspheres, 5% (w/w), [yellow–green (505/515 nm), orange
(540/560 nm) and red (580/605 nm)], 0.04 mm, were obtained
from Invitrogen (Carlsbad, United States). Nitrocellulose AC100
membrane and absorbent pad were purchased from Whatman
(Maidstone, United Kingdom). ELISA microplate, F96 MicroWellTM
plates, was obtained from NUNC (Roskilde, Denmark).
Dengue Virus NS1 glycoprotein mouse monoclonal antibody
was obtained from Abcam (Cambridge, United Kingdom).
Puriﬁcation procedure is described in Supplementary Informa-
tion. NS1 Ag ELISA kits were purchased from Standard
Diagnostics (Hagal-Dong, Korea) and Biorad Laboratories
(Marnes-La-Coquette, France).
2.2. Serum samples
A total of 83 serum samples were obtained by the S~ao Paulo
Institute of Tropical Medicine, University of S~ao Paulo. The tests
were approved by the ethics committee from the university.
The samples were analyzed for NS1 using the commercial kit
PlateliaTMNS1 (Biorad Laboratories, Marnes-La-Coquette, France).
Dengue diagnostic is described in the supplementary information.
2.3. Synthesis of polystyrene nanoparticle–albumin conjugates
An aliquot of 1 mg of albumin at 3 mg/mL was dissolved in
phosphate buffer 0.01 mol/L, pH 7.4. Then, 500 mL of a 2% aqueous
suspension of carboxylate-modiﬁed sphere was added and incu-
bated at RT for 30 min. Subsequently, 0.5 mg of EDC was added
and mixed by vortexing and the pH was adjusted to 6.570.2 with
diluted NaOH. The dispersion was incubated on a shaker for 3 h at
RT. To remove unbound proteins, dialysis was performed through
a membrane with MWCO of 100 kDa against phosphate buffer
0.01 mol/L, pH 7.4, during 24 h and 5-times change of the external
solution. 6ctronics (2012), http://dx.doi.org/10.1016/j.bios.2012.08.005
Fig. 1. Comparison of ﬂuorescence for three different labels and microscopic
characterization. Fluorescence spectra (a) from three different ﬂuorescent parti-
cles at 5% (w/w) of solid content: orange, red and yellow carboxylated nanopar-
ticles. Arrow indicates the chosen orange nanoparticles for immunospot
development. Bright-ﬁeld (TEM) images (b) from the orange nanoparticles. The
diameter histogram (c) reveals the monomodal dispersion of the particles in
3775 nm.
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692.4. BSA-coated particle functionalization with monoclonal dengue
NS1 antibody
A 500 mL particle aqueous dispersion 1% (w/w) was added to
0.09 mL of a 0.5 mg/mL solution of antibody dissolved in phos-
phate buffer 0.01 M, pH 6. In principle, the conjugate has 9 mg of
NS1 antibody per mg of nanoparticles. The suspension was
incubated for 30 min at RT. Brieﬂy after, 1 mg of EDC was added
and mixed by vortexing. The dispersion was constantly stirred for
1 h at RT. To separate the protein-labeled conjugates from
unbound antibodies, a dialysis membrane with MWCO of
130 kDa was used against phosphate buffer 0.01 mol/L, pH
7.4 for 24 h and 5-times change of the external solution. The
conjugates were stored at 4 1C.
2.5. Immunospot tests
For single analysis, the strip test contains the reaction membrane
and the absorbent pad. Nitrocellulose membrane (10 mm60 mm)
was pasted on a polyvinyl back (10 mm100 mm) and an absor-
bent pad (10 mm45 mm) was ﬁxed on the opposite side. Four
microliters of serum were slowly spotted on the center area of the
nitrocellulose membrane. After drying the serum droplet, 40 mL of
BSA 3% in phosphate buffer 0.01 mol/L, pH 7.4, was added directly
on the dried serum spot and the excess of liquid was absorbed by
the absorbent pad. Subsequently, 30 mL of ﬂuorescent conjugates 1%
in phosphate buffer 0.01 mol/L, pH 7.4, was added to the membrane
and the excess was absorbed with the absorbent pad. To remove
unbound particles, 100 mL of washing buffer (phosphate buffer
0.01 mol/L, pH 7.4, Tween 20 0.01% and NaCl 0.05 mol/L) was added
to the membrane.
For mutiple tests, 4 mL of serum was deposited on the nitro-
cellulose membrane (7 cm10 cm) with 15 mm spacing between
each spot to avoid contamination and checking the alignment
between them to ﬁt on the wells of an ELISA microplate. This
sample volume was the minimum volume necessary to observe a
clear result. After 10 min, a blocking solution containing BSA 3% in
phosphate buffer 0.01 mol/L, pH 7.4 was added to cover the entire
membrane for 15 min at RT. Subsequently, the blocking solution
was removed and 3 mL ﬂuorescent conjugates 1% in phosphate
buffer 0.01 mol/L, pH 7.4 was added and incubated for 30 min.
2.6. Fluorescence spectroscopy
The spectroﬂuorometric measurements were performed with a
LS-55 Perkin–Elmer luminescence spectrometer (Connecticut, USA)
coupled to an optical ﬁber accessory. The negative control con-
sisted of a membrane blocked with BSA, treated with ﬂuorescent
particles and rinsed with washing buffer. Protein NS1 from the
Standard Diagnostics NS1 Ag ELISA kit was used as positive control.
To compare the ﬂuorescence measurements with an ELISA reader,
measurements were performed using SAFIRE II Multimode Micro-
plate Reader (Ma¨nnedorf, Switzerland). For the measurement,
nitrocellulose membranes were deposited on an ELISA microplate
(F96 MicroWellTM plates, NUNC, Roskilde, Denmark) and enclosed
with a microplate cover. Data was obtained using XFluorTM soft-
ware version 4.62n. To perform qualitative ﬂuorescence measure-
ments, an UV-Lamp Biometra T1 (Foster, USA) was used.
2.7. Fluorophore linked immunosorbent assay for dengue fever
detection
FLISA test was performed following the steps as described in
2.5; however, nanoparticles were replaced by not conjugated
antibodies and only three serum samples with known NS1
concentration (see Supplementary information) were used inPlease cite this article as: Linares, E.M., et al., Biosensors and Bioeledifferent diluted solutions with phosphate buffer, pH 7.4. Subse-
quently, the membrane was washed three times with phosphate
buffer 0.01 mol/L, pH 7.4, and incubated with anti-mouse IgG–
FITC antibody 1:64, following the manufacturer instructions, for
30 min in a dark chamber at RT. After washing with phosphate
buffer 0.01 mol/L, the ﬂuorescence was measured.
2.8. Transmission electron microscopy (TEM)
For electron microscopy analysis, samples were prepared by
drying a suspension droplet of particles at 0.1% (w/w) on
carbon-coated parlodio ﬁlms supported in 200-mesh copper
grids. Particles were analyzed using a Carl Zeiss Libra 120 kV
TEM equipped with omega ﬁlter to obtain bright-ﬁeld images
with low chromatic aberration when the energy slit was
selected to zero. The images were recorded using iTEM Uni-
versal TEM Imaging Platform.3. Results and discussion
The accessibility to sensitive and fast assays to detect diseases
for routine or emergency diagnostics in non-well equipped
laboratories is still a challenge. The presented work is driven by
the current limitations to combine the speed of analysis, ease of
use and the sensitivity for Dengue fever detection. This will lead
to the development of a reliable assay based on ﬂuorescence
detection devices. To achieve the high detection sensitivity, a
ﬂuorescence intensity screening of three different ﬂuorescent
particles was performed and the spectra are depicted in Fig. 1a.
Fluorophores incorporated in polymer particles were chosen toctronics (2012), http://dx.doi.org/10.1016/j.bios.2012.08.005
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dyes. The particles consist of polystyrene containing multiple
carboxylic acids for covalent ligand attachment. The emission
wavelengths of the ﬂuorophores covered a spectrum range from
450 to 600 nm. The spectra comparison clearly shows that the
particles with emission in 567 nm (orange, see arrow in Fig. 1a)
present up to 3.2-times higher intensity than the other particles
and was therefore chosen as the label of choice for the immuno-
spot development.
Monodispersity and uniform morphology are prerequisites for
adequate particles in immunospot applications. These character-
istics directly affect the performance and repeatability of the tests.
Therefore, particle morphology was analyzed by TEM, which is a
well-known tool for particle characterization (Linares et al., 2009,
2010). A bright ﬁeld image of the particle dispersion, dried on
parlodion ﬁlm, is shown in Fig. 1b. The particles show a round
shape of polymer latex and form aggregates on the nanoscale,
which do not exceed 300 nm in the x- or y-axis. The aggregation
does not affect the ﬂow through the membrane, due to the fact that
their size is hundreds times smaller than the nitrocellulose
membrane pores (8 mm). The size histogram, obtained by measur-
ing 100 particles (Fig. 1c), shows that the particles are monodis-
persed and have a mean diameter of 3775 nm. Due to uniform
morphology, high ﬂuorescence emission and monodispersity,
the particles were used to develop the immunoassay. Focusing
on rapidity and ease of use by concurrent high sensitivity, we
present single and multiple tests using common available
materials and equipment in clinical laboratories. The single
tests, or strip tests, were constructed combining celluloseFig. 2. Scheme of three different possible detection tools for immunospot based on ﬂuo
preparation including serum deposition, blocking of unspeciﬁc site, anti-NS1 nanoparti
ﬂuorescence signal from the tests; (c) quantitative mutiple tests performed on a single n
ELISA-reader; (d) picture from the membrane positioned in the microplate; (e) sche
nitrocellulose membrane; (f) cheap LED on UV range used for ﬂuorescent nanoparticle
Please cite this article as: Linares, E.M., et al., Biosensors and Bioeleand nitrocellulose membranes in a layer-by-layer structure, as
show in Fig. 2a.
This test requires only 4 mL of serum sample and could be
performed in 1 h. In case of multiple sample analysis, parallel tests
can be performed by applying the 4 mL samples directly on the
same nitrocellulose membrane with sufﬁcient 15 mm spacing
between each spot to avoid contamination. After the serum
application area onto the membrane being already saturated, other
protein molecules from the sample will laterally migrate through
the membrane and will form a deﬁned spot area. The molecules in
the spot are pulled out of solution by the membrane and stick to
the paper avoiding cross contamination between neighboring
spots. This also remains stable after several washing steps. Experi-
ments comparing the ﬂuorescence intensity of the same samples
analyzed in single and multiple tests revealed a variation lower
than 16%. The presented direct sample application is analogous to
indirect ELISA tests, with the advantage of a shorter incubation
time and no further washing steps. These steps are time consuming
and need higher sample volume, dependent on antibody-solid
phase absorption. By using nitrocellulose, the high membrane-
protein afﬁnity assures the retaining of the analyte into the
membrane and only a single sample deposition step is necessary
and some minutes for drying are enough for detection.
Versatility was also achieved for the ﬂuorescence measurement.
Considering that laboratories around the world have different
equipment availability and even lack of instruments, three differ-
ent instruments were used and evaluated: simple ﬂuorometer
coupled to an optical ﬁber (Fig. 2b); ELISA reader, which allows
the measurement ﬁtting the membrane in a ELISA microplaterescent particles for Dengue NS1 protein determination. (a) Four steps for sample
cle conjugate and washing steps; (b) use of optical ﬁber to measure quantitatively
itrocellulose membrane placed in a ELISA microplate and measured using an usual
me of UV-lamp used to show ﬂuorescent spots of serum samples applied on a
s excitation; (g) multiple tests analyzed under UV-lamp.
ctronics (2012), http://dx.doi.org/10.1016/j.bios.2012.08.005
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unequipped laboratories and that can provide qualitative results
(Fig. 2g). Although, UV-lamp can only perform qualitative tests, it is
a very cheap apparatus and can be easily obtained, besides the fact
that many tests only need a yes/no diagnostics, such as for Dengue
fever detection. We chose a lamp in the UVB range due to the fact
that they are mostly used in clinical laboratories and the emission
is capable to excite the band-tail of the ﬂuorophore. Besides that,
the lamp emission in the visible excitation range would be so close
to the ﬂuorophore emission that would be very difﬁcult to
distinguish the signal of the lamp and from the labels.
To compare the performance and consequently the detection
limits for measurements performed with these three aparatus, a
NS1 protein dilution series from 5–500 ng/mL was analyzed by all
of them (Fig. 3). The ﬂuorescent spots under UV-lamp (Fig. 3a) can
be easily visualized from 200 ng/mL NS1 protein. Below this
concentration, it is not possible to precisely conﬁrm the positive
NS1 protein serum signal. A positive and negative control is used
to provide the limits for yes/no deﬁnition by comparison with the
sample spot (Fig. 3c). The measurements performed by the
ﬂuorometer coupled to an optical ﬁber revealed a lower detection
limit compared to the ELISA reader (Fig. 3b).
The detection limits were calculated for optical ﬁber coupled
to ﬂuorometer and ELISA reader measurements, showing 5.2 and
11.5 ng/mL, respectively. The relative standard deviation of the
proposed method was evaluated by performing ten successive
determinations of two serum samples. The calculation was
performed dividing the standard deviation by the mean of the
measurements. The values, 17% and 12%, were low considering
that the tests are performed on membranes, where the pore
structure is not totally homogeneous like ELISA substrate.
Although these two instruments showed different sensitivities
for NS1 protein detection, both are adequate to be used for the
diagnostics. According to Libraty et al. (2002), plasma levels of
secreted NS1 protein may vary between 150 and 250 ng/mL for
the second day of contracting the disease for patients that are
both Dengue hemorrhagic fever and secondary infections. The
concentration for the ﬁrst day is scarce and variable, due to the
difﬁculty to get samples from patients in this infection stage.
Therein, the immunospot is indeed capable of providing a reliable
diagnostic below the NS1 concentration that exists in infected
patients on the second day of the disease. The low detection limit
is decisive for early Dengue fever detection based on the NS1
protein and can be vital for the rapid assessment of patients
developing more severe cases of the disease. When an UV-lamp is
the only available tool, Dengue fever can be detected at the third
day of infection. Lateral ﬂow immunoassays are faster than theFig. 3. Comparison between quantitative and qualitative detection. Fluorescent
spots from infected serum dilution with anti-NS1 coated ﬂuorescent particles
measured under UV-lamp (a), by ﬂuorometer coupled with optical ﬁber and ELISA
reader (b). Positive (left) and negative (right) controls are shown in (c).
Please cite this article as: Linares, E.M., et al., Biosensors and Bioelepresented immunospot assay, but they require 25-times more
sample volume, two antibodies for capture and detection of the
analyte and they provide a visual signal emanating from a very
small physical area, which often causes doubtful evaluation due
to heterogeneous ﬂow of particles.
In order to evaluate the gain in performance of the proposed
method in comparison to classical FLISA, analytical curves for NS1
antibody coated ﬂuorescent particles and anti-mouse IgG FITC
antibodies were obtained on nitrocellulose. Fig. 4 shows that
higher signals were recorded when particles were used, resulting
therefore in a more sensitive assay. Besides avoiding bleaching
effects, the use of particles permits to concentrate the ﬂuoro-
phores and contribute to a higher ﬂuorescence signal per anti-
body bound to the antigen, unlike FLISA.
Precisely, considering the concentration range between 2 and
100 ng/mL, the particles used as enhancers resulted in a curve
slope of 0.758 a.u. mL/ng, which is higher than the assay using
only FITC (0.539 a.u. mL/ng). It means that the proposed assay is
more sensitive to detect variations on the concentration axis.
In order to verify the potential of the proposed methodology in
the biological analysis, 83 blood serum samples from infected
patients were analyzed and compared to a commercial NS1 ELISA.
Analysis provided satisfactory results compared to the commer-
cial test (Table 1). The ﬂuorescence measurements performed in
ELISA reader revealed sensitivity of 81% and speciﬁcity of 88%.
However, the qualitative measurements using UV-lamp showed
low sensitivity, 59%, and speciﬁcity of 83%. The low sensitivity is
justiﬁed by the difﬁculty to establish visual limits for considering
a positive or a negative result. The limit was deﬁned by the
negative control, in which non-infected serum was analyzed and
non-speciﬁc interaction provided background intensity. Thus, the
diagnostic was obtained by comparing visually the sample spotsFig. 4. Comparison of sandwich ﬂuorescent immunolinked sorbent assay using
ﬂuorescent particles and ﬂuorescent molecules as the detection label. Dengue NS1
antibody conjugated to orange particle signal is compared to anti-mouse IgG FITC
antibody.
Table 1
Dengue NS1 detection using the proposed method with reference to a commercial
NS1 ELISA in 83 serum samples from infected patients.
NS1 status Immunospot (ELISA reader) Immunospot (UV-lamp) Total
Positive Negative Positive Negative
Positive 48 11 35 24 59
Negative 3 21 4 20 24
Total 51 32 39 44 83
Sensitivity 81% 59%
Speciﬁcity 88% 83%
ctronics (2012), http://dx.doi.org/10.1016/j.bios.2012.08.005
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not excited in their maximum wavelength, which reduces the
emission intensity and consequently the sensitivity. After com-
paring the values obtained with commercial NS1 ELISA and
ﬂuorescent measurements in ELISA reader (paired t-test), no
signiﬁcant statistical differences were found. Based on the
exposed results, the proposed test described using particles and
ﬂuorescence readers shows high potential to be applied as
detection tool for Dengue NS1.
This test has the advantage of being performed during 45–
60 min in comparison to classical ELISA or FLISA, which usually
take 3–5 h. Thus, it is possible to save time and keep good
sensitivity in routine procedures of clinical analysis laboratories.
In addition, those tests based on UV-lamp detection can provide
qualitative diagnostics in laboratories with lack of adequate infra-
structure. Although, they showed low sensitivity, it is still accep-
table as a diagnostic tool due to its sensitivity be superior to 50%.4. Conclusion
We present the development of an immunospot assay for
Dengue fever diagnosis based on anti-NS1 ﬂuorescent nanoparti-
cle conjugates, combining principles of ﬂuorescence linked immu-
nosorbent assay and enzyme linked immunospot. The use of
ﬂuorescent nanoparticles allowed high sensitivity and ease detec-
tion using different laboratory equipment. In addition, the appli-
cation of reagents and samples on nitrocellulose membrane
provided easy manipulation, low volume samples and lower
costs. We proved that the combination of principles of different
assays can produce a fast and high sensitive test to be applied to
Dengue fever detection, mainly in impoverished environments
and epidemic areas, where sensitivity, speed and simplicity are
essentials. Furthermore, this method can be easily applied to the
diagnosis of other neglected tropical diseases, which require fast
and alternative detection tools.Acknowledgments
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Antibody purification 
The NS1mAb (Abcam, Cambridge UK) was purified by Protein G affinity chromatography. One ml 
Hitrap protein G HP column for affinity chromatography and the PD10 desalting column were 
purchased from GE Healthcare (Uppsala, Sweden). The supernatant was slowly passed through the 
protein G column using Äktapurifier 100 (GE Healthcare, Uppsala, Sweden). The NS1mAb was 
eluted from protein G in 10 ml of 0.1 mol/L glycine, pH 2.8. The eluent was concentrated to 1 ml 
by centrifugation at 5000 rpm and buffer exchange into 1x PBS, pH 7.4, using a desalting column at 
RT. 
 
Dengue diagnostics 
The samples belong to a repository collection obtained during previous studies conducted by the 
Virology Laboratory of the Instituto de Medicina Tropical de São Paulo of the University of São 
Paulo, and stored at -20oC. Aliquots were prepared from samples with laboratory-confirmed acute 
DF infection, defined by detection of DF RNA by qPCR, and/or anti-DF IgM antibodies (Dengue 
ELISA IgM, Focus Technologies, Cypress, USA), and/or dengue NS1 antigen. Commercial kits 
were used as described by the manufacturers instructions.  
 
Sandwich enzyme linked immunosorbent assay for NS1 protein quantification: 
The NS1 protein determination in serum samples was performed adapting a SD NS1 Ag ELISA kit 
for quantification analysis. Microplate wells were coated with NS1 monoclonal antibodies from 
Abcam at a concentration of 5 μg/ml in a 0.01 M carbonate/bicarbonate buffer, pH 9.6. The plate 
was covered with an adhesive plastic and incubated overnight at 4°C. The coating solution was then 
removed and the wells were washed, by filling with 200 μl of washing buffer (0.01 M phosphate 
buffer containing 0.01% of Tween 20, pH 7.4). The remaining protein-binding sites in the coated 
wells were blocked by adding 200 μl of a 5% albumin solution in 0.01 M phosphate buffer, pH 7.4. 
The plate was covered with an adhesive plastic and incubated for 2 h at RT. After washing the wells 
twice with 200 μl of washing buffer, NS1 protein solutions and samples were added. For the 
standard curve, 100 μl of diluted NS1 protein solutions, 1, 50, 100, 250, 500, 650 and 800 ng/mL 
were added to the wells, using a triplicate for each concentration and incubated for 90 min at 37°C. 
For the standard curve and the positive control, NS1 protein from the SD NS1 Ag ELISA kit was 
used. NS1 protein concentration was determined using UV method. Three different samples were 
also incubated in triplicate. Subsequently, the wells were washed twice, by filling with 200 μl of 
washing buffer. After washing, 100 μl of 0.01μg/mL mouse monoclonal detection antibody 
conjugated with horseradish peroxidase was added to each well and the plate was covered with an  
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adhesive plastic and incubated for 2 h at room temperature. The plates were then washed six times 
with washing buffer. The substrate for the enzyme was prepared by mixing 1:1 of substrate A 
(sodium acetate, hydrogen peroxide and gentamicin) and B (tetramethylbenzidine and hydrochloric 
acid) from the kit. Finally, 100 μl of substrate was added in each well and the solutions were 
measured after 30 min using an ELISA reader.  
 
Sensitivity and specificity calculation 
Sensitivity measures the proportion of actual positives which are correctly identified and it is 
calculated using the equation SI-1: 
 
Equation SI-1  
 
 
And specificity measures the proportion of negatives which are correctly identified and the 
percentage is calculated using the equation SI-2: 
 
Equation SI-2 
 
Fluorescence spectroscopy 
The spectrofluorometric measurements were performed with a LS-55 Perkin-Elmer luminescence 
spectrometer (Connecticut, USA) equipped with a xenon discharge lamp (20 kW, 8 ms), a 
Hamamatsu photomultiplier, a reference photodiode and a bifurcated optical fiber bundle of quartz 
(4.0 mm diameter at the common end) coupled to an optical fiber accessory. The excitation and 
emission of fluorescent nanoparticles were monitored at 542 and 565 nm, respectively. In order to 
compare the fluorescence measurements between fluorometer coupled to an optical fiber and an 
ELISA reader, measurements were performed using SAFIRE II Multimode Microplate Reader 
(Männedorf, Switzerland), setting excitation and emission slits to 10 nm and 20 nm, respectively. 
The UV-Lamp Biometra T1 emits at UV-A and B lamp (280-400 nm). For fluorometer coupled 
with optical fiber and ELISA readers, the influence of the variables that potentially affect the 
fluorescence intensity was investigated in order to optimize the measurement conditions. Besides 
the excitation and emission slit and the monochromator scan rate, the distance between the optical 
fiber tip and the irradiated surface was optimized. An important parameter is the acceptance angle 
when optical fibers are used, which is the angle at which the maximum amount of light goes back 
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into the optical fiber through total internal reflectance. Thus it is very important to find the distance 
between the optical fiber tip and the irradiated surface, in order to reach the maximum signal. 
Figure SI-1 shows that the best sensitivity was attained with the distance varying from 1-10 mm. 
Therefore, for further experiments a distance of 7 mm was used. 
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Figure SI-1. Influence of instrument variable on the fluorescence intensity. Effect of the 
distance between optical fiber and the sample on the nitrocellulose membrane obtained for the 
fluorescent orange nanoparticles covered with Ab-NS1; Cparticles: 2 % (w/w). 
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Abstract 
 
Luminescent core-shell particles are structures widely applied to biomedical purposes with the 
potential of combining multiple features within one single particle. The development of particles 
that are easily synthetized and tunable for each application, combining biocompatibility, easy 
bioconjugation and high detection signal as a label, is highly desired. In this work, we describe one-
step synthesis of poly[styrene-co-(2-hydroxyethyl methacrylate)], PSHEMA, core-shell particles 
containing [Ru(4,4’-dicarboxilate-2,2’-bpy)3] luminescent complexes. These particles show 
monodispersity, biocompatibility, easy functionalization and dye incorporation to focus on 
bioapplications, such as cell-tracking and diagnostics. The natural monomer self-assemble during 
the polymerization produces core-shell structure with hydrophilic-hydrophobic character.  It allows 
the concentration of hydrophilic ruthenium complexes into the particle due to HEMA hydrophilic 
character and incorporation of hydrophobic molecules (e. g. diphenylanthracene) due to the styrene 
hydrophobic character. The incorporation of Ru complex into the particle resulted in higher 
photostability than the free dye. Furthermore, carboxylic groups on the particle surface originated 
from carboxylated ligands of Ru complexes were used to immobilize biomolecules. The particles 
were successfully used as a diagnostic label for an immunospot assays for Dengue fever (DF) 
detection, which is a viral infection transmitted by mosquito that lacks in early reliable detection 
tools. The immunospot assay for viral Dengue non-structural glycoprotein detection provided a 
detection limit (DL) of 187 ng/mL. The particles are promising for paper based assays due its high 
stability and low agglomeration. The particles showed a considerable decrease in DL and allowed 
the infection diagnosis 24h before in comparison to current assays based on gold nanoparticles. In 
addition, the particle biocompatibility was demonstrated with an adherent grown fibroblast cell line. 
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Introduction 
Core-shell particles play an important role in life science applications ranging from drug 
delivery1 and biosensing for diagnosis to therapeutic use2,3 and contrast agent for multimodality 
imaging.2-5 Particles with specific features are required for these wide range of applications. Due to 
the vast variety of morphologies and molecular compositions, polymer latex particles are 
considered as the first choice to fulfill the requirements for each use. Numerous structures involving 
polymers have been described, including polymer shell-polymer core,6 polymer shell-silica core,7 
polymer shell-quantum dot core8 and polymer shell-magnetic core9,10. Among these, special interest 
is given to core-shell particles with hydrophobic core and hydrophilic shell. This assembly provides 
functional groups for bioconjugation and a protective coating between the core and the external 
medium, which make it especially suitable for hydrophobic drug delivery systems or 
nanoreactors.11,12 In addition, hydrophilic shells are produced to avoid hydrophobic particle 
aggregation in aqueous medium13 and for improving the photostability of incorporated luminescent 
dyes.7  
Among latexes with hydrophobic properties, polystyrene particles (PS) are predominantly 
applied to biomedical purposes and have been extensively used as a specific carrier for diagnostic 
reagents, detection labels, agglutination tests and other applications.14 Unfortunately, PS particles 
show low colloidal stability and problems with bioconjugation step.15 Its low stability causes 
particle agglomeration, which affects its use in flow tests, such as paper based assays. Accordingly, 
poly[styrene-co-(2-hydroxyethyl methacrylate)] (PSHEMA) polymer particles are used as a suitable 
material for bioapplications substituting PS particles.15 PSHEMA particles consist of a 
hydrophilic/hydrophobic heterogeneous surface, providing high colloidal stability, insensitive non-
specific agglutinability, free-emulsifier polymerization and high monodispersity. The particles are 
characterized as core-shell structures, where the HEMA richer chains are more concentrated at the 
particle periphery.16 In addition and due to the structural array, the surface modification allows the 
functionalization with biomolecules and the incorporation of different molecules into the 
hydrophobic core and/or the hydrophilic shell, i.e. as luminescent (fluorescent, phosphorescent) 
dyes.  
The incorporation of luminescent dyes into the PSHEMA particles makes them potential 
candidates for bioapplications such as detection system in diagnostics or living cell imaging. 
Luminescent transition metal complexes can provide high emissive particles due to high quantum 
yields and long luminescence lifetimes in comparison with most organic fluorophores. In addition, 
luminescent transition metals show large Stokes shifts eliminating self-quenching processes, intense 
Chapter 4 
 
81 
 
absorption in the visible spectral range as well as thermal, chemical and photochemical stability.17 
Hence particles with luminescent transition metal complexes are capable to overcome the typical 
limitations of organic fluorophores, such as poor brightness, fast photobleaching, non-specific 
quenching and solvatochromic effects.13  
Ruthenium (Ru) complexes show many advantages over other transition metal complexes and 
have been extensively investigated both from the fundamental and technological point of view.18,19 
To use Ru complexes in biological applications and take advantage from their luminescent 
properties, they should be incorporated into a matrix to avoid non-specific binding to proteins and 
membranes. A recent work by Lin and coworkers20 described the fabrication of core-shell 
nanostructures from near-infrared electrochromic amphiphilic diblock copolymers containing a 
pendant dinuclear ruthenium group. Although this work produced stable micelles and vesicles, the 
copolymer of styrene and the ruthenium complex requires very complicated and time-consuming 
sequential steps for the polymer synthesis. 
Here we describe one step synthesis of core-shell particles composed of PSHEMA, containing 
high luminescent [Ru(4,4’-dicarboxilate-2,2’-bpy)3] complex. These particles combine 
photostability and high luminescence intensity from the transition metal complex with the stable 
monodispersed PSHEMA core-shell structure. The ruthenium complex has a hydrophilic nature that 
results in an accumulation into the particle shell, which also has a hydrophilic character. The 
presence of 2,2’-bipyridine-4,4’-dicarboxylic acid ligands provide carboxylate groups anchored on 
the particle surface that allow further biofunctionalization. Single step reactions produce core-shell 
particles with luminescent dye and functional groups incorporated on the surface. It overcomes the 
current challenge of probe conjugation to target biomolecules, which usually involves additional 
polymerization steps to incorporate functional groups. The concentration of Ru complexes into the 
shell allows further molecule incorporation in the hydrophobic core. Furthermore, the surfactant 
free polymerization avoids desorption of surfactant molecules, producing stable dispersions without 
undesired interactions of emulsifiers with biomolecules. The PSHEMA-Ru particle architecture 
results in the improvement of various properties, such as reduced photobleaching, minimized 
solvatochromic shift, and increased luminescence efficiency relative to a free dye in aqueous 
solution and allows colocalization of multiple fluorophores/molecules within a single particle.  
In order to demonstrate the potential of Ru-PSHEMA bioconjugates as detection system, we 
developed a paper based immunospot assay for the ambitious task of early Dengue fever detection. 
Dengue fever is a viral infection transmitted by mosquito that in recent decades has become a major 
international public health concern,21 which has a lack in early reliable detection tools. The stability 
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and low agglomeration produce more homogeneous spots on the membrane. While efficient 
approaches to control the insect vector are ongoing22, there is an increase necessity for sensitive and 
reliable tools for Dengue fever detection. Furthermore, we show the use of these particles for 
hydrophobic fluorescent dye incorporation, resulting in successful hydrophobic molecule 
entrapment inside the particles. Biocompatibility tests are also reported, which illustrate the 
potential use in cell-tracking applications. 
 
Experimental Procedures 
 
Materials and reagents 
 
Styrene, 2-Hydroxyethyl methacrylate, ruthenium(III) chloride trihydrate, 2,2’-bipyridine-4,4’-
dicarboxylic acid, sodium persulfate, sodium bicarbonate, bovine serum albumin (BSA) powder, N-
(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC), 9,10-Diphenylanthracene 
(DPA), dichloromethane and potassium phosphate, mono- and dibasic, were purchased from Sigma-
Aldrich (Milwaukee, USA). Dimethylformamide and ethanol were obtained from Merck 
(Darmstadt, Germany). Dengue Virus NS1 glycoprotein mouse monoclonal antibody (supernatant) 
was obtained from Abcam (Cambridge, United Kingdom). RPMI media and Vectashield were 
purchased from Biochrom AG (Berlin, Germany) and Vector Laboratories (Burlingame, USA), 
respectively. Aminosilane coated glass slides were purchased from Schott (Mainz, Germany). The 
fluorescent dyes Hoechst 33342 and DilC12(3) perchlorate were purchased from Invitrogen 
(Eugene, USA) and Enzo Life Sciences (Lörrach, Germany), respectively. Hitrap protein G HP 
column for affinity chromatography and the PD10 desalting columns were purchased from GE 
Healthcare (Uppsala, Sweden). Nitrocellulose membrane (8µm) was obtained from Whatman 
(Maidstone, United Kingdom). 
 
Synthesis of Na4[Ru(4,4’-dicarboxilate-2,2’-bpy)3].13 H2O 
 
Tris-chelated complex of Ru(II) was synthesized according to the  protocol described by 
Nazeeruddin et al.23 with slight modifications. In a three-necked round bottomed flask, linked to a 
reflux condenser, 50 mL of N, N’ dimethylformamide was deaerated with N2 for 10 minutes at RT. 
Then, 0.214 g of Ruthenium (III) chloride trihydrate and 0.610 g of 2,2’-bipyridine-4,4’-
dicarboxylic acid were added. The mixture was heated to 150°C for 3 hours at reflux with vigorous 
stirring. Shortly after, 9.6 mL of 0.5 mol/L NaHCO3 aqueous solution was added and the reflux was 
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kept at 150°C for additional 4 hours. The reaction procedure was monitored by checking the 
reaction solution color. The initial blue-green starting solution turned immediately into pink after 
adding NaHCO3, then red, and finally orange at the end of the reaction. The solid produced was 
directly collected on a sintered glass filter and washed three times with 20 mL DMF at RT. The 
material was recrystallized using methanol and diethylether. The final product was dried under 
vacuum, resulting in a 79% yield. NMR-1H analysis of the complex is shown in the Electronic 
Supporting Information (ESI-1). 
 
Synthesis of the poly[styrene-co-(2-hydroxyethyl methacrylate)] latex, PSHEMA  
 
The latex was prepared by batch surfactant-free emulsion copolymerization of styrene (S) and 
2-hydroxyethyl methacrylate (HEMA) adapting procedures described by Tamai et al.24 and Cardoso 
et al.25 The polymerization was carried out in a 500 mL three-neck round-bottom flask connected to 
a condenser, a Teflon paddle stirrer and a gas inlet providing a constant flow of nitrogen gas. Five 
reactions were performed containing different monomer percentages: 1.5, 2.5, 4.2, 5.5 and 7.3 wt. 
% of HEMA. Only the high HEMA concentration is described herein. Initially, the reaction flask 
was filled with 220 mL of water. The system was purged with nitrogen gas and kept at 70 ºC. After 
stirring for 30 minutes, 31.5 g styrene and 2.5 g 2-hydroxyethyl methacrylate were added. In a 
subsequent step, 0.0543g of sodium persulfate was dissolved in 5 mL of water and was added to the 
reaction after 1 h. The reaction was kept for 10 h at 70 °C under constant stirring at 450 rpm. The 
latex was filtered with a mesh steel sieve, to remove coagulated latex. In order to eliminate 
monomers and initiator, the dispersion was centrifuged twice at 13 000 rpm for 10 minutes at RT. 
The zeta potential measurement indicated -43 mV for PSHEMA particles.  
 
Synthesis of PSHEMA latex containing Na4[Ru(4,4’-dicarboxilate-2,2’-bpy)3].13 H2O, PSHEMA-
Ru  
 
The reaction was performed in the same reactor and conditions (nitrogen atmosphere, stirring at 
450 rpm and temperature at 70°C) as used for the poly[styrene-co-(2-hydroxyethyl methacrylate)] 
synthesis. The flask was filled with 220 mL of water, heated up to 70°C and stirred during 30 min 
in a nitrogen atmosphere. Subsequently, 31.5 g styrene and 2.5 g 2-hydroxyethyl methacrylate were 
added. In a subsequent step, 0.0543g of sodium persulfate dissolved in 5 mL of water was added 
after 1 h. After a reaction time of 7 h at 70ºC, a solution of ruthenium complex containing 7.5 mg in 
10 mL water was added to the flask. The reaction was kept up to 10h at 70 °C under constant 
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stirring at 450 rpm. Finally, the latex was filtered to remove coagulated latex and centrifuged twice 
at 13 000 rpm for 10 minutes at RT in order to eliminate monomers, initiator and non-incorporated 
complexes. The PSHEMA-Ru particles have a zeta potential of -54 mV. 
 
9,10-Diphenylanthracene incorporation in PSHEMA-Ru particles 
 
The DPA incorporation was performed Allard and Larpent26. Dye loading was performed in an 
aqueous suspension containing 0.4% (w/v) of PSHEMA-Ru particles. An aliquot of 20 µL of DPA 
23 mM in dichloromethane was added to 1 mL of the PSHEMA-Ru particles. The sample was 
stirred at RT, in the dark for 48 h, to allow the diffusion of dye within the polymer matrix and the 
progressive evaporation of dichloromethane. Subsequently, the dispersion was centrifuged to 
remove non-incorporated DPA from the dispersion and the water was replaced by phosphate buffer 
0.01M, pH 7.4. The incorporation was evaluated by acquiring an emission spectrum (λex: 350nm). 
 
Antibody purification 
 
The NS1mAb (Abcam, Cambridge UK) was purified by Protein G affinity chromatography. The 
supernatant was slowly passed through the protein G column using Aektapurifier 100 (GE 
Healthcare, Uppsala, Sweden). The NS1mAb was eluted from protein G in 10 ml of 0.1 mol/L 
glycine, pH 2.8. The eluent was concentrated to 1 ml by centrifugation at 5000 rpm during 5 min 
and buffer exchange into 1x PBS, pH 7.4, using a desalting column at RT. 
 
Biomolecule immobilization on the PSHEMA-Ru particles 
 
Bovine serum albumin was covalently bound to the PSHEMA-Ru particles as a spacer for 
further biomolecule immobilization. Water-soluble carbodiimide activates the surface carboxyl 
groups originated from the complex on the particle surface. An aliquot of 1 mg of albumin was 
dissolved at 3 mg/mL using 0.1 mol/L PBS buffer, pH 6.5. Then, 500 µL of a 0.3 % aqueous 
suspension of particles was added and incubated for 30 min at RT. Subsequently, 1.5 mg of EDC 
was added and mixed by vortexing. The dispersion was incubated on a shaker for 3 hours at RT. To 
separate the protein-labeled microsphere particles from unbound protein and EDC molecules, the 
dispersion was centrifuged at 10 000 rpm for 10 min at RT. The suspension was stored at 4ºC with 
phosphate buffer 0.01M, pH 7.4, until being used for biomolecule conjugation. 
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Immunospot assay for Dengue virus NS1 protein detection 
 
For single analysis, the strip test contains the reaction membrane and the absorbent pad. 
Nitrocellulose membrane (5mm x 60mm) was placed glass slide and an absorbent pad (5mm x 
45mm) was fixed on the opposite side. An aliquot of 0.5 µL of serum was slowly spotted on the 
center area of the nitrocellulose membrane. After drying the serum droplet, 20 µL of BSA 3% in 
phosphate buffer 0.01 mol/L, pH 7.4, was added directly on the dried serum spot and the excess of 
liquid was absorbed by the absorbent pad. Subsequently, 20 µL of fluorescent conjugates 1% in 
phosphate buffer 0.01 mol/L, pH 7.4, was added to the membrane and the excess was absorbed with 
the absorbent pad. To remove unbound particles, 100 µL of washing buffer (phosphate buffer 0.01 
mol/L, pH 7.4, Tween 20 0.01% and NaCl 0.05 mol/L) was added to the membrane. NS1 
concentration was detected using sandwich ELISA. The membrane was analyzed by fluorescence 
microscopy. 
 
Dengue virus infected serum samples 
 
The samples belong to a repository collection of the Virology Laboratory of the Instituto de 
Medicina Tropical de São Paulo, University of São Paulo. The serum samples were stored at -20oC 
until the analysis. Aliquots of positive samples were used for detection of DF RNA by qPCR, 
and/or anti-DF IgM antibodies (Dengue ELISA IgM, Focus Technologies, Cypress, USA), and/or 
dengue NS1 antigen. Commercial kits were used as described by the manufacturers instructions.  
 
Cell staining and particle incorporation 
 
L929 mouse fibroblasts were grown on glass slides for testing the particle biocompatibility and 
cellular uptake of PSHEMA-Ru particles. L929 were cultured to a confluent layer in RPMI media 
with 10% fetal calf serum, 1% antibiotic–antimycotic solution and incubated at 37º C in a 
humidified 95% air and 5% CO2 atmosphere. PSHEMA-Ru particles without coating treatment were 
added to the cell medium in two concentrations, 7 and 15 µg/mL, and the cells were incubated for 
24h. For each concentration, 3 samples were prepared after 24h, 48h and 72h of particle incubation 
and a fourth sample for negative control. Firstly, RPMI medium was removed and cells were 
incubated with DilC12(3) perchlorate in RPMI for 20min at 37°C. Secondly, the medium with Dil 
was removed and cells were fixed with 2% paraformaldehyde for 15min at RT. Fixation was 
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stopped by washing the cells twice with 1mol/L PBS at RT. The nucleus was stained with the 
incorporating dye Hoechst 33342 1% by incubating for 10min at RT. Finally the samples were 
washed with 1mol/L PBS, sealed with 10µl Vectashield mounting medium and covered with a 
cover slide. The samples were kept in the dark at 4°C until use. 
 
Confocal microscopy 
 
For confocal images, a Carl Zeiss LSM 510 NLO (Göttingen, Germany) confocal microscope 
equipped with 10x and 63x water objective was used. Images were obtained by depositing 0.5% 
(w/v) of particle dispersion on a glass slide. The serum analyses were performed by pasting the 
nitrocellulose membrane on a glass slide. Images were recorded using the software LSM 510 
version 4.2 SP1. Instrument parameter for the spatial distribution analysis of each dye of the stained 
cells is shown in the Electronic Supporting Information (ESI-2). More information about the image 
analyses of the serum spots is described in the (ESI-3). Stacks with 0.1 µm z steps were obtained 
and images were processed using the software LSM Image Examiner and Adobe Photoshop CS3.  
 
Spectroscopy 
 
Measurements were performed using SAFIRE II Multimode Microplate Reader (Männedorf, 
Switzerland), setting the excitation and emission slits to 10 nm and 20 nm. The excitation and 
emission of luminescent particles were monitored at 470 and 630 nm, respectively. For the 
measurement, an ELISA microplate (F96 MicroWellTM plates, NUNC, Roskilde, Denmark) was 
used. Data were obtained using the XFluorTM software version 4.62n. 
 
Atomic force microscopy analysis 
 
For high resolution atomic force microscopy (AFM) analysis each particle dispersion was 
diluted to a 0.05% dispersion of solid components and deposited onto freshly cleaved mica. 
Particles were analyzed using an AFM (JPK Nanowizard 1, Berlin, Germany) in intermitent contact 
mode using Si tips NSC 15 with 40 Nm-1 spring constant from Mikromasch (Las Rozas de Madrid, 
Spain). Images were processed using JPK DP Data Processing Software 4.0 and Gwyddion 2.2. 
 
Transmission electron microscopy 
 
Images were acquired using a Carl Zeiss Libra 120 kV transmission electron microscope (TEM) 
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equipped with an omega filter. Energy-filtered transmission electron microscopy (EFTEM) was 
used to obtain bright-field images with low chromatic aberration when the energy slit was set to 
zero. Elemental maps were acquired by imaging inelastically scattered electrons using electron 
spectroscopy imaging (ESI). Energy selecting slits of 5eV were set at energy loss of Ru (43 eV). 
The images were recorded using a CCD camera and iTEM Universal TEM Imaging Platform. 
Samples were prepared by drying an aqueous suspension droplet of PSHEMA with and without Ru 
on carbon-coated parlodion films supported in 400-mesh copper grids (SPI supplies, West Chester, 
USA). 
 
Photostability 
 
Photostability measurements were performed to a Ru complex aqueous solution at 0.0808 g/mL 
and an aqueous Ru-PSHEMA dispersion at 0.1 g/mL, using a Photon Technology International, 
PTI, (Birmingham, USA) spectrofluorometer, with a photomultiplier detection system (model 
810/814), operated in the emission mode. Samples were irradiated at 470 nm wave-length for 3400 
seconds and the emission maximum of the Ru complex was monitored at 630 nm. All samples were 
continuously stirred during the measurements and kept under room conditions. 
 
Results and Discussion 
 
In order to assure reproducibility in different uses, the particles were characterized in terms of 
luminescence intensity, monodispersity and morphology using microscopies. Particles and 
agglomerates are shown in Figure 1a and appear as highly intense luminescent spots in the 
luminescence digital image in Figure 1b. Particles were excited at 470 nm and the spectrum in the 
Figure 1c shows the emission band of the Ru complex with maximum emission at 630 nm. 
Particle morphology was analyzed by AFM and the results are depicted in Figure 1d and f. 
Hexagonal packing caused by high uniformity of particle sizes is observed with low deformation 
due to high glass temperature of PSHEMA (PS: 104°C and PHEMA: 85°C).27 This kind of 
arrangement has been described in the literature for colloidal latex particles in dry films with highly 
ordered structures.28,29 Additionally, these structures are also attributed to a peculiar distribution of 
the chemical elements in particles by electrical dipole formation.30 PSHEMA particles have a 
smooth surface also for particles without ruthenium complex. This is contrary to the description in 
the literature, where particles contain convoluted protrusions like in a “raspberry-like” particle 
model.28 We attribute the smooth character of the particles to a lower 2-hydroxyethylmethacrylate 
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concentration in the synthesis than the procedures described in the literature. This is based on the 
results described by Martin-Rodriguez and co-authors,31 which indicated that the surface roughness 
is proportional to the HEMA percentage in the polymerization process. In order to determine the 
size distribution, 150 particles were measured and an average diameter of 183 ±16 nm and 185 ±15 
nm (Figures 1e and g) were obtained for PSHEMA and PSHEMA-Ru, respectively. The similar 
diameter indicates that the addition of Ru complex after 7 hours of reaction did not notably affect 
the polymerization process and the stabilization, and monodispersity is maintained.  
Five reactions were performed using additional concentration of HEMA. The first three 
reactions containing 1.5, 2.5 and 4.2 wt. % of monomers produced unstable system forming 
agglomerates in the first 3h of reaction, probably caused by insufficient HEMA to stabilize the 
particles. The last two reactions with 5.5 wt. % and 7.3wt. % provide stable colloidal dispersions, 
but only the highest HEMA concentration yields highly luminescent particles.  
 
 
Figure 1. Microscopic characterization of PSHEMA and Ru-PSHEMA particles. Optical (a) and digital fluorescence 
(b) images from a PSHEMA-Ru particles dried on glass slide (630 x magnification). (c) Emission spectrum of the 
ruthenium complex. AFM topography images and histograms of diameter distribution from the film surface of PSHEMA 
(d and e) and PSHEMA-Ru (f and g) particles, showing a monodispersed size distribution evidenced by the particle 
homogeneous hexagonal packing.  
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The incorporation of a hydrophobic dye inside of the particle is demonstrated by the entrapment 
of the hydrophobic 9,10-diphenylanthracene, DPA, using the soaking technique.26 The swelling of 
the polymer particle with a dichloromethane solution of DPA allowed the hydrophobic dye to 
diffuse into the polymer matrix. After evaporation of the organic solvent, the dye molecules remain 
entrapped within the particles. The PSHEMA-Ru-DPA particle spectrum (Figure 2) shows that the 
particles could incorporate a high percentage of DPA, revealed by the emission band intensity close 
to the free DPA in dichloromethane. 
 
Figure 2. Hydrophobic dye incorporation. Fluorescence spectra of 9,10-diphenylanthracene in dichloromethane and 
incorporated in PSHEMA-Ru particles by soaking technique (λex: 350 nm). 
 
Many methods are used to probe the detailed internal structure of core-shell latex particles. 
Recently, energy filtered TEM (EFTEM) in the low-energy-loss spectral region was successfully 
used to observe and distinguish domains with sizes in the nanometer range and with small 
differences in the chemical composition.32,33 Hence, energy filtered transmission electron 
microscopy (EFTEM) in combination with electron spectroscopy imaging (ESI-TEM) were used to 
investigate the Ru complex distribution in the particle structure.34,34 Bright-field images for 
PSHEMA and Ru-PSHEMA particles (Figure 3a and c) confirm the smooth spherical particles that 
present slight deformations as necks between the particles, even more evident for PSHEMA-Ru. 
Energy loss TEM images were obtained at 40 eV, which is the N absorption threshold region of Ru 
(Figures 3b and d). Image series from 30 to 50 eV are shown in the Supporting Information (ESI – 
3). PSHEMA core-shell structure has been already described in the literature using molecular maps 
at the low energy loss range (0-80eV).35 The PSHEMA polymerization is described as a process 
with growing chains in the polymer-swollen particles and the HEMA richer chains are more 
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concentrated at the particle periphery.25 X-ray photoelectron spectroscopy also indicated that the 
HEMA component is localized at the surface.36 The images at 40 eV in the Figure 3d show that 
shell presents a higher contrast in comparison to the core for PSHEMA particles without Ru (Figure 
3b).Thus, considering the hydrophilic structure of Ru complex, it can be expected that the 
complexes are more concentrated into the shell due to its higher hydrophilicity. Cardoso and col.25 
investigated the elemental distribution within PSHEMA particles and showed that the initiator 
counter ions, K+, concentrate in a thin outer particle surface. The positive layer around the particles 
can have an important role to keep the ruthenium complex attached to the particle shell.   
 
Figure 3. TEM images from PSHEMA and Ru-PSHEMA particles showing core–shell structure with Ru complex in 
the shell. Bright-field and energy loss images at 40 eV (N shell of Ru) for PSHEMA (a and b) and Ru-PSHEMA (c and 
d). Line profile (e) from a Ru-PSHEMA particle at 40 eV revealing the contrast difference between shell and core in 
presence of Ru.  
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According to the energy image and the line profile (Figure 3e), the thickness of the shell 
containing ruthenium is approximately 27±9 nm, which corresponds to the HEMA-rich polymer 
shell observed in the Figure 3b. It is possible to observe that the shell structure is not symmetric 
around the hydrophobic core. 
     The time-dependence of the emission, and consequently the photostability, for the free and the 
incorporated Ru complex dye is shown in Figure 4.  
 
 
Figure 4. Photostability of Ru complex and Ru complex incorporated in PSHEMA particles. Measurements were 
performed during 3400 seconds, exposing the sample to λex= 470nm and measuring at λem= 630nm. Fluorescence 
decays show that bleaching effects on fluorescent Ru complex is reduced after incorporation in PSHEMA polymer 
particles. 
 
The values are shown as a percentage in comparison to the initial intensity. The time-
dependence for the incorporated dye is slightly lower than the free dye, indicating higher 
luminescence stability. The decay for the incorporated dye after 3400 seconds of irradiation was 
98.5% in comparison to 97.9% for the free dye. Although the difference is low, it may be 
significant for the detection limit in diagnostic applications and in long time storage. It can be 
explained by the diffusional limitations of oxygen molecules inside of the polymer shell. It avoids 
that singlet state oxygen molecules decompose dye molecules in their excited state.37,38 Therefore, 
immobilization or encapsulation of the complex in polymeric material is necessary and provides 
possibilities for increasing photostability, besides of minimization of toxicity and invasive 
perturbation of biological systems.  
Besides the TEM images, experiments were performed to verify the character of interaction in 
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the bioconjugation, showing the availability of carboxylate groups for covalent bond on the particle 
surface. Two bioconjugate systems with streptavidin were prepared, one in the presence and the 
other in the absence of N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride, EDC, 
which activates carboxylate groups for further reaction with amines. The conjugate without EDC 
showed very slight emission after interaction with a biotin spot, whereas the conjugates with EDC 
revealed much higher luminescent spot (Electronic Supporting Information 4, ESI – 4). This is an 
indirect indication that carboxylate groups are available on the particle surface and play an 
important role in the biofunctionalization step. 
In order to demonstrate the potential of the particles for bioconjugation, biomolecules were 
immobilized on the particle surface (ESI – 5) and the bioconjugates were applied as detection 
system for microscopy. Monoclonal Dengue virus antibodies for a viral non-structural glycoprotein, 
NS1, were conjugated to the PSHEMA-Ru particles and they were used to analyze infected serum 
samples. The resulting analytical curve and the respective luminescent spots (Figure 5a and b) show 
a linear range from 200 to 400 ng/mL and a detection limit of 187 ng/mL. The image analysis is 
described in the (ESI – 6). Libraty and coworkers39 investigated the plasma levels of secreted NS1 
protein from free Dengue-2 virus during the infection. They demonstrated that the concentration 
may vary between 150 and 250ng/ml per day of illness for the second day of the disease for patients 
that suffer from Dengue haemorrhagic fever. 
 
 
Figure 5. Anti-NS1 coated PSHEMA-Ru particles used to detect Dengue virus NS1 protein. Analytical curve (a) for 
Dengue virus NS1 performed on nitrocellulose membrane and digital fluorescent images from each spot. Values were 
obtained by subtracting the background intensity from the spot signal. Images were recorded at 10x of magnification. 
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Serum positive samples from the second and third day of infection from a group of 10 patients 
were analyzed using PSHEMA-Ru particles and microscope (Digital images are shown in the 
Electronic Supporting Information 7, ESI – 7). The test was positive for all samples, proving that 
the luminescent particles are indeed capable of providing a reliable diagnostic below the NS1 
concentration that exists in infected patients at the first days of the disease. Immunospot assay based 
on gold nanoparticles are able to detect after the third to fourth days of the disease (detection limit: 
575 ng/mL)21. Using PSHEMA-Ru particles, it is possible to detect the disease from the second 
day. This can help in the rapid assessment of patients developing more severe cases of the disease. 
Due to the high stability of these core-shell particles, current agglomeration problems of 
polymer particles related to flow in the membrane were not observed for PSHEMA-Ru (ESI – 7). 
The PSHEMA-Ru particles can also provide a useful tool for cell tracking by immobilizing 
proteins specific for receptors on cell surface, following examples described in the literature.40,41 To 
verify this possible application, the biocompatibility of PSHEMA-Ru particles for fibroblast cells 
was evaluated. Polymer based on HEMA monomer is known as biocompatible.42  Fibroblasts are 
the most common cells of connective tissue in animals and are responsible for the extracellular 
matrix and collagen synthesis. After incubating for 24, 48 and 72 h with PSHEMA-Ru particles, the 
cells were stained and analyzed in a confocal microscope. The pseudo-colored fluorescence images 
were overlaid and Figure 6 shows a combined image of the fibroblasts after 72 h cultivated in 
presence of the PSHEMA-Ru particles.  
 
20 um  
Figure. 6. Biocompatibility of PSHEMA particles with fibroblast cell.s Confocal fluorescent microscopic image of 
fibroblast cells grown and stained on a glass surface in the presence of PSHEMA-Ru particles after 72 h of incubation, 
as indicated by the white arrows. The cell membrane was labelled with Dil and the nuclei were counterstained with 
Hoechst 33342. 
 
The stained membrane and nucleus shows that the cell morphology was maintained. Moreover, 
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the particles concentrate on the surface and are not incorporated by the cells, as indicated by the 
white arrows. This result shows that the PSHEMA-Ru particles are biocompatible and could be 
used for cell-surface antigen detection, neutral retrograde tracers, sensitive diagnostic reagents and 
for blood flow measurements. 
Supernatant luminescence measurements were performed during ten weeks with no measurable 
luminescence and the biocompatibility is an indirect confirmation of the stability of the luminescent 
particles, in terms of ruthenium leaching.  
 
Conclusions 
 
In this work, we described one-step synthesis of surface-functional, [Ru(4,4’-dicarboxilate-2,2’-
bpy)3] labeled poly[styrene-co-(2-hydroxyethyl methacrylate)] particles. Particles present a core-
shell structure that allows the incorporation of hydrophilic ruthenium complexes and hydrophobic 
molecules. The special design with carboxylate groups on the surface, surfactant-free and high 
monodispersity makes them appropriate for biomedical applications. A real system composed by 
Dengue virus non-structural protein antibody was used for Dengue fever detection utilizing 
microscopy, which also showed homogeneous luminescent spots with low particle agglomeration. 
Moreover, the particles are biocompatible expanding the application range to cell-based assays. We 
show that PSHEMA-Ru particles have a high potential to be successfully used in life science and 
biomedical applications. The ease conjugation with biomolecules and the vast diversity of 
molecules to be incorporated, given the structural characteristics of the PSHEMA particles, enable 
the easy development of particles with a broad range of precisely controlled characteristics and, 
consequently, vast applications. 
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ESI-1 Characterization of the ruthenium complex 
Comparative analysis between 1H NMR spectra of tris-chelated complex of Ru(II), obtained using a 
Bruker Avance II 250 MHz spectrometer in D2O 
 Literature 1 Synthesis 
C-H (1) 7,93 (d) 7,58 (d) 
C-H (2) 7,73 (d) 7,67 (d) 
C-H (3) 8,94 (s) 8,79 (s) 
 
(1) Nazeeruddin, M. K.; Kalyanasundaran, K.; Grätzel, M.; Sullivan, B. P. and Morris, K. (1998) 
One-Pot Synthesis of Tetrahydronium Tris(4,4′-Dicarboxylato-2,2′-Bipyridine)-Ruthenium(II) 
Dihydrate. Inorganic Syntheses. Volume 32: Transition metal complexes and precursors 
(Darensbourg, M.Y. (Ed.) pp 181-186, Chapter 3, John Wiley & Sons, Inc., New York. 
 
ESI-2 Parameters used in the confocal microscope to analyze cells and serum spot. 
 
Material Dye Excitation 
and 
emission 
wavelength 
(nm) 
Laser Filter configuration 
Nucleus Hoechst 33342 350/460 Argon (488) HFT KP700/514, 
mirror, mirror, BP 
435-485 
Membrane DilC 549/565 543 NT80/20/543, 
BG39, LP560 
Particles (cells) Ruthenium 
complex 
470/630 Argon (488) HFT488/543, 
mirror, BG39, 
KP685 
Particles (serum 
spots) 
Ruthenium 
complex 
470/630 Argon (488) HFT488, mirror, 
NFT545, KP685 
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ESI-3 TEM bright-field and low energy loss (30 to 50 eV) images for PSHEMA particles without 
(a-d) and with ruthenium complex (e-h). 
 
 
 
 
 
 
 
 
 
 
 
    
 
The images at 40 eV (c and g) show that the shell of PSHEMA particles with Ru complexes present 
a slight higher contrast in relation to the core in comparison to PSHEMA particles without Ru 
complexes. This affirmation was confirmed by dividing the signal difference between the shell and 
the core by the background signal. All images were converted to gray scale and then to a colored 
(white to red) to facilitate the visualization. 
 
ESI-4 Application of Ru-PSHEMA particles for conjugation with biomolecules using biotin-
streptavidin interaction.  
BSA coated PSHEMA particles were conjugated to streptavidin by adding 0.2 mg of protein to 400 
µL of an aqueous particle dispersion at 3 mg/mL. The suspension was stirred for 30 minutes at RT. 
Subsequently, 1.5 mg of EDC was added and mixed by vortexing and then adjusted to pH 6.5. The 
dispersion was kept on a shaker for 3 h at RT. To separate the protein-labeled particles from 
unbound proteins and EDC molecules, the suspension was centrifuged at 5000 rpm for 5 min at RT 
and washed twice with phosphate buffer 0.01 mol/L, pH 7.6, for 10 min at 4°C. Streptavidin 
particles were used to analyze biotin immobilized onto a glass slide using fluorescence microscopy. 
Amine coated slides were functionalized with albumin by adding a solution containing 5% of BSA 
and 100 mg of EDC in 4 mL of phosphate buffer 0.01 mol/L, pH 6, to the glass slide. The system 
was incubated in a humidity chamber for 1 h. Then, the glass slide was three times washed with 
200 nm 200 nm 200 nm 200 nm
200 nm 200 nm 200 nm 200 nm
50 eV 40 eV 30 eV 
e) 
BF 
f) g) h) 
30 eV 40 eV 50 eV 
a) b) c) d) 
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phosphate buffer 0.01 mol/L, pH 7.4, and dried at RT. Biotin-NHS was diluted in 
dimethylformamide for 1 mmol/L and dilutions from 10-4 to 10-10 mol/L were prepared using 
phosphate buffer 0.01 mol/L, pH 7.4. 2 µL spots from each biotin solution were deposited on the 
albumin coated glass slide and kept in a humidity chamber for 1h at RT. A solution of streptavidin 
monoclonal antibody 0.01 mg/mL containing 0.2 mg of EDC was deposited on the albumin coated 
glass slide and was used as positive control. After 1 h, the glass slide was three times washed with 
phosphate buffer 0.01 mol/L, pH 7.4, and dried at RT. A dispersion of streptavidin coated particles 
1% (w/v) in phosphate buffer 0.01 mol/L, pH 7.4, was deposited onto the glass slide, which has 
then kept in the humidity chamber for 20 minutes. After washing with water, the glass slide was 
dried and kept in the dark until analysis. 
Biotin-streptavidin interaction was chosen as model system due to its extensive use to bind 
molecules such as antibodies and nucleic acids to the detection system, like fluorescent particles. 
Therefore, streptavidin was covalently bound to the PSHEMA particles. Bovine serum albumin was 
firstly immobilized on the particle surface as spacer for the conjugations to avoid conformation 
changes on the protein and to provide better steric accessibility to the forthcoming interaction. An 
amine coated glass slide was functionalized with biotin spots from 1 mmol/L to 0.1 nmol/L and a 
representative scheme of the functionalized glass slide is shown in Figure 1. 
 
Figure 1. Scheme of particle structure (a) showing carboxylate groups used for bioconjugation with proteins and 
antibodies. Bioassay (b) based on streptavidin coated Ru-PSHEMA particles and biotin functionalized albumin glass 
slide. Digital fluorescence images of three spots: (c) 1 mmol/L biotin, (d) 0.01 µmol/L biotin and (e) positive control 
consisting of anti-streptavidin antibody immobilized on the glass slide, 10 µg/mL. The images were taken through a 40 
x microscope objective. 
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 Fluorescent particles attached to biotin-modified glass slides are clearly confirmed by the density 
of fluorescent dots in Figure 1c-e. The density of fluorescent particles per spot increased with the 
increase of biotin concentration immobilized on the glass slide. After 10 nmol L-1, the particle 
density is similar to the observed in the negative control, caused by non-specific adsorption of 
particles on the glass slide. Positive control formed by anti-streptavidin antibody clearly shows high 
number of attached particles in contrast to the negligible number observed in negative control. 
These findings demonstrate that the test succeeds and that PSHEMA particles are successfully 
applied to bioconjugation. An image series is presented in the Figure 2.  
 
Figure 2. Digital fluorescence image of the bioassay on glass slide based on biotin-streptavidin interaction. The 
concentrations of biotin are (a) 1 mmol/L, (b) 0.1 mmol/L, (c) 0.01 mmol/L, (d) 1 µmol/L, (e) 0.1 µmol/L, (f) 0.01 
µmol/L, (g) 1 nmol/L, 0.1 nmol/L, (h) 0.01 nmol/L (e) positive control consisting of anti-streptavidin antibody 
immobilized on the glass slide, 10 µg/mL and (j) negative control formed by amine coated glass slide. The images were 
taken through a 40 x microscope objective. 
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ESI-5 Digital fluorescence images of spots of serum samples after interacting with PSHEMA-Ru 
particles coated with anti-NS1 protein antibodies through (a) absorption and (b) covalent coupling. 
(Magnification: 100x) 
 
 
 
ESI-6 Digital fluorescence images of spots of ten serum samples after interacting with PSHEMA-
Ru particles covalently coated with anti-NS1 protein antibodies. (Magnification: 100x) 
   
The image below is a serum spot detected with fluorescent nanoparticles used in the Chapter 3. 
Those particles show extensive agglomeration and tend to concentrate at the edge of the serum spot. 
Comparing the images of the seum spots with the luminescent particles, it is possible to observed 
the better performance of PSHEMA-Ru particles in comparison to fluorescent polystyrene particles. 
 
a) b) 
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ESI-7 Calculation of the spot intensities for plotting the analytical curve.  
 
Five images were acquired from different areas of each serum spot of the analytical curve: four at 
the edge and one at the center. The image below shows an example of the analyzed area from the 
spot edge and the histograms obtained for each part (spot and background). An average of the mean 
background signal value was subtracted of the spot signal average and used to plot the curve 
according to the NS1 concentration. All images were obtained controlling the source intensity to 
operate at the same conditions and the same areas were analyzed for all spots. 
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Abstract 
Dengue fever is a tropical viral disease that annually affects millions of people in developing 
countries and has a lack of sensitive tools for point-of-care diagnosis. Lateral flow immunoassays 
(LFIAs) are especially interesting for impoverished environments due to the ease of handling, low 
sample volume, low cost and rapid result. However, the challenge of these assays is the low 
sensitivity, which prevents the application for disease diagnostic in the early stages. In order to 
overcome the sensitivity limitation, we describe a novel detection system for LFIA that provides an 
enhanced visual signal based on clusters of gold and fluorescent nanoparticles. The detection 
system consists of gold nanoparticles concentrated in a cluster with antibodies to recognize each 
analyte, instead of only a single colored particle per analyte molecule. Additionally, when the 
colored spot is slightly positive, providing an uncertain result, a UV lamp can be used to excite the 
fluorescent particles containing fluorophores that emit in the visible spectrum. Similar to the gold 
particles, the cluster concentrates fluorescent nanoparticles, which increase the fluorescence 
emission signal. This set up allows improving the detection limit in comparison to current tests. 
LFIA based on nanoparticle cluster was prepared for Dengue fever detection, using a protein of the 
virus, NS1, as target biomolecule for early stage illness detection. These assays showed a detection 
limit, 2.5 ng/mL, for Dengue virus NS1 protein superior to standard gold nanoparticles, 500 ng/mL, 
and carbon black, 10 ng/mL. The clusters showed a detection limit 4 times superior to the best 
colored label for LFIA, carbon black, providing more confident results for early disease detection.  
Keywords 
Lateral flow immunoassay, immunospot assay, carbon black, gold nanoparticles, fluorescence, 
Dengue fever 
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Introduction 
Dengue fever (DF) has emerged as a rapidly spreading vector-borne disease affecting mainly 
poor populations and also the leading cause of hospital admissions in several countries (WHO, 
2010). DF results from viral infection transmitted by Aedes aegypti, a species of mosquito with a 
global distribution.  The incidence of DF has dramatically grown over the world in the last decades. 
Over 2.5 billion people are now endangered from DF. The World Health Organization (WHO, 
2012) estimates 100 million cases of dengue fever, 500 thousand cases of dengue hemorrhagic fever 
(DHF). For DHF, early medical care can save lives, decreasing mortality rates from more than 5% 
to less than 1% (Allwinn, 2011). Due to the low visibility in the rest of the world and limited access 
to interventions and support services, DF is considered as a neglected disease and causes thousands 
of victims every year (Wagstaff, 2002). 
To attend this population in terms of affordable medical assistance, there is an increasing 
necessity for point-of-care (POC) assays that provide fast, specific, sensitive and low cost 
diagnostics. Lateral flow immunoassays (LFIAs) are currently appropriate technologies that fulfill 
most of these requirements. LFIA provides low-cost and fast analysis without trained personnel for 
handling or expensive apparatus for reading (Posthuma-Trumpie et al., 2009). Due to these 
characteristics, LFIA is a good alternative for off laboratory or resource-poor settings. The test 
allows analysis in the field, providing real-time results and avoiding expensive sample 
transportation and long waiting times for results (Bai et al., 2012). Besides human pathogens 
detection, LFIA can be used to detect different analytes and have been applied in various fields, 
such as food analysis (Lai et al., 2009; Kolosova et al., 2008), environmental monitoring (Fisher et 
al., 2009) and forensic diagnostics (Pathak et al., 2001). 
The conventional LFIA employs colloidal gold (Ghandi et al., 2009; Zhang et al., 2011), dyes 
(Ho et al., 2008) or latex beads (Takanashi et al., 2008) as reporters to generate visual signals. An 
investigation indicated that 75% of LFIA have gold nanoparticles as labels for the detection of 
pathogen agents and chemical contaminants, followed by carbon black 4.2%, luminescent particles 
4.2% and others (Ngom et al., 2010). Colloidal gold-based test strips, in particular, have been 
produced commercially in large amounts for a variety of applications (Bai et al., 2012). However, 
the applicability of LFIA is limited when low concentration of analyte should be detected, such as 
in early diagnosis of diseases like Dengue fever. Sensitivity limitations persist on commercial 
systems and reduce their applications, as exemplified for 8 commercial kits for DF based on 
IgG/IgM detection (Blacksell et al., 2006). From all kits, only one showed the necessary specificity 
(97.6%) and sensitivity (65.3%) to be considered of clinical use (>50%). It means that only one test 
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had the proportion of actual positives correctly identified (sensitivity) higher than 50% and the 
proportion of negatives correctly identified (specificity) higher than 50%. The need for tests with 
improved detection limit is not only highlighted for DF, but also for commercially available point-
of-care tests (Fu et al., 2011), such as for Chlamydia (van Dommelen et al., 2010; Skidmore, 2010) 
and influenza (Vasoo et al., 2009; Drexler et al., 2009). 
We recently showed a comparison of the four most used colored labels in LFIA and the results 
revealed that carbon black provides the best detection limit in comparison to gold nanoparticles, 
gold enhanced with silver and blue polystyrene particles (Linares et al., 2012a). Sensitivity in the 
picomolar range was achieved using carbon black, even by visual inspection (Gordon and Michel, 
2008). Carbon black has been applied to detect different analytes (Posthuma-Trumpie et al., 2012), 
such as progesterone (Posthuma-Trumpie et al., 2008), methiocarb in water (Blažková et al., 2009), 
microorganism (Blažková et al., 2011), DNA (Kalogianni et al., 2011). Due to the fact that carbon 
black is cheap and provides good contrast and high sensitivity, it has some disadvantages for LFIA 
applications (Posthuma-Trumpie et al., 2012). It mainly concerns the presence of larger and 
irregularly shaped carbon particles that requires the use of nitrocellulose with larger pore openings 
and it causes relatively low captured ligand concentration/density, resulting in "relative diffuse" 
signal. In addition, some types of carbon with low oxidation require the addition of surfactants to 
obtain stable suspensions in aqueous media and such surfactants may interfere with test 
performance.  
Fluorescent immunoassays are a promising alternative to conventional colorimetric detection 
methods due to their increased sensitivity (Linares et al., 2007, 2012b). Recently a work developed 
by Khreich and co-authors (Khreich et al., 2008) evaluated different labels (colloidal gold, 
fluorescent microsphere, dextrane rhodamine, dye microsphere and liposomes) for Staphylococcus 
aureus enterotoxin B (SEB) detection. Colorimetric labels allowed the detection of SEB close to 0.5 
ng/mL. Colloidal gold was twice as sensitive as the dye microspheres. On the other hand, 
fluorescent microspheres showed better sensitivity than colorimetric labels, resulting in a strong 
increase in sensitivity with limit of detection close to 0.02 ng/mL. 
Although fluorescent labels generally provide lower detection limit, it requires the use of 
fluorescence reader, which is contrary to the concept of a simple assay for impoverished 
environments. Therefore, there have been several attempts trying to enhance the sensitivity of fast 
immunoassays based on visible signal. Horton and colleagues (Horton et al., 1991) reported a 100-
fold reduction of the detection limit via the immersion of a lateral flow strip into a silver 
enhancement solution. Reports include improvements in the detection limit of approximately 10-
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fold, using an enzymatic amplification system (Parolo et al., 2012). However, in these studies, the 
user was still required to perform numerous time-consuming steps, limiting the format 
appropriateness for use as a POC. 
Here, we describe a novel high sensitive detection system for LFIA based on clusters 
constituted by two structures: gold and fluorescent particles. The novel detection system provides 
an enhanced visual signal. Gold nanoparticles are concentrated in a cluster with at least one 
detection molecule to recognize each analyte molecule, instead of only one single gold nanoparticle 
to provide a visual signal for each analyte molecule. The assay performance is also enhanced by the 
combination of colored particles with fluorescent beads. When the colored spot is slightly positive, 
providing an uncertain result, a ultra-violet (UV) lamp or light emitted diode (LED) can be used to 
excite the fluorescent particles and the fluophores will emit in the visible range. Comparable to the 
gold particles, the cluster concentrates fluorescent nanoparticles, which previously concentrate 
fluophores, increasing the fluorescence emission signal. This set up allows improving the detection 
limit in comparison to current tests, which are usually based on single nanoparticles as detection 
label.  
The use of clusters formed by two particles was already described in the literature. Bai and co-
authors (Bai et al., 2012) bound CdTe quantum dots (QD) onto larger silica nanoparticles, which 
increased greatly the fluorescence intensity due to the QD accumulation. However, the silica 
particles were only used as a QD carrier to concentrate the labels and the detection was exclusively 
based on fluorescence. In another study, an immunodipstick assay was developed by Tang and co-
authors (Tang et al., 2009) for the fast screening of aflatoxin B2 (AFT B2) in food. The detector 
reagent consisted of magnetic nanogold microspheres (MnGMs) with nano- Fe2O3 particles as core 
and gold nanoparticles as shell, and bio-functionalized with monoclonal anti-AFT B2 antibodies. 
Result showed that the cutoff detection value was 3 times lower than gold nanoparticles at 0.9 
ng/mL AFT B2. However, the Fe2O3 nanoparticles act as a substrate for the assembly of gold 
nanoparticles and did not played a direct role in the signal intensification. 
Herein, we describe the development of a lateral flow immunoassay, which combines both gold 
and fluorescent nanoparticles in a cluster as detection labels for Dengue fever diagnostics. The 
target molecule is the non-structural (NS1) protein of the virus, which is released in the blood 
stream on the first days of the infection after the outbreak of the symptoms. In order to compare the 
performance of our combined colorimetric/fluorescent assays, we produced LFIA for DF detection 
based on gold nanoparticles and carbon black, as the most sensitive colorimetric label for LFIA. 
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Materials and Methods 
 
Chemicals and Materials  
 
Gold nanoparticles (mean diameter: 40 nm), bovine serum albumin (BSA) powder, biotin, 
streptavidin, boric acid, anti-streptavidin IgG antibody, N-(3-Dimethylaminopropyl)-N′-
ethylcarbodiimide hydrochloride (EDC), dialysis membranes (MWCO 100kDa and 130kDa), 
sucrose, potassium phosphate mono- and dibasic were purchased from Sigma-Aldrich (Milwaukee, 
USA). Streptavidin-labeled gold nanoparticles (mean diameter: 40 nm) was purchased from British 
Biocell (Cardiff, United Kingdom). FluoSpheres (PS) carboxylate-modified microspheres 
(excitation: 580 nm/ emission: 605 nm, see SI-1) 0.04 µm, and nitrocellulose AC99 membrane were 
obtained from Invitrogen (Carlsbad, United States) and Whatman (Maidstone, United Kingdom), 
respectively. Sample and conjugate pad were obtained from Pall (Dreieich, Germany). Absorbent 
pad and backing card were provided from Millipore (Billerica, USA) and Lohmann (San Jose, 
USA). Dengue virus NS1 glycoprotein mouse monoclonal antibody (supernatant) and Melon gel 
IgG purification kit were obtained from Abcam (Cambridge, United Kingdom) and Thermo 
Scientific (Rockford, United States), respectively. Dengue NS1 Ag ELISA was purchased from 
Standard Diagnostics (Youngin, Korea). The solutions were prepared with water purified in a Milli-
Q Millipore system and the actual pH of the buffer solutions was determined with a Cyberscan pH 
meter model 500 (Queensway, Singapore). 
 
Serum samples 
 
A total of 48 serum samples were obtained by the São Paulo Institute of Tropical Medicine, 
University of São Paulo. The tests were approved by the ethics committee from the university. The 
samples were analyzed for NS1 using the commercial kit Platelia™NS1 (Biorad Laboratories, 
Marnes-La-Coquette, France). The Dengue diagnostic procedure is described in the supplementary 
information. 
 
Preparation of gold- and polystyrene-nanoparticle protein conjugates 
 
Gold nanoparticle dispersions at 15% were adjusted to pH 8 with NaOH 0.01M and 30 μL of an 
albumin solution at a concentration of 1 mg/mL was added to 0.3 mL of the gold dispersion. The 
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mixture was stirred for 30 min, and then, to remove the excess of proteins, it was centrifuged at 
5000 rpm for 15 min at 4 ºC. The clear supernatant was carefully removed, and the precipitated gold 
conjugates were resuspended in 400 µL of 0.01M phosphate buffer, pH 7.4, and stored at 4 ºC. Gold 
nanoparticles conjugated with NS1 antibody was produced by following the same procedure. 
Albumin coated polystyrene nanoparticles were prepared as described by Linares and coauthors 
(Linares et al., 2012b).  
 
Preparation of gold-polystyrene nanoparticle clusters  
 
Colloidal gold and fluorescent particles, previously coated with albumin, were covalently bound 
by forming a peptide bond between albumin molecules using water-soluble carbodiimide to activate 
the surface carboxyl groups. Clusters were produced containing a gold:polystyrene nanoparticle 
ratio of 80:20, 60:40, 40:60, 20:80 (wt. %). For instance, to produce clusters with 80:20 (wt. %) of 
gold:PS, 300 µL of gold nanoparticles at 15% of solids was mixed with 562 µL of PS nanoparticles 
at 2% and incubated during 30 minutes in a shaker at RT. Both particles were dispersed in 
phosphate buffer 0.01M, pH 6. Subsequently, 2 mg of EDC was added to the suspension and 
incubated for 3 hours at RT. After, the suspension was centrifuged twice at 3000 rpm for 2 minutes 
and washed with 0.01M phosphate buffer, pH 7.4. The suspension was kept 48h hours in a black 
box and 600 µL were removed from the upper part of the dispersion (avoiding precipitates). The 
removed clusters were deposited on 1 mL of 1 mol/L sucrose solution in a centrifuge tube and 
centrifuged at 13000 rpm at 4ºC for 45 min. An aliquot of 100 µL was removed from the top and 
the rest was divided in two aliquots. The aliquot on the upper part was used for the assay after 
washing steps with phosphate buffer 0.01M, pH 7.4. 
 
 Cluster functionalization with biomolecules 
 
Clusters were conjugated to streptavidin and monoclonal NS1 Dengue antibody. An aliquot of 
200 µL of cluster dispersion 80:20 gold:PS was added to 500 µL of a 0.5 mg/mL solution of protein 
dissolved in 0.01 phosphate buffer, pH 6. The suspension was incubated for 30 minutes at RT. 
Subsequently, 1 mg of EDC was added and mixed by vortexing and the pH was adjusted to 6.5 with 
diluted NaOH. The dispersion was incubated on a shaker for 3 hours at RT. To separate the protein-
labeled clusters from unbound proteins, the suspension was centrifuged three times at 3000 rpm for 
30 minutes at RT. The final suspension was kept in a phosphate buffer containing 1% BSA. A 
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scheme of the cluster preparation is shown in the Supplementary Information (SI-2). 
 
 Preparation of carbon black bioconjugates 
 
Carbon black–streptavidin and carbon black–NS1 monoclonal antibodies covalently bound 
particle-conjugates were prepared according to Rayev and co-authors (Rayev et al., 2008) with 
modifications described by Linares and co-authors (Linares et al., 2012). 
 
Strip tests and immunospot assay 
 
Before setting up the strip test for clusters, all used membranes received different treatments: 
the sample pad was dipped into 0.01M phosphate buffer, pH 7.4, containing with 5% BSA and 
0.05% Tween20 and dried for 2 hour at 60ºC; the conjugate pad was previously immersed in 
1mmol/L borate buffer, pH 9, with 10% of sucrose, and then clusters at 5% (w/v) was deposited and 
dried at RT; anti-NS1 protein antibody and biotinylated-albumin at a concentration of 1 mg/mL in 
0.01 M phosphate buffer, pH 7.4, were spotted onto nitrocellulose to form the detection and control 
lines by using Dimatix printer from Fujifilm (Santa Clara, USA). BSA was biotinylated according 
to Guesdon and co-authors (1979). The detection pad was dried at RT; and the absorbent pad was 
used as received. Subsequently, all membranes were laminated on the backing card with an overlap 
of 2 mm between them. The membranes were cut at 4 mm wide. Serum samples were analyzed by 
adding 100 µL on the sample pad. When the flow stopped, 100 µL of 0.01 M phosphate buffer at 
pH 7.4 was added. The same buffer was used as blank. Analysis was perfomed after 25 min. 
For the carbon black LFIA, the nitrocellulose was prepared as described for the LFIA. In this 
case, only the nitrocellulose and absorbent were laminated on the backing card. An aliquot of 50 µL 
of serum sample was added to a microplate well and one extremity of the LFIA was immersed in it. 
After 10 minutes, the assay was positioned in another well containing 10 µL of 2% streptavidin 
coated carbon black and 30 µL of 2% anti-NS1 protein antibody coated carbon black. The test was 
removed again after 10 minutes and immersed in a well containing washing buffer for at least 5 
minutes. The washing buffer contains 0.1 mol/L of borate buffer at pH 8.5, 1% (w/v) BSA, 1% 
(v/v) Tween20, 10% (w/v) sucrose and 0.9% (w/v) sodium chloride.  
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Atomic force microscopy (AFM) analysis 
 
Particle dispersion was 10 min sonicated and rinsed on a glass slides resulting in a 0.01% 
dispersion of solid components. Particles were analyzed using an AFM (JPK Nanowizard 1, Berlin, 
Germany) in intermitent contact mode with 100 mm xy-scan range and 15 nm z-scan range and Si 
tips NSC 15 with 40 N/m spring constant from Mikromasch (Las Rozas de Madrid, Spain). Images 
were processed using JPK SPM Software (version 3.1 10/07) and Gwyddion 2.19. 
 
Transmission electron microscopy 
 
Images were also acquired using a Carl Zeiss Libra 120 kV transmission electron microscope 
(TEM) equipped with omega filter. Energy-filtered transmission electron microscopy (EFTEM) was 
used to obtain bright-field images with low chromatic aberration when the energy slit was selected 
to zero. Elemental map was acquired imaging inelastically scattered electrons by electron 
spectroscopy imaging (ESI). Energy selecting slits of 5eV were set at energy losses of carbon (303 
eV). The images were recorded using a CCD camera and iTEM Universal TEM Imaging Platform. 
Samples were prepared by drying aqueous suspension droplets of gold and polystyrene 
nanoparticles, besides of clusters on carbon-coated parlodium films supported in 400-mesh copper 
grids (SPI supplies, West Chester, USA). 
 
Results and Discussion 
 
In order to produce a simple, fast, reliable and sensitive assay for Dengue fever detection, we 
developed a LFIA based on nanoparticle cluster as detection label. The clusters are formed by 
combining gold and fluorescent nanoparticles in a single structure. Gold and fluorescent 
nanoparticles were characterized using atomic force and transmission electron microscopy.  
AFM non-contact image of the gold nanoparticles is depicted in Figure 1a and shows well 
dispersed particles with average diameter of 39 ± 5 nm. On the other hand, fluorescent 
nanoparticles (Figure 1b) demonstrate a slight aggregation likely occurred during the drying process, 
besides single particles. Dynamic light scattering measurements did not indicate aggregation with 
particles in solution (results are not shown). The particles have a mean diameter of 38 ± 8 nm. 
When AFM images are obtained for the clusters, bigger agglomerates are obtained in comparison to 
the fluorescent nanoparticles indicating successful coupling of nanoparticles. 
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Figure 1. Microscopic characterization of nanoparticles and clusters. Atomic force microscopy images of (a) gold 
nanoparticles, (b) polystyrene nanoparticles and (c) cluster of gold and polystyrene nanoparticles. Transmission 
electron microscopy images of clusters (d) bright field, (e) 25 eV image and (f) carbon spectra of the background and 
the polystyrene particles. 
 
TEM was used to provide more chemical information about the clusters. Bright field image and 
carbon map from the same area are depicted in the Figure 1d and 1e, respectively. Black particles in 
the bright field image are consisted by gold due to its higher atomic number in comparison to 
polystyrene nanoparticles. It is possible to observe small agglomerates consisted by gold-gold, 
gold-polystyrene and polystyrene-polystyrene. Carbon map indicates all materials containing 
carbon atoms in their composition with an intense bright signal. Hence, it demonstrates that there is 
organic material around the gold nanoparticles likely formed for biomolecules from the 
bioconjugation, as well as observed for the polystyrene nanoparticles evidenced by undefined 
borders around the particles. The agglomerates consisted by gold and polystyrene show their 
organic shell of biomolecules in contact, suggesting interactions between particles with different 
nature. The carbon map is confirmed by the electron energy loss spectroscopy (EELS), which 
shows the high intensity of carbon signal for the polystyrene nanoparticles in comparison to the 
parlodium background. 
In order to achieve reproducible results, the cluster preparation needs to be controlled in terms 
of cluster composition. This task is not easy, but it is possible to have fractions that produce useful 
results. For that reason, they were centrifuged and two fractions were removed and analyzed. For 
these analyses, low energy loss TEM was used due to better resolution and less sample damage than 
in the high energy loss.  
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Figure 2. Transmission electron microscopy of clusters after separation. Bright field images of (a) gold nanoparticles, 
(b) polystyrene nanoparticles and (c) low energy loss spectra of gold and polystyrene nanoparticles. Bright field (d) 
and 25 eV energy loss (e) from the same area showing better resolution for polystyrene nanoparticles observation. 
Cluster images (e-g) at 25 eV of the fraction used in lateral flow tests and images (h and i) of the removed fraction of 
clusters. 
 
Spectra from EELS were obtained for gold (Figure 2a) and polystyrene (Figure 2b) 
nanoparticles from the areas indicated in the images and are depicted in the Figure 2c. Polystyrene 
spectrum has higher intensity at the low energy loss than gold, and hence it will appear brighter in 
the energy image. The bright field (Figure 2d) and its respective image at 25 eV (Figure 2e) show 
clearer that polystyrene particles are poorly observed at bright field but better observed in the low 
energy loss image. The acquisition of maps at the low energy loss, also known as molecular maps 
(Linares et al., 2009, 2010) allows obtaining images with better resolution than bright field and 
fewer damages to the sample in comparison to high energy loss range. The first fraction (from up to 
down in the centrifuge tube) concentrates smaller clusters as observed in the Figures 2e-g, where it 
is possible to observe cluster up to 5 particles with mixed composition. The images from the second 
fraction indicate the presence of bigger clusters with variable composition and format. Tests with 
Chapter 5 
 
117 
 
each fraction showed that the first fraction produces better signal and reproducibility. 
In order to use the immunoassay based on carbon black, the nanoparticles were analyzed by 
AFM and the image is shown in the Figure 3. 
                 
Figure 3. Microscopic characterization of carbon black. Atomic force microscopy non-contact image of carbon black.  
 
It indicates that the carbon black nanoparticles tend to agglomerate in clusters from 400 to 2 µm. 
The particles have a mean diameter of 150 ± 48 nm. The microscopic characterization of the gold-
nanoparticle and carbon black cluster are essential to understand and develop the immunoassays. A 
scheme of both assays is represented in the Figure 4. 
The immunoassay with detection system based on carbon black is shown in the Figure 4a. The 
assay has a format of a LFIA, but one extremity is immersed in the serum sample. The test is 
formed by two parts: nitrocellulose membrane, where the test (monoclonal anti-NS1 antibody) and 
control (anti-streptavidin antibody) lines are deposited; and the absorbent pad, where the excess of 
liquid is absorbed and guarantee the flow of liquid through the membrane. Firstly the stick is 
immersed in the serum sample, and then the NS1 protein can flow through the sample and reaches 
the test line where it is trapped by the anti-NS1 capture antibody. The membrane does not only act 
as the support for the biomolecules, but also as a filter for the sample. Secondly the test is immersed 
in the carbon black dispersion and the anti-NS1 detection antibody previously immobilized on 
carbon black nanoparticles interact with the NS1 protein and forms the black line on the test, 
indicating the positive result for Dengue fever (Figure 4b). 
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Figure 4. Scheme of the developed lateral flow immunoassays. LFIA based on carbon black (a)  in a microplate after 
dipping one extremity in the serum, carbon black dispersion and washing buffer solution. Zoom of the test line (b) 
showing the carbon black agglomerate bound to the NS1 protein previously immobilized on the nitrocellulose 
membrane. Lateral flow immunoassay (c) based on gold-polystyrene nanoparticles clusters and zoom of the test line (d) 
showing the cluster bound to the NS1 protein previously immobilized on the nitrocellulose membrane. 
 
In addition, streptavidin-carbon black conjugates added to the nanoparticles dispersion bind to 
the anti-streptavidin antibody and create the black control line, indicating a properly working test 
and positive control. The last step involves the immersion of the assay in a washing buffer, which is 
responsible for helping the flow of the carbon black nanoparticles, besides removing unspecific 
nanoparticles and cleaning the nitrocellulose membrane. It assures a better signal to noise ratio and 
lower detection limit. The LFIA with immersion in the sample format was preferred in relation to a 
conventional lateral flow test due to the microscopic characteristic of the carbon black agglomerates. 
As shown in the Figure 3, carbon black forms agglomerates up to 2 µm of mean diameter and this 
agglomeration is even intensified in the porous nitrocellulose membrane. Hence, this test avoids 
drying the conjugates on the membrane and provides better performance. 
Lateral flow immunoassay format was chosen as result of the gold-fluorescent cluster structure. 
This test consists of four parts: the first membrane is the sample pad where the sample is applied 
and filtered; then the liquid flows to the second membrane and the protein NS1 binds to the anti-
NS1 protein detection antibody previously immobilized on the cluster surface; the cluster-protein 
complexes flow through the nitrocellulose membrane and bind to the anti-NS1 capture antibody, 
forming the red-fluorescent line indicative of a serum sample positive for Dengue fever (Figure 4d); 
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the last pad is an absorbent membrane. The control line is also constituted of streptavidin coated 
cluster bound to biotin-albumin on the nitrocellulose membrane. 
In order to evaluate the performance and detection limit, the assays based on clusters, gold and 
carbon black were tested with different concentrations of NS1 protein and the pictures are shown in 
the Figure 5. 
 
 
Figure 5. Lateral flow immunoassay and immunospot assay for Dengue virus NS1 protein detection. Pictures of the 
LFIA based on clusters (a) under UV light (b), gold nanoparticles (c) and carbon black (d). Immunospot assay based on 
clusters (e) under UV light (f).  
 
LFIA based on clusters (Figure 5a) shows a visible signal up to 10 ng/mL, but when the strip 
tests are under UV light, the detection limit achieves lower values, up to 2.5 ng/mL. In order to 
compare the clustering effect on the detection limit, LFIA based on gold nanoparticles were built 
and depicted in the Figure 5c. It shows a visible test line until 500 ng/mL, once the signal at 250 
ng/mL is barely observable. On the other hand, carbon black assay (Figure 5d) demonstrates a 
detection limit, 10 ng/mL, superior to gold nanoparticles, but comparable with the visible signal of 
the clusters. Accordingly, gold-fluorescent nanoparticles cluster provides comparable sensitivity to 
one of the best colored labels, carbon black, and even shows additional sensitivity provided by the 
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fluorescent nanoparticles. Thus, if the colored sign is slightly positive, indicating uncertain result, a 
lamp/LED can be used to excite the fluorescent particles and the fluorophores will emit in the 
visible spectrum. Additional results for an immunospot assay based on clusters are shown in the 
Figure 5e and 5f. A panel with 48 samples of Dengue infected patients were deposited on 
nitrocellulose and detected with gold-fluorescent nanoparticles cluster. The pictures indicate that the 
fluorescent nanoparticles provide an additional signal that contributes to a more reliable assay. 
Based on the exposed results, nanoparticle clusters represent a powerful option to overcome 
sensitivity limitations of LFIA. 
 
Conclusion 
 
The detection system based on gold-fluorescent nanoparticles cluster for LFIA provides an 
enhanced visual signal, because gold nanoparticles are concentrated in a cluster with NS1 protein 
antibodies to recognize the protein, instead of only a single colored particle per analyte. 
Furthermore, the signal is enhanced by combining colored particles with fluorescent beads. When 
the colored spot is slightly positive, providing an uncertain result, an UV lamp or LED can be used 
to excite the fluorescent particles and the fluorophores will emit in the visible spectrum. Similar to 
the colored particles, the cluster concentrates fluorescent beads, increasing the fluorescence 
emission signal. This set up allows improving the detection limit in comparison to current labels, 
which are usually based on single colored nanoparticles or carbon black. 
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SI1 – Fluorescence spectrum of the polystyrene particles 
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SI2 – Scheme of preparation and bioconjugation of gold/fluorescent nanoparticle clusters: (a) 
reaction between the carboxylated nanoparticles and albumin and (b) interaction among the albumin 
coated particles to form the cluster. 
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  SI3 – Dimensions of a conventional lateral flow immunoassay and for a lateral flow immunoassay 
with immersion in the sample. 
 
 
 
SI4 – Scheme of the immunospot for NS1 protein detection based on gold-polystyrene nanoparticle 
cluster. 
          
     
 
For mutiple tests, 4 µL of serum (a) was deposited on the nitrocellulose membrane (7cm x 10cm) 
with 15 mm spacing between each spot to avoid contamination and checking the alignment between 
them to fit on the wells of an ELISA microplate. This sample volume was the minimum volume 
necessary to observe a clear result. After 10 minutes, a blocking solution containing BSA 3% in 
phosphate buffer 0.01 mol/L, pH 7.4 was added to cover the entire membrane for 15 minutes at RT. 
Subsequently, the blocking solution was removed and 3 mL fluorescent conjugates 1% in phosphate 
buffer 0.01 mol/L, pH 7.4 was added and incubated for 30 minutes (b). Scheme of interaction is 
shown in (c). 
(a) (b) (c) 
Conclusion 
 
126 
 
Conclusion and outlook 
 
In order to enhance the detection limit and applicability of immunoassays for uses in 
impoverished environments, different nanostructures were evaluated and tested as labels for Dengue 
fever infection detection. An increase in sensitivity can only be achieved by changing the detection 
label, if the best available antibody and the best combination of materials are already being used. 
The detection limits and signal intensity were compared among the four most used labels: gold, 
silver enhanced gold, blue latex bead and carbon black nanoparticles. The results indicate carbon 
black as a suitable colorimetric label for lateral flow immunoassays with a detection limit fifty 
times lower than obtained with standard gold nanoparticles. This higher sensitivity motivated its use 
to improve strip test detection.  
An immunoassay for multiple analyses in epidemic periods was developed as an alternative for 
the time-consuming ELISA procedure. The assay combines principles of ELISPOT and FLISA and 
uses nitrocellulose as support membrane and commercial fluorescent nanoparticles as labels. This 
immunospotting assay shows detection limits hundred times lower than standard gold nanoparticles 
for Dengue fever detection, besides rapidity and lower cost in comparison to ELISA. 
The current problem of polymer particle agglomeration in LFIA and ISA limits the label 
performance, and consequently affects the sensitivity, reproducibility and reliability. The one-step 
synthesis of luminescent [Ru(4,4’-dicarboxilate-2,2’-bpy)3] labeled poly[styrene-co-(2-
hydroxyethyl methacrylate)] core-shell particles was a further step to develop low agglomeration 
structures that can be applied as labels in immunoassays. These particles provide more 
homogeneous visual signal in comparison to commercial polymer particles based on polystyrene. 
Finally, a label that combines the ease of optical visualization of gold nanoparticles with the 
high sensitivity of fluorescent nanoparticles was developed. The cluster formed by these 
nanostructures provides an enhanced visual signal, because gold nanoparticles are concentrated in a 
single structure and an additional enhancement is offered by fluorescent beads. When optical 
detection finds a sensitivity limitation, providing an uncertain result, an UV lamp or LED can be 
used to excite the fluorescent particles and to show a signal in the visible spectrum. This set up 
allows improving the detection limits by two hundred times in comparison to current assays based 
on gold nanoparticles.  
The combination of different detection systems and principles of different assays can produce 
fast and high sensitive tests, which are suitable for impoverished environments and epidemic areas. 
In terms of applicability for early disease detection, these improvements provide immunoassays 
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with sensitivity enough to diagnose a patient with Dengue fever on the first day of infection, which 
is crucial in severe cases. I therefore conclude that sensitivity limitations can be overcome by using 
different approaches suggested in this thesis.  
A careful screening of detection labels should be performed as a necessary step during an 
immunoassay development in order to enhance the detection limit in a final test system. These 
results can facilitate the development of immunoassays in terms of the suitable label choice in order 
to achieve a necessary sensitivity. 
 
Drawback of the investigated labels 
 
Despite improvements of immunoassay sensitivity described in this thesis, there are a number 
of issues that require more experiments and further development.  
Carbon black particles are very promising as cheap and sensitive labels (Chapter 2 and 5); 
however the particles agglomerate in the conjugate membrane during the drying process and remain 
agglomerated during sample flow. It avoids the use of conventional lateral flow immunoassay set 
up and requires additional steps during operation in the field. Different carbon black particle 
sources and chemical treatment (surfactants, polymers etc) were used to overcome the problem, but 
the overall chemical adjust was disturbed and additional problems were created. For example, 
surfactants solved partially the agglomeration problem, but they were responsible for spreading the 
test and control lines. As a result, the antibodies in the lines were not covalently bound to the 
membrane, and therefore were detached from the nitrocellulose during the sample flow. Further 
experiments could be performed to overcome the agglomeration problem, including more detailed 
screening or controlled production of carbon black particles and use of different sets of conjugate 
and reaction membranes. A commercial system can be even developed using more than one step, 
but the design and the operation should remain simple, user-friendly and cheaper, as suggested by 
the WHO. 
High sensitivity, rapidity of analysis and detection equipment versatility were obtained with 
fluorescent particles as labels for the immunospot assay (Chapter 3). Although it showed many 
advantages in comparison to conventional ELISA or FLISA, the use of equipment is not favorable 
when the assay must be performed in laboratories with low resources. Therefore, assays based on a 
UV-lamp or a LED are cheap and appropriate alternative. In this work, an UVB lamp was used to 
excite the fluorophores with high intensity emission based on the usual available equipment in 
impoverished clinical laboratories. The lamp emission does not peak on the fluorophore excitation 
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maximum, only exciting it in the tail excitation band. Further experiments with particles containing 
fluorophores with larger Stokes shift could allow getting closer to the fluorophore excitation 
maximum and consequently reducing the detection limit (200 ng/mL of NS1 protein based on the 
UVB) and enhancing the sensitivity (59%) based on the UVB (See below Future general 
improvements for LFIA and ISA). 
PSHEMA particles (Chapter 4) demonstrated good performance for paper based immunoassays. 
The particles have very important characteristics as a diagnostic tool label: they show low 
agglomeration and ease of bioconjugation, they are monodisperse and surfactant free. However, the 
detection limit obtained with the particles is inferior to the commercial luminescent particles. 
Further experiments should be performed in order to produce higher luminescent particles by 
increasing the HEMA/styrene ratio in the reaction allowing more Ru complex incorporation, or use 
of soaked hydrophobic dye as emitter or incorporation of fluorophores with higher quantum yield. 
Gold-fluorescent nanoparticle clusters (Chapter 5) showed lower detection limit in comparison 
to all other tested labels. The use of two particle kinds combines the practical colorimetric detection 
with high sensitivity from fluorescence. Further experiments can be focused on more precise 
composition control and stability over time. 
 
Future general improvements for LFIA and ISA 
 
In addition to the progress achieved with the presented results in this work, current available 
technologies used in other fields can be used to improve paper based immunoassays and lead them 
to a more reliable tool for point-of-care testing.  
Following the arrangement of these assays, several limitations have been described about 
contaminants that cross-react with the detection molecules and show false-positive results. To avoid 
this interference, the sample should receive a pre-treatment to remove these compounds and this 
step must be incorporated in the assay for keeping simplicity. Therefore, technologies available for 
polymer reinforcement with coupling reaction of glass fibers into polymer matrix can be very useful 
for use as sample pad in LFIA/ISA. The sample pad is responsible for filtering undesired material 
from the sample. Currently this step is restricted to solid filtering, but it can be extended to a 
chemical trap by changing the chemical functionalities of the membrane. Specific proteins can be 
covalently bound to the membrane, removing undesired compounds. 
The next challenge is associated with the labels used in the detection systems. The label choice 
is crucial to the assay sensitivity, as extensively discussed in this thesis, and requires a specific 
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knowledge of the sample and the necessary detection limit. Fluorescent labels incorporated in 
particles are very promising for high sensitive tests, but the fluorophores must be carefully chosen 
to provide high emission and to avoid interference with the sample and membrane fluorescence 
(background). For unskilled operators, misinterpretation may happen if the person is not able to 
separate the sample signal from the background signal, which has different emission wavelength 
(color). Chemiluminescence is very promising in terms of sensitivity and no background 
interference. Another interesting option is the technology of near infrared upconversion 
fluorescence resonance energy transfer. This process allows exciting a compound at the infrared 
range and reading out at the visible range, eliminating background interference.  
Although numerous methods are very sensitive, the use of enzymes to catalyze reaction with 
colored products is still the most used sensitive detection method for immunoassays (e.g. ELISA). 
On the other hand, its use in point-of-care immunoassays is limited due to the harsh environmental 
conditions where the tests must be operated. For example, Dengue endemic regions are normally 
located in tropical regions that have high temperature, exceeding 30ºC. The storage and operational 
conditions can affect the enzyme structure and activity. Therefore, the stabilization of enzymes can 
extend their application to field uses. A recent collaboration with Prof. Thomas Bein’s group 
(Department of Chemistry, Ludwig Maximilians Universität) aims to use whole enzymes or enzyme 
active sites incorporated in mesoporous silica particle as label for LFIA. Up to date results promise 
to overcome enzyme stability problems and even enhance the sensitivity of immunoassays. The 
“synthetic enzymes” have the potential to combine the high sensitivity of ELISA with LFIA 
advantages for reliable field analysis. 
Molecule stability is not only a challenge for enzymes but it is also an issue for antibodies. 
Depending on the environment conditions, antibodies show inappropriate performance, disabling 
the test. Hence, plastic antibodies can be a solution for LFIA that must be operated in harsh 
conditions. The technology uses the principles of molecular imprinting polymer, where 
polymerization of monomers is performed in the analyte presence. Complementary functional 
monomers polymerize around the analyte and create a template of the molecule in the polymer 
matrix, after its extraction. This mimics an antibody structure, but involved in a very robust polymer 
matrix. The polymers can be produced as colloidal structures with dye incorporation and used as 
labels for LFIA. Plastic antibodies increase the stability and even reduce the assay cost. 
In cases where the price is the bottle neck for LFIA application, the costs from the most 
expensive part, the antibodies, should be reduced. Besides plastic antibodies, immunoglobulins 
produced by plants can be very promising. The technology is still in the beginning, but it shows 
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high potential for cheap antibody production. 
 
Future prospects for Dengue fever diagnostics 
 
Early Dengue fever detection is now possible given the results presented in this work. 
Although NS1 protein detection provides early disease diagnosis, it is only sensitive in the early 
phase of infection and therefore it is not suitable for sole use in dengue-endemic settings where late 
clinical presentations may occur. Hence, a complete immunoassay for Dengue fever diagnosis 
should combine NS1 protein and IgM antibody detection. Patients with secondary or later dengue 
infections are considered to have an increased risk of the more severe forms of the disease. The 
accurate detection of primary and secondary infection at presentation to a clinical facility may 
become a promising patient management tool. It is possible to differentiate primary and secondary 
dengue virus infections using the following criteria: (1) acute primary dengue virus infection 
defined as an IgM-positive and IgG-negative (IgM+/IgG−) result and (2) acute secondary dengue 
virus infection defined as IgM-positive and IgG-positive (IgM+/IgG+) or IgM-negative and IgG-
positive (IgM−/IgG+) results. More precise results can be obtained by semi-quantitative IgM/IgG 
ratio detection. A simple colored scale bar could provide the necessary quantification. Based on that, 
a sensitive NS1 protein detection system combined with semi quantitative detection of IgM/IgG 
ratio is a powerful tool for point-of-care testing for Dengue fever diagnosis. 
To take evidence based decisions about the usefulness of this test in clinical settings, it is 
recommended to assess its performance in consecutive patients with potential dengue infection 
under routine conditions at health centers with different levels of complexity. Further studies are 
required to assess the potential impact of implementing early laboratory diagnosis of dengue in 
terms of prognosis and cost-effectiveness. In order to further strengthen the current diagnostic 
accuracy estimates, prospective recruitment studies are required in different dengue-endemic 
locations, where there are variations in dengue infection status, days of illness, and prior to 
presentation. Further studies are also required to examine some of the more practical aspects of 
dengue immunoassay performance that includes the influence of operator training, interoperator 
variation, and ease of use of the assays.  
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List of abbreviations 
A: absorbance 
A’: cross sectional area perpendicular to flow 
Ab: antibody 
AFM: atomic force microscopy 
Ag: antigen 
ASSURED: Afordable, Sensitive, Specific, User-friendly, Rapid and Robust, Equipment-free, 
Delivered to those who need it. 
b: path length 
Bpy: bipyridine 
c: concentration 
DF: dengue fever 
DHF: dengue hemorrhagic fever 
DL: detection limit 
DV: dengue virus 
E: electronic energy state 
EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EFTEM: energy filtered electron microscopy 
ELISA: enzyme linked immunosorbent assay 
ELISPOT: enzyme linked immunospotting 
ESI: electron spectroscopy imaging 
Fab: antigen-binding fragment 
Fc: crystallizable fragment 
FITC:  fluorescein isothiocyanate 
FLISA: fluorophore linked immunosorbent assay 
GS: ground state 
Ig: immunoglobulin 
IgA: immunoglobulin type A 
IgD: immunoglobulin type D 
IgE: immunoglobulin type E 
IgG: immunoglobulin type G 
IgM: immunoglobulin type M 
ISA: immunospot assay 
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ISC: intersystem crossing 
K: permeability 
K’: constant that depends on the efficiency quantum of the fluophore 
k: rate constant 
L: liquid height 
LED: light emitting diode 
LF: ligand field 
LFIA: lateral flow immunoassay 
LSPR: localized surface Plasmon resonance 
mAb: monoclonal antibody 
NHS: N-hydroxysuccinimide 
NS1 protein: non-structural protein 1 
NP: nanoparticles 
P: light beam 
PEG: polyethylene glycol  
PSHEMA: poly(styrene-co-2-hydroxyethylmethacrylate) 
PSHEMA-Ru: poly(styrene-co-2-hydroxyethylmethacrylate) containing ruthenium complex PVA: 
polyvinylalcohol  
PVP: polyvinylpyrrolidone 
Q: volumetric flow rate 
R: Ab-Ag complex 
r: effective pore radius 
RT-PCR: real-time polymerase chain reaction 
T: transmittance 
TEM: transmission electron microscopy 
TRIS: tris(hydroxymethyl)aminomethane 
UV: ultraviolet 
WHO: World Health Organization 
ΔP: pressure gradient 
: molar absortivity 
: surface tension 
: solution viscosity 
: contact angle 
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